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ABSTRACT OF THE DISSERTATION 
DURABILITY ASSESSMENT OF POLYMER TRILEAFLET HEART VALVES 
by 
Siobhain Lynn Gallocher 
Florida International University, 2007 
Miami, Florida 
Professor Richard T. Schoephoerster, Major Professor 
The durability of a polymer trileaflet valve is dependent on leaflet stress 
concentrations, so valve designs that reduce stress can, hypothetically, increase 
durability.  Design aspects that are believed to contribute to reduced leaflet stress include 
stent flexibility, parabolic coaptation curvature, and leaflet anisotropy.  With this in mind, 
the purpose of this investigation was to elucidate what specific combinations of these 
parameters promote optimal acute and long-term valve function. 
  A combination of four stent designs, seven leaflet reinforcement materials, and 
three coaptation geometries were evaluated through a combination of experimentation 
and modeling.  Static tensile and Poisson’s ratio tests and dynamic tensile fatigue testing 
were used to evaluate the individual leaflet components; and hydrodynamic testing and 
accelerated valve fatigue was used to assess complete valve prototypes.  The two most 
successful designs included a 0.40 mm thick knit-reinforced valve with a fatigue life of 
10.35 years, and a 0.20 mm thick knit-reinforced valve with a 28.9 mmHg decrease in 
pressure drop over the former.  
A finite element model was incorporated to verify the impact of the above-
mentioned parameters on leaflet stress concentrations.  Leaflet anisotropy had a large 
 vii
impact on stress concentrations, and matching the circumferential modulus to that of the 
natural valve showed the greatest benefit.  Varying the radial modulus had minimal 
impact.   Varying coaptation geometry had no impact, but stent flexibility did have a 
marked effect on the stress at the top of the commissure, where a completely rigid stent 
resulted in a higher peak stress than a flexible stent (E = 385 MPa). 
In conclusion, stent flexibility and leaflet anisotropy do effect stress 
concentrations in the SIBS trileaflet valve, but coaptation geometry does not.  Regions of 
high stress concentrations were linked to failure locations in vitro, so a fatigue prediction 
model was developed from the S/N curves generated during dynamic tensile testing of 
the 0.20 mm knit-reinforced leaflets.  Failure was predicted at approximately 400 million 
cycles (10 years) at the top of the commissure.  In vitro fatigue of this valve showed 
failure initiation after approximately 167 million cycles (4.18 years), but it was related to 
a design defect that is subsequently being changed.    
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1. INTRODUCTION 
1.1. General Statement of Problem Area 
Diseased and dysfunctional heart valves are routinely repaired or replaced through 
surgical intervention.  If damage is too severe to enable valve repair, the native valve is 
replaced by a prosthetic valve.  According to the 2006 American Heart Association 
Statistical Update [1], an estimated 95,000 inpatient valve procedures were performed in 
the United States alone during 2003, with the majority of the patients over the age of 65.  
The average cost per procedure was $118,656 and the in-hospital death rate was 5.6%.  
Commercially available prosthetic valves are either mechanical or bioprosthetic in 
nature.  The designs of mechanical valves available today include the tilting disc and the 
bileaflet valve; while the bioprosthetic valves consist of either a homograft or heterograft, 
whose source is a porcine aortic valve or bovine pericardium.   There is not a vast array 
of valve prostheses available for implant, with the majority representing variations of 
successful designs that have been in existence for the past 35 – 45 years [2].  Only minor 
improvements have been made to these valves over the years; yet they continue to exhibit 
problems, including thromboebolism in mechanical valves and reduced durability in 
bioprosthetic valves [2, 3].  Patients receiving mechanical valves are subjected to lifelong 
anticoagulant therapy, which is not required for the bioprosthetic valves that produce 
physiological hemodynamics. 
Polymer trileaflet valves have been investigated in an attempt to produce a valve 
alternative that is both durable and non-thrombogenic.  Human implantation of flexible 
polymeric aortic valve prostheses was carried out in the late 1950’s, but persistent 
problems with these valves included thromboembolic complications and overall valve 
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degeneration [4].  The success of mechanical valves resulted in the withdrawal from 
clinical use of these polymeric valves, although further research and analyses in this area 
continued in parallel with the mechanical and bioprosthetic valves.  To date, polymeric 
valves have met with limited success due to calcification, thrombogenicity, and long-term 
material degradation as a result of oxidative reactions and high dynamic stresses borne by 
the material [4-6].  Polymers utilized included silicone rubber, Teflon®, 
polyetherurethaneurea, polycarbonate-urethane, and most commonly, segmented 
polyurethanes.  By selecting an oxidatively stable and durable polymer in combination 
with refining valve design, it is proposed that a polymer trileaflet valve can be developed 
that has equivalent, if not superior, durability than mechanical valves and that does not 
require the use of anticoagulant therapy due to its physiological hemodynamics. 
With this objective in mind, a novel polyolefin, poly(styrene-b-isobutylene-b-
styrene) (also known as polystyrene-polyisobutylene-polystyrene, or “SIBS”), was 
selected for the design of a fiber-reinforced polymer trileaflet heart valve [7].  SIBS has 
been proven to be stable in oxidative and acidic environments through a combination of 
degradation resistance and in vivo transplantation [8]; it has been proven to be equally as 
thromboresistant as polyurethane by measuring platelet deposition with radiolabelled 
platelets in a parallel plate flow configuration [7]; and the fatigue resistance of fiber-
reinforced SIBS has been proven through a combination of cyclic tensile and bending 
fatigue tests [7].  The numerous different iterations of valve designs that have been 
evaluated include: different reinforcement techniques, variable valve geometries, varying 
stent flexibilities, and variable SIBS formulations [9-14].  The hydrodynamics of each of 
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these iterations has been encouraging, but some of these valves failed prematurely during 
in vivo implantation in a sheep model or during accelerated in vitro fatigue. 
On average the heart contracts 70 times per minute, which equates to 100,000 
cycles per day, 35 million cycles per year, or 2.5 billion cycles per lifetime.  The natural 
valves are complex, anisotropic structures with the innate ability to sustain the alternating 
flexural fatigue without impairment; furthermore, they are endowed with the capacity to 
self-repair [3], putting them at an advantage over the static mechanical, bioprosthetic, and 
polymer trileaflet valves.  Nevertheless, if it were possible to elucidate what primary 
characteristics provide the natural valve with its fatigue resistance, it is hypothesized that 
one could produce a polymer trileaflet valve with improved endurance. 
 
1.2. Research Purpose 
The long-term objective of this research is to develop a polymer trileaflet valve 
with superior hemodynamics, durability, and biocompatibility than both commercially 
available mechanical and bioprosthetic valves.  If this goal is realized, the valve has the 
potential to be an alternative for aortic valve replacement.   
The more immediate goal, and the focus of this work, was to assess the design 
parameters that had the greatest impact on both valve function/hemodynamics and 
durability.  Knowledge of the natural valve, and bioprosthetic valve experience, was used 
to identify the particular characteristics that have the greatest influence on valve 
hemodynamics and durability for incorporation into the polymer valve design.  Aspects 
of the valve that were analyzed included: (1) leaflet geometry, (2) support structure 
(stent) and mechanics, and (3) fiber reinforcement.  A finite element model was 
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developed to determine the impact of each of these critical parameters on leaflet stress 
distribution, and this information was employed during experimental evaluations of the 
valve and each of its components, thereby verifying the impact of different valve designs 
on hemodynamic and fatigue performance.   
The final outcome of this work was a mathematical model used to predict fatigue 
in the valve.  Experimental assessment of valve durability is a time-consuming process, 
where 15 years (600 million cycles) worth of fatigue data takes approximately one year to 
collect.  The fatigue model can be incorporated as a design tool, accelerating the 
development process by eliminating valves with insufficient durability. 
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2. BACKGROUND AND SIGNIFICANCE 
2.1. The Heart & Valve Disorders 
The heart is a muscular organ whose function is to deliver blood to the rest of the 
body [15].  It is separated into a left and right side, each composed of atrial and 
ventricular compartments.  During diastole, both atrioventricular valves (tricuspid on the 
right and mitral on the left) are open, allowing the ventricles to fill with blood.  During 
systole, the ventricles contract in unison, pumping blood into the pulmonary and systemic 
circulations. Blood enters the right hand side of the heart through the vena cava, and is 
routed through the atrium and ventricle before being pumped into the pulmonary 
circulation and lungs.  Oxygen-rich blood returns to the left atrium and then ventricle, 
where it is pumped into the systemic circulation.  
Valves are located at the exit of each compartment to control the unidirectional 
flow of blood through the cardiovascular system.  They open and close in response to 
pressure differentials as the heart contracts and relaxes [15].  The mitral and aortic valves, 
located on the left hand side of the heart, are the most common sites for heart valve 
disease as a result of the left heart’s significantly higher workload [16].  Valvular heart 
disease can be as a result of either congenital or acquired defects, including rheumatic 
fever, endocarditis, calcific degeneration, myxomatous degeneration, or congenital 
anomalies [16].  The two main problems associated with valvular disease are stenosis and 
insufficiency/regurgitation.  In the former case, the opening through which blood can 
pass becomes narrowed due to the leaflets either becoming rigid or fused together.  In the 
latter case, the valve does not close completely, and a portion of the ejected blood flows 
backwards.  As a result of both, blood accumulates in the chamber, and the heart is 
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required to work harder in order to supply the body.  This increased workload leads to the 
heart muscle thickening and dilating and can result in congestive heart failure.  Once the 
heart valve has lost its normal functioning ability, drugs can only relieve the symptoms.  
Valve replacement surgery is recommended when damage to the valve is considered to 
be significant enough to be life threatening.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  A diagrammatic frontal section through the heart, showing major landmarks and the path of 
blood flow [17].  
 
2.2. Commercially Available Prosthetic Valves 
The complete replacement of damaged and diseased heart valves by prostheses 
has become routine practice, but the question remains, which valve prosthesis should be 
chosen?  Commercially available valves can be divided into two primary classes, 
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mechanical and bioprosthetic, each with its associated advantages and disadvantages.  
Factors influencing which valve is most suited to a patient include: the patient’s age, 
comorbidities, need for associated procedures, availability of a given replacement, patient 
agreement, and surgeon expertise [2].  Present regulations for heart valves are very strict, 
making it difficult for new valve designs to enter the market place.  As a result, the valves 
available today represent variations of prostheses with a long-proven history [2, 18].   
2.2.1. Mechanical Valves 
Mechanical valves, that are well-known for their durability, are the preferred 
valve for individuals under the age of 65 [2].  There was an assortment of mechanical 
valves available in the past, but the primary designs implanted today include the tilting 
disc design that was introduced in 1969 (Figure 2b), the bileaflet design that was 
available from 1977 (Figure 2c), and to a lesser extent, the ball and cage design that was 
developed in the 1960’s (Figure 2a) [3, 18, 19]; the former two valves utilized pyrolytic 
carbon.       
 
 
 
 
Figure 2.  Three basic types of mechanical heart valves: (a) Ball and cage valve, (b) Tilting disk valve, and 
(c) Bileaflet valve (http://www.edwards.com/PatientsandFamilies/MyHeart/ClinicalProcedures/ 
ValveReplacementEU.aspx). 
 
According to a report by Senthilnathan et al. [18], the St. Jude and Carbomedics 
bileaflet mechanical valves were the most widely implanted valves in the United 
Kingdom in 1996, accounting for 41% of the valves implanted.  The advantages of the 
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bileaflet mechanical valves include that they have a low profile so can be implanted into 
smaller hearts without obstructing any components, such as the mitral valve and 
coronaries; they have good hemodynamics in that the transvalvular pressure gradient is 
low with minimal regurgitation; and they are durable, showing a low occurrence of 
mechanical failure [2, 3, 18].  The tilting disc valves, including the monostrut Bjork-
Shiley and Medtronic Hall, were the second most commonly implanted mechanical 
valves, accounting for 7% of the valves implanted.  Like the bileaflet valves, the tilting 
disc valves have a proven history of durability.  The third and least commonly implanted 
valve on this list is also the oldest valve: the Starr-Edwards Caged Ball valve.  While not 
having as favorable hemodynamics as the bileaflet and tilting disc valves, it is still a 
reliable valve that is used when surgeons require a valve that is easy to handle under 
difficult surgical circumstances [18, 19].  In a more recent study by the 2002, Health 
Research International [20], it was reported that mechanical valves had lost a portion of 
the market share to the bioprosthetic valves, whose further development has increased 
their expected durability.  In the 2002 report, mechanical valves only accounted for 40% 
of the market, with the St. Jude bileaflet valves still being the most popular. 
One common problem for all the mechanical valves is that their design results in 
partial occlusion of blood flow, leading to non-physiological flow characteristics [2, 3, 
18].  It is this characteristic that contributes to morbidity and mortality as a result of 
thrombosis, embolism, and bleeding complications.  Consequently, patients receiving 
mechanical valves are subjected to life-long anticoagulation therapy.  The problems 
associated with the long-term use of warfarin include insufficient monitoring, resulting in 
either under or over anticoagulation, and hemorrhagic complications. 
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2.2.2. Bioprosthetic Valves 
Since their introduction into the market in the 1970’s, bioprosthetic heart valves 
have been plagued with problems resulting in decreased durability when compared with 
mechanical valves [2, 3, 18, 21].  They do, however, reproduce the central flow 
characteristics of the natural valve and are less thrombogenic than mechanical valves; 
therefore, long-term anticoagulation treatment is not required.  As a result, bioprosthetic 
valves are chosen for older patients with a life expectancy less than 10 - 15 years and for 
younger patients in whom anticoagulation therapy is contraindicated. 
There are three tissue sources utilized in bioprosthetic valves: human, 
glutaraldehyde-treated porcine aortic valves (Figure 3a and Figure 3c), and 
glutaraldehyde-treated bovine pericardium (Figure 3b).  The homografts, which are 
human valves excised from cadavers, are the least commonly used due to an overall 
shortage in both numbers and sizes and because they are difficult to insert [2, 18].  The 
stented porcine (Figure 3a) and bovine (Figure 3b) valves are the most commonly 
implanted, with Medtronic and Edwards Lifesciences being the dominant suppliers [2].  
According to the 2002, Health Research International report [20], Edwards Lifesciences 
accounted for 74% of stented valve units and sales in 2001, with the Carpentier-Edwards 
Perimount pericardial prosthesis being the most popular.  Medtronic accounted for almost 
26% of sales, mainly due to their experience with the Hancock porcine bioprosthesis.  
Both valves are said to be third-generation valves with an approximate durability of 10-
15 years [2].   
The stented valves, either porcine or bovine, are supported by a metallic or 
polymer structure/stent.  The stent allows for ease of implantation, but the downfall is 
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that it results in a stenotic region caused by partial orifice occlusion [2].  This prompted 
the development of stentless porcine valves (Figure 3c), which consist of aortic roots 
modified with a sewing ring [2, 18].  The entire root is implanted either within the native 
root or in place of the native root, and the design provides the advantage of an increased 
orifice area.  This design is significantly more complicated to implant than the stented 
version, and conclusive information as to the long-term durability is still unknown.  
 
 
 
 
 
Figure 3.  Three types of bioprosthetic heart valves: (a) Stented porcine valve, (b) Stented bovine 
pericardial valve, (c) Stentless porcine valve (http://www.edwards.com/PatientsandFamilies 
/MyHeart/ClinicalProcedures/ValveReplacementEU.aspx). 
 
When comparing stented pericardial versus porcine valves, pericardial valves can 
be fabricated into a multitude of designs, whereas porcine valve designs are restricted by 
the valve anatomy.  Pericardial valves are fabricated from flat sheets of glutaraldehyde-
fixed bovine pericardium that are oriented to mimic the natural/porcine valve in both 
form and function [18].  The pericardial valves tend to have superior hemodynamics to 
the porcine valves as a result of their improved inner-to-outer diameter ratio and leaflet 
dynamics during forward flow; however, the traditional designs have been modeled to 
exhibit significantly higher stresses when loaded in tension (i.e. during diastole). 
The primary problem with all xenogenic prostheses is tissue failure, which often 
begins within 10 years of implantation [2, 3, 18, 21].  Degradation is as a result of 
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calcification, mechanical damage, or a combination of both, and it has been linked to 
glutaraldehyde fixation and the stent-valve interaction, among other things.  
Glutaraldehyde treatment effectively cross-links the tissue and reduces its antigenicity 
while preventing proteolytic degradation.  As a consequence, the tissue loses its 
mechanical compliance, and the resultant increase in leaflet stress concentrations 
accelerates fatigue.  The dead, phosphate-rich cells are proposed to initiate calcification: 
when they come into contact with calcium-rich plasma, the calcium accumulates and 
forms calcium phosphate [21].  The presence of calcium deposits on the leaflets can 
result in stenosis and leaflet tearing. 
The world market for bioprosthetic heart valves has increased by approximately 
5% per year [21].  This is due in part to the increasing percentage of individuals over 65 
but also as a result of developments that have increased bioprosthetic valve durability. 
 
2.3. Polymer Trileaflet Valves 
Decades of research have gone into the development of the two commercially 
available valve categories.  Although these valves have met with clinical success, the 
mechanical valves still require anticoagulant therapy and the bioprosthetic valves lack 
durability.  In theory, the flexible membrane polymer trileaflet valve design was meant to 
overcome the disadvantages of these commercially available valves and provide a valve 
alternative that is both durable and non-thrombogenic.  In reality, this has not been the 
case; a successful polymer valve for human implantation is not yet available.  Failure of 
polymer valves has been caused by calcification, thrombogenicity, and long-term 
material degradation as a result of oxidative reactions and high dynamic stresses borne by 
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the material [4-5, 22-26].  A combination of inappropriate design and material selection 
has been blamed. 
Flexible polymer heart valve prostheses are not a new concept.  Roe began human 
implantation of a flexible silicone rubber valve in 1958, but mortality and morbidity due 
to embolization resulted in cessation of the study [4, 26].  Shortly after that, Braunwald 
implanted a tricuspid polytetrafluoroethylene (PTFE) valve in the aortic position of 23 
patients.  Mortality was again high in these patients as a result of thickening and rupture 
of the valve leaflets.  Two more clinical studies performed by Roe in 1966 and Hufnagel 
in 1977 had similar clinical outcomes with high patient mortality.  The 1966 study 
included a Dacron and silicone prosthesis, and the 1977 study utilized a monoleaflet 
Dacron prosthesis.   
Due to the success of the mechanical and bioprosthetic valves, human 
implantation of polymeric valves stopped in the 1980s, although research continued.  
Animal testing of a range of different polymers and designs continued to have problems 
related to valve durability.  Materials used and tested in these valves included silicone 
rubber, Silastic®, PTFE, segmented polyurethanes, and Biomer® (a segmented aromatic 
diamine chain extended polyetherurethane urea (PEUU)) [4, 5, 26], and failure modes 
included thrombosis, calcification, oxidation, hydrolysis, and mechanical breakdown 
occurring either alone or in conjunction with the previous mechanisms. 
The trileaflet polyurethane design is the most highly investigated valve to date.  
The trileaflet valve design allows the valve to mimic the hemodynamics of the natural 
valve, while the implementation of a block polymer makes it possible to control the 
physical, mechanical, and chemical properties of the valve [22].  Bernacca, Mackay, 
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Wheatley, and colleagues have concentrated their efforts on polyurethane for trileaflet 
heart valves, but their results revealed that calcification, lack of durability, and thrombus 
formation were still existent problems preventing the success of these valves [4, 22, 23, 
24, 26].  In addition to these findings, biodegradation of polyurethanes in vivo has been a 
persistent problem [24, 27].  Polyurethanes have proven to have suitable mechanical 
strength, flexibility, and durability for use in trileaflet heart valves, which led Bernacca et 
al. [24] to adopt a biostable polyurethane with a silicone-based soft segment chemistry.  
The two particular polymers chosen included EV3.35 which incorporated a diol chain 
extender and EV3.34 which incorporated a diamine chain extender.  These polyurethanes 
have shown resistance to biodegradation, and after implantation for 6 and 9 months in the 
mitral position of 18 month old sheep, no incidence of thrombus formation, calcification, 
fibrin deposition, and mechanical breakdown was evident [24].  Young adult sheep are 
not a good model for calcification and sheep in general have a lower incidence of 
thrombosis than humans, so conclusive evidence as to the potential of this valve is still 
elusive [24, 26]. 
Valve durability is not only a function of the polymer selected for leaflet 
construction, it is highly dependent on valve design and manufacturing process.  As was 
evident in many polyurethane prostheses, calcium accumulates in regions of high stress 
concentrations and surface defects, so mechanical degradation can act as a precursor to 
calcification [23].  It is hypothesized that by closely mimicking the natural valve’s 
transvalvular flow pattern, one can produce a valve with increased durability and reduced 
incidence of thrombosis.  It was with this concept in mind that Daebritz et al. [4, 26] 
developed mitral and aortic polycarbonate-urethane (PCU) prostheses.  The aortic PCU 
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prosthesis adopted a leaflet configuration and thickness distribution that effectively 
reduced the stresses and strains in the leaflet for increased durability.  The design also 
included a supporting stent and sewing cuff that were minimized to increase the effective 
orifice area, thereby decreasing transvalvular pressure drop.  In vivo evaluation of these 
valves was carried out in a growing calf model, where incidence of calcification and 
thrombosis are generally high.  The PCU aortic valves were implanted with a Medtronic 
Mosaic® and an Edwards Perimount bioprosthesis as controls.  The animals with the 
bioprostheses died prematurely due to severe valve degeneration and stenosis, whereas 
five of the seven animals with the PCU valve survived the full 20 week study.  The two 
animals that died prematurely were as a result of subvalvular pannus overgrowth, and the 
remaining valves were found to have minimal incidence of degeneration with 
calcification.  The calcific deposits were only present on the polymer surface.  In vitro 
accelerated fatigue of these valves is ongoing, and an equivalent of 7.9 years of cycling 
has been attained without failure.  Thus far, this appears to be the most successful 
polymer trileaflet valve to date, but further information as to the valve’s in vitro and in 
vivo function is required. 
The high tensile and bending stresses borne by the leaflet material can lead to the 
valve’s ultimate failure.  Reduction of stress concentrations have been attempted by 
changing leaflet geometry, manufacturing techniques, and frame mounting methods, but 
according to Cacciola et al. and De Hart et al. [28-30], fiber reinforcement may be the 
answer.  Due to the fact that natural valve leaflets are a composite design with stress-
reducing collagen fibers, it has been proposed that the incorporation of fiber 
reinforcement in polymeric trileaflet heart valves can reduce the stress concentrations in 
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the matrix, potentially increasing valve durability due to a reduction in tears and 
perforations.   De Hart et al. [29] performed a three-dimensional analysis of a stented 
aortic valve with either a circumferential or sinusoidal fiber reinforcement.  A decrease in 
stress of up to 60% was observed, where the load was transferred to the higher-modulus 
fibers.  Cacciola et al. [30] repeated this study for a stentless aortic valve, where a 75% 
reduction in stress was achieved.  The stress-reducing capabilities of fiber reinforcement 
are obvious from these studies, even though non-physiological reinforcement geometry 
was incorporated.  By adopting a more physiological fiber layout, it is assumed that a 
further reduction in stress concentration can be achieved, creating a valve leaflet with 
unrestricted motion during opening and closing and strength and stiffness while the valve 
is closed.   
 
2.4. Design Criteria: The Natural Aortic Valve as a Model 
The natural valve is a complex anisotropic structure that is able to endure 2.5 
billion cycles in a lifetime without generating regurgitation, hemolysis, thrombosis, or 
extreme stress concentrations in the leaflets or surrounding tissue [3, 4, 26].  No other 
prosthetic valve has been capable of replicating the natural valve’s performance or 
durability, but the secret to their success may lie in the form and function of the natural 
valve.  Synthetic polymer trileaflet valves have the greatest potential to replicate the 
critical properties of the natural valves as, unlike bioprosthetic valves, they have no 
constraints with respect to geometry and mechanical properties.  One can hypothetically 
produce a synthetic valve that more closely approximates the natural valve than any 
prosthetic valves have to date.  What is known about the natural valve and what has been 
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learned from bioprosthetic valves can be applied to polymer trileaflet designs for 
improvement of valve function and durability.  The potential for a polymer valve’s 
success is supported by reports by Daebritz et al. [4, 26], whose close approximation of 
the natural valve’s flow characteristics produced a valve with a low incidence of 
thrombosis in vivo, and Cacciola et al. [28, 30] and de Hart et al. [29], whose use of fiber 
reinforcement resulted in a decrease in leaflet stress concentrations during diastolic 
loading. 
The valve leaflet has a specialized structure that allows it to endure large tensile 
stresses during diastole, while allowing wide rotations during systole.  In the following 
section, each of the valve’s predominant tissue elements and primary structural 
organizing centers will be discussed in relation to the role they play in valvular 
mechanics.  In addition, the properties of bioprosthetic valves and their deviation from 
the natural valve will be discussed with respect to their impact on function and durability. 
2.4.1. Tissue constituents 
Historically, the natural aortic valve has been viewed as a tri-layered structure 
consisting of a thin ventricularis layer, a thicker fibrosa layer, and an inner spongiosa 
layer (Figure 4) that are free to move with respect to one other as the valve opens and 
closes [3, 31-35].  Histological analysis of thin tissue sections has revealed that the 
ventricularis layer is composed of a network of collagen and elastin fibers, the fibrosa 
layer consists primarily of collagen bundles that are believed to be the primary stress-
bearing elements in the leaflet, and the spongiosa layer is a proteoglycan-rich layer that 
separates the ventricularis and fibrosa.  Under resting conditions, the fibrosa and 
ventricularis are preloaded, with the fibrosa under compression and the ventricularis 
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under tension [35].  The surface is covered with a layer of endothelial cells providing 
additional thromboresistance.  Each of the connective tissue elements of the valve are 
found in different quantities and orientations throughout the leaflets and supporting 
structures, and their construction is directly related to the role they play in valve 
mechanics [36]. 
 
 
 
 
 
 
 
 
Figure 4.  A cutaway through the leaflet and aortic wall showing the internal configuration of the fibrosa, 
spongiosa, and ventricularis.  Adapted from Vesely [32] 
 
2.4.1.1. Collagen 
Collagen fibers and fiber bundles are believed to control the shape of many of the 
valve components, including the fibrous ring, commissures, and leaflets [36].  It is this 
particular tissue element that is said to endow the natural aortic valve with its high fatigue 
strength.  Thick collagen fibers are found beneath the endothelium of the aortic valve and 
are interspersed with elastin fibers and thin collagen fiber bundles.  The thick collagen 
fibers emanate from the commissures in a circumferential direction, forming the leaflet 
belly and free edge (Figure 5) [31, 36].  Thin collagen fibers are interwoven with the 
thick bundles and form a network that radiates and branches in multiple directions while 
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maintaining the collagen cross sectional area.  The density of these fibers is proportional 
to the local leaflet load.  In their relaxed form, collagen fibers display crimped patterns, 
but when they are loaded in tension, the collagen straightens and assumes the load.   
 
 
 
. 
 
 
Figure 5.  Typical collagen fiber architecture in the aortic valve leaflet [37].  The commissures are denoted 
by 'c'. 
 
Doehring et al. [31] utilized a system that combined high resolution digital 
imaging with transmitted elliptically polarized light to visualize the collagen structures in 
porcine aortic valve leaflets.  Instead of finding the collagen predominantly in the fibrosa 
layer, as was the historical view, the collagen fibers were found to be in a more complex 
branching network in multiple layered membrane mesostructures.  This multi-layered 
arrangement was proposed to facilitate valvular function by allowing the layers to slide 
upon each other during valve cycling, thereby allowing leaflet flexibility without 
sacrificing the tensile strength provided by the collagen fibers.  In addition to this, 
Doehring et al. concluded that, although the general collagen architecture was in the form 
shown in Figure 5, each of the three cusps was not identical: the non-coronary cusps 
typically had narrow fiber bundles that were long and did not branch extensively; the 
right and left cusps had fewer large bundles and extensive branching; the non-coronary 
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and left coronary cusps appeared to be mirror images of each other, and the right 
coronary cusp was self symmetric.  The development of collagen architecture results 
from cuspal loads, so it may be possible that non-uniform loading created this non-
uniform distribution from one leaflet to another.  The cusps’ sizes were also found to be 
different, where the non-coronary cusp was significantly smaller than the right and left 
cusps.  These factors could have implications in surgical orientation of porcine valves and 
the symmetry of bovine pericardial and polymer trileaflet valves. 
Collagen fibers are thought to be the predominant valve constituent when 
considering tensile properties; however, the fiber interaction and orientation does play a 
role in the flexural properties of valve leaflets [38, 39].  The impact of collagen fiber 
reinforcement during systole was evaluated in a numerical study performed by de Hart et 
al. [38].  The numerical model implemented the natural collagen reinforcement pattern in 
a three-dimensional model with a fully coupled fluid-structure interaction.  The values 
applied for the Reynolds and Strouhal number were below the characteristic 
physiological values due to model constraints, but a comparative analysis with a non-
reinforced model revealed that the presence of fiber reinforcement reduced the peak 
systolic matrix stress by 63% while stabilizing leaflet motion during systole.   
In the natural valve, the collagen orientation is not anticipated to impact the 
transvalvular pressure drop, but the combined tensile and compressive properties of the 
leaflet as a whole do contribute to its flexural stiffness.  In order to improve 
hemodynamics one must reduce the flexural rigidity of the valve leaflets.  Bioprosthetic 
valves made from bovine pericardium do not have the tri-layered structure that native 
human and porcine valves do, and yet they are capable of maintaining an equivalent 
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durability to the porcine valves.  Bovine pericardium lacks the spongiosa layer that is rich 
in GAGs, and the impact of this was seen by Mirnajafi et al. [39] in a 3-point bending 
evaluation of bovine pericardium and porcine leaflet specimens.  The curvature versus 
applied moment response of the porcine tissue was a linear one, whereas the bovine 
pericardial response was non-linear and dependent on collagen fiber orientation.  The 
linear response of the porcine tissue was attributed to the GAG content that allowed the 
collagen layers to slide with respect to one another.  Bovine pericardial tissue showed 
increased stiffness when it was flexed perpendicular to the collagen fiber orientation, so 
pericardial orientation can have an impact on valvular mechanics.  In the same study, 
glutaraldehyde fixation was found to increase the flexural stiffness of bovine pericardial 
tissue.  This fixation method results in inter- and intramolecular crosslinks within 
collagen fibers, so non-collagenous tissue components and collagen 
interactions/crosslinks are believed to play the major role in flexural stiffness, not the 
stiffness of the collagen fibers themselves.  The important aspects of this study that can 
be applied to synthetic valves are: (1) exact replication of the natural collagen 
architecture is not essential for valve durability, (2) fiber orientation can affect the 
flexural stiffness of leaflets and (3) free movement of fibers with respect to one other can 
enhance the flexural properties of leaflets, while inter-fiber linkage can lead to matrix 
stiffening. 
2.4.1.2. Glycosaminoglycans (GAGs) 
GAGs are the ground substance for collagen and elastin fibers and are found 
within the interfibrillar spaces and linked to collagen.  They are believed to provide the 
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native cusp with its three-dimensional architecture while creating an environment that 
influences the mechanical behavior of the valve [33, 36].   
The three primary GAGs found in porcine aortic valves are hyaluronic acid, 
chondroitin sulfate, and dermatin sulfate [33].   They are negatively charged, hydrophilic 
molecules that have the potential to absorb high quantities of water and, therefore, 
hydrate the extracellular matrix.  GAGs are a large constituent of the extracellular matrix 
of porcine valves, especially within the spongiosa, whose primary function is to allow 
shearing between the collagen fibers of the fibrosa and ventricularis layer.  It is this 
function that results in a reduction of stresses related to leaflet flexure and allows the 
collagen fibers to move with respect to one other without resulting in wear-related 
fatigue.  Additional functions of GAG molecules are their ability to sustain compressive 
forces and diminish calcification by chelating calcium ions and preventing 
hydroxyapetite nucleation. 
Glutaraldehyde fixation and storage of bioprosthetic heart valves has been 
associated with a loss of GAGs.  Lovekamp et al. [33] reported that saline storage and/or 
glutaraldehyde fixation causes an approximate 20% decrease in tissue thickness with 
almost a complete loss of GAGs.  A 60% increase in flexural rigidity, associated with the 
shearing function of GAGs, was reported in GAG-free cusps when compared with 
controls.  This increase in leaflet rigidity has been associated with the premature fatigue 
of bioprosthetic valves due to cusp delamination and wear. 
2.4.1.3. Elastin 
Elastin constitutes a small percentage of the aortic valve leaflet’s dry weight, 
accounting for only 13% (collagen accounts for 50%) [35].  This low percentage of 
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elastin implies that it does not contribute significantly to leaflet mechanics; however, the 
collagen fibers align and the cusps elongate beyond 50% strain during diastole and recoil 
during systole.  Since collagen is not a highly elastic material, the high strain and recoil 
of valve leaflets is believed to be as a result of the elastin components.     
Vesely [35] investigated the role of elastin in the fibrosa and ventricularis of 
porcine aortic valves by comparing the mechanical properties of fibrosa and ventricularis 
elastin with intact fibrosa, ventricularis, and whole leaflets.  Elastin was found to impose 
tensile loads during valve unloading, and it was believed to enforce the preloaded 
configuration of the fibrosa and ventricularis.  The ventricularis is capable of a 60% 
strain in the radial direction with recoil back to its original configuration.  Since collagen 
fibers exhibit low extensibility, they are proposed to be in a corrugated configuration 
under resting conditions, and application of force results in them straightening until they 
take up the load and inhibit further extension.  The mechanical properties of the leaflet 
prior to collagen elongation are believed to be dominated by the elastin fibers.  Upon 
release of the load, the collagen fibers spring back to their original configuration as a 
result of the elastin properties.  The ventricularis attains a maximum strain of 
approximately 20% in the circumferential direction, where collagen fibers are believed to 
play a more predominant role in leaflet mechanics.  The elastin plays a small part in valve 
mechanics for the fibrosa layer, where the properties of the wavy collagen dominate; the 
fibrosa/ventricularis interaction is believed to enable fibrosa restructuring.   
Elastic fibers provide the valve with high extensibility in the radial direction of 
leaflets and in the circumferential direction for the walls of the aortic sinus and ascending 
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aorta [36].  The radial extensibility of heart valves promotes leaflet coaptation and 
reduces regurgitation during diastole.    
2.4.2. Structural Organizing Centers 
Each of the structural organizing centers of the valve are composed of the same 
basic tissue constituents, but their quantity and arrangement differs dependent on the 
mechanical loads and function of the organizing centers [36, 40].   
2.4.2.1. Commissures 
The commissure is responsible for supporting large tensile stresses during diastole 
while allowing large deformations during systole [40].  It is the primary shock absorbing 
element of the valve leaflet, and it is in this location that the load on the leaflet is 
effectively transferred to the aortic wall [36]. 
Collagen fibers in the commissural region are better aligned than in other regions 
of the valve, such as the belly [31, 36, 40].  At the apex of leaflet attachment, the 
commissure is composed of thick, twisted bundles of collagen fibers, some of which 
radiate to form the free edge of the leaflet.  It is the twisted makeup of the collagen fibers 
that provides this region with high tensile strength.  Under loaded conditions, such as 
those during diastole, the fibers rapidly align and straighten, and the extent to which this 
occurs depends on the amount of ground substance.   
Flexure is a key mode of deformation, especially in the commissural area where 
an approximate 65° angle of rotation occurs from the fully closed to fully open leaflet 
configuration [40].  The stiffness in this area has a direct effect on leaflet opening and can 
have a significant impact on valve hemodynamics; therefore, quantification and design 
for this flexural stiffness is an important part in prosthetic valve development.  According 
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to Mirnajafi et al. [40], the flexural stiffness in the commissural region is approximately 
one third of that in the belly region, and a decrease in flexural stiffness occurs with 
increasing angle.  When flexed in the non-physiological, reverse direction, flexural 
stiffness increases by approximately 50%, so it can be hypothesized that the valve is 
constructed for specific unidirectional flexure.  The combination of high flexural and 
tensile stress can accelerate fatigue in this region, thereby making it a critical region for 
design optimization in bioprosthetic and polymer trileaflet valves.  
The commissures are attached to the aortic wall by collagen bands along their 
entire length.  It is through these bands that the load is transferred to the aortic wall [36].  
The attachment zone is composed of wavy collagen bands which have a twofold 
function:  they limit the displacement of the commissures, and they shield the leaflet from 
overloading due to the rapid increase in pressure during diastole.  It is likely that the 
commissure facilitates aortic valve opening through this attachment; the aortic wall 
dilates during initial systolic ejection, pulling the commissural region as it moves.  Early 
designs of porcine and pericardial valves utilized rigid supporting stents that did not 
permit commissure dilation during systole [21].  Valve failure was often as a result of 
tearing at the commissure, and this was linked to the rigid stent.  Newer designs 
incorporated a flexible supporting stent, but no conclusive clinical evidence has been 
provided as to its benefit.  Commissural tears still remain a problem, and the true cause is 
unknown.  Computational modeling has proven the theoretical advantage of flexible stent 
posts, but further analyses are still required to improve the concept.  Two common 
problems that have been associated with flexible stent posts have been: stent deformation 
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during implant and cardiac contraction resulting in valve failure, and polymer stent creep 
resulting in valve deformation and failure. 
2.4.2.2. Area of Coaptation 
The pressure exerted on aortic valve leaflets during diastole forces them to extend 
radially and coapt with adjacent leaflets. When the valve is in this closed configuration, 
the majority of the leaflet is loaded in tension, but the area of coaptation is loaded in a 
combination of tension and compression [21, 31].  It is the radial extensibility of the 
natural valve that allows the coapting region geometry to be more parabolic in nature, 
reducing the load on the leaflet.  Pericardial valves, especially those that are cross-linked, 
do not exhibit this radial elasticity, so the design of an appropriate leaflet geometry is 
required for coaptation.  As a result, many pericardial valves have a practically horizontal 
free edge and spherical leaflet geometry.  This deviation from the natural valve geometry 
has been proven to result in increased stress concentrations in the pericardial leaflet when 
compared with natural or porcine leaflets [21], but closer replication of the natural valve 
geometry is not possible due to the lack of distensibility inherent in pericardial tissue.     
2.4.2.3. Fibrous Ring 
The fibrous ring is found at the base of the leaflets where they attach to the aortic 
wall.  This ring was originally believed to be rigid and un-wielding, but animal 
experiments have shown that a 22-28% deformation may occur during cardiac ejection 
[36].  The fibrous ring is composed of circumferentially oriented collagen fibers 
interspersed with elastin.  In the relaxed state, the collagen fibers are slightly rippled, but 
during systole, circumferential load causes these to straighten, allowing a small increase 
in circumference.   
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2.4.2.4. Belly Region 
At the center of the leaflet, or the belly region, the collagen fiber architecture is 
more disorganized and noticeable spaces exist [36, 40].  Elastin fibers are found between 
the collagen fibers, and the orientation of each provides the valve with the capacity to 
undergo large radial deformation while supporting high circumferential stresses.  During 
diastole, when the leaflet is exposed to high tensile loads, collagen fibers undergo gradual 
alignment when compared with those in the commissural region [40].  There is an 
increased flexural stiffness in this region, which may facilitate multidirectional flexure 
without leaflet wrinkling during valve opening.   
 
2.5. SIBS Polymer Trileaflet Valve 
The SIBS trileaflet valve is being designed with the intention of overcoming the 
failure modes of previous polymer valves, thereby providing a valve with superior 
hydrodynamics in addition to increased durability and biocompatibility.  Many polymer 
valve designs have incorporated an isotropic polymer, predominantly polyurethane, and 
failure modes have been as a result of inappropriate material and design choice.  The 
chemical degradation of polymers in conjunction with material fatigue in vivo can 
enhance the overall physical degeneration of a valve, thereby accelerating its ultimate 
failure [7].  Cyclic fatigue of polymers results in the progressive formation of defects that 
grow and interact, ultimately resulting in the failure of the material at a stress lower than 
its tensile strength [41].  With the introduction of a fibrous reinforcement, propagation of 
cracks in the polymer matrix is inhibited by the presence of the fibers, and fatigue of the 
sample is primarily due to fiber breaks and delaminations [42].  The highest resistance to 
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fatigue is achieved when the fibers are parallel to the applied stress.  Consequently, a 
fiber-reinforced polymer trileaflet valve is being designed with an oxidatively stable 
polymer (SIBS) to reduce chemical degradation and a design reminiscent of the natural 
valve to reduce material fatigue.   
Biodegradation of polymers is due to a cooperative interaction between enzymatic 
hydrolysis and oxidation [7].  Materials that are more resistant to oxidation are less 
vulnerable to enzymatic degradation; therefore, overall biodegradation is reduced.  
Polymer backbones that are composed of alternating quaternary and secondary carbon 
linkages (including polyisobutylene (PIB)) do not have sites to oxidize, as shown in 
Figure 6.  PIB is not well suited as an elastomer due to its gummy consistency, but by 
extending the ends of the polymer with harder blocks of polystyrene, a triblock 
copolymer can be formed with suitable elastomeric properties. With this in mind, a 
polyolefin, poly(styrene-b-isobutylene-b-styrene) (also known as polystyrene-
polyisobutylene-polystyrene, or “SIBS), was chosen for the development of the novel 
trileaflet heart valve.  The polymer’s physical properties place it between polyurethane 
and silicone, and its inertness to oxidative and acidic environments, such as the body, has 
been proven through a combination of degradation resistance and in vivo transplantation 
[7, 8]. 
 
 
 
Figure 6.  Polyisobutylene backbone showing alternating quaternary and secondary carbon linkages that do 
not have sites to oxidize. 
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Preliminary studies of both the completed SIBS valve and material samples have 
revealed: 
• SIBS valves have comparable hydrodynamics to commercially available 
mechanical and bioprosthetic valves [9, 10, 43]. 
• The fatigue life of a SIBS composite is longer than polyurethane [7]. 
• Appropriate alignment of embedded fibers can minimize the stress concentrations 
in the matrix and at the leaflet/stent interface [44]. 
• Fiber reinforcement aids leaflet motion and stress concentrations through the 
transference of the maximum curvature between the basal region and free edge 
[45]. 
• SIBS is no more thrombogenic than polyurethane [12]. 
• Platelet activation potential of the SIBS valve is equivalent to a commercially 
available bioprosthetic and mechanical valve [46]. 
• The SIBS valve does not elicit a thrombotic response in vivo [11]. 
 
Elliptical and spherical prototype SIBS valves (Figure 7a and b respectively) that 
incorporated individually placed polypropylene fibers (7-0 monofilament polypropylene 
sutures, Prolene, Ethicon) oriented in the same manner as the natural collagen 
architecture were manufactured.  In vitro hydrodynamic testing was performed on both 
designs, and they were found to have a valvular pressure gradient and regurgitation equal 
to or less than that of a St. Jude Bileaflet Mechanical Valve (St. Jude Medical, 
Minneapolis), proving that short-term functioning was suitable [9, 10].   
In order to assess polymer fatigue, SIBS dogbone samples with embedded 10-0 
monofilament fibers were subjected to cyclic bending and tensile testing.  The composite 
samples were found to have superior tensile fatigue characteristics than polyurethane, and 
fiber reinforcement was found to improve the bending fatigue properties over isotropic 
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SIBS.  The actual fiber volume percentage greatly impacted each of these properties, 
demonstrating the importance of fiber-refinement in the development of a reinforced 
valve [7].   
 
 
 
 
 
 
 
Figure 7.  Composite SIBS polymer trileaflet valve designs: (a) Polypropylene embedded spherical valve, 
(b) polypropylene embedded elliptical valve, (c) LARS® mesh embedded spherical valve, (d) Dacron 
embedded thermal-form valve. 
 
A finite element analysis (FEA) of the statically loaded polymer trileaflet valve 
was performed, and parametric analysis revealed that a double ply model led to a 
reduction in the stress on the polymer matrix.  Optimum results were achieved when the 
fibers were oriented perpendicular to each other and the leaflet/stent interface [44].  The 
results of the FEA were utilized in the fabrication of valves, where the adoption of a 
knitted polyester mesh marketed by Boston Scientific/Meadox Medical, Inc. (Oakland, 
NJ), called LARS® Mesh made it possible for reliable and repeatable orientation of the 
embedded fibers during fabrication.  Polypropylene fibers, that were positioned one at a 
time, were replaced with the LARS® Mesh to create the composite (Figure 7c). The 
mesh resulted in a deviation from the natural collagen architecture, but hydrodynamic 
assessment of the valves proved them to have favorable hydrodynamics when compared 
with a St. Jude Bileaflet Mechanical Valve and a St. Jude porcine bioprosthetic Toronto 
SPV stentless valve [43].  During in vitro hydrodynamic testing, the transient geometry 
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of the leaflet surface was captured using dual camera stereo photogrammetry, and an 
enhanced numerical method was used to reconstruct the three-dimensional surface in 
order to quantify changes in leaflet geometry during cyclical motion [45].  The composite 
LARS® reinforced valve was compared with an isotropic valve, and it was concluded 
that fiber reinforcement helped leaflet motion by transferring the maximum curvature 
between the basal region and free edge of the leaflet during cycling.  For the non-
reinforced valve, the maximum curvature remained in the basal region throughout the 
cardiac cycle, thereby resulting in a high stress in this critical region.    
The thrombogenic potential of SIBS was quantified by measuring platelet 
deposition with radiolabelled platelets in a parallel plate flow configuration.  The SIBS 
was found to be no more thrombogenic than a medical grade polyurethane approved for 
cardiovascular applications; however, platelet deposition on SIBS was found to be 
significantly less than that onto tissue samples extracted from a St. Jude porcine 
bioprosthetic Toronto SPV stentless valve [7].  This unexpected result prompted further 
analysis of platelet activation potential under mock physiological conditions in a left 
ventricular assist device [46].  Platelet activation potential was compared with a St. Jude 
Bileaflet Mechanical Valve and a St. Jude porcine bioprosthetic Toronto SPV stentless 
valve, and no significant differences existed.  Furthermore, chronic (20 weeks) in vivo 
studies are being performed in an ovine model, where safety and hemodynamic 
performance of valves implanted in the aortic position are of interest.  In an animal that 
survived 10 weeks, no sign of thrombus or embolus formation was found, further 
supporting the valve’s biocompatibility [11].  In this particular animal, chronic 
regurgitation as a result of mechanical failure of the valve was the cause of death, which 
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prompted a design change from the LARS® embedded leaflet (Figure 7c) to a Dacron 
embedded thermal-formed valve (Figure 7d).  Preliminary in vivo evaluation of this 
design has shown tissue ingrowth and deposition to be a factor in valve failure, but 
thrombosis and embolic complications are still absent. 
The preliminary studies have proven that a SIBS trileaflet valve can be fabricated 
with suitable hemodynamics and thrombogenicity, and fiber reinforcement can be 
effectively used to improve the fatigue resistance of SIBS by minimizing stress 
concentration in the matrix.  Although preliminary in vivo evaluation of the Dacron-
reinforced valve revealed tissue ingrowth, contributing to stenosis and valve failure, the 
LARS®-reinforced valve did not experience this.  It is hypothesized that surface quality 
and hemodynamics contributed to this tissue ingrowth, so valve design can eradicate this 
problem.  What can be concluded from these preliminary tests is that both the design and 
material show promise, and continued experimentation is necessary to determine its 
success.  Further valve development is required to produce a valve that can sustain 15 
years of use (600 million cycles).   
 
2.6. Valve Characterization Methods 
2.6.1. Hydrodynamic Testing 
In vitro hydrodynamic testing is a key element in the evaluation of performance 
for a prosthetic valve [41].  The ISO 5840:2005 and FDA standards stipulate the specifics 
for testing equipment and conditions, thereby providing stringent parameters to assess 
acute valve function.   
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In vitro evaluation of an aortic valve only requires replication of the systemic 
circulation, including the left atrium, left ventricle, and the large and small arteries.  The 
left ventricle pumps oxygenated blood into the systemic arteries, which progressively 
decrease in size as they branch.  The large arteries offer no resistance to flow, and can be 
considered as compliance elements, whereas pressure drops across the small arteries are 
high, defining them as resistance elements.  Blood is routed back to the left ventricle 
through the left atrium, which acts as a reservoir for the system.  As a result, the systemic 
circulation can be represented by a reservoir (left atrium), a pump (left ventricle), 
compliance elements (aortic (characteristic) and peripheral (systemic) compliance), and a 
resistance element (peripheral resistance) (Figure 8).  A system composed of these 
elements and capable of reproducing physiological flow characteristics is referred to as a 
“Pulse Duplicator”.   
A pulse duplicator is required to have a valve chamber with relevant dimensions, 
thereby replicating the hemodynamic characteristics across the valve.  The system must 
be capable of producing pressure and flow waveforms that approximate a range of 
physiological conditions from rest to exercise, and the arrangement of resistance and 
compliance elements must simulate the arterial tree in the human body in order for the 
hydrodynamic evaluation to hold any significance.  Pressure and flow measurements are 
the primary determinants of valve performance, and hydrodynamic performance is 
evaluated with respect to the following parameters:  
• Stroke volume:  the volume of fluid flowing through a valve in the forward direction 
during one cycle (Figure 9). 
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• Regurgitation: The volume of fluid that flows through a valve in the reverse direction 
during one cycle; it is the sum of the closure volume and leakage volume and is 
expressed as percentage of the stroke volume (Figure 9). 
• Cardiac output:  The mean flow through a valve per minute. 
• Mean systolic pressure difference: the average value of the pressure difference 
(ventricle pressure – aortic pressure (Figure 10)) across a valve during the systolic 
ejection period. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.  Hydrodynamic function tester for prosthetic heart valves is shown.  The fluid mechanical 
environment is monitored with direct pressure transducers and flow probes. 
 
Due to the variability between test systems, direct comparisons between valve 
performance on different pulse duplicator systems is not possible; therefore, comparative 
evaluation with commercially available prototypes is necessary for complete 
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hydrodynamic assessment of prototype valves.  Nevertheless, minimum performance 
requirements for prosthetic valves have been provided in ISO 5840:2005 (Table 1).    
 
 
 
 
 
 
 
 
 
 
Figure 9.  Representative flow waveform where (1) represents the closing volume, (2) represents leakage 
volume, and (3) represents the stroke volume (ISO 5840:2005). 
 
 
Table 1.   Minimum performance requirements for aortic valve prostheses (ISO 5840:2005). 
Parameter Value 
Valve Size (TAD, mm) 19 21 23 25 27 29 31 
AEO (cm2) ≥ 0.70 ≥ 0.85 ≥ 1.00 ≥ 1.20 ≥ 1.40 ≥ 1.60 ≥ 1.80
Regurgitant Fraction (%) ≤ 10 ≤ 10 ≤ 10 ≤ 15 ≤ 15 ≤ 20 ≤ 20 
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Figure 10.  Simultaneous tracings of the left ventricular and aortic pressure waveforms 
(math.bd.psu.edu/faculty/stevens/PVpresentation.ppt) 
 
In the above table, the effective orifice area (AEO) can be derived as follows: 
Equation 1.  Effective orifice area. 
ρ
P
Q
A rmsvEO Δ×
=
6.51
.  (cm2), where: 
ΔP:  mean pressure difference during forward flow (mmHg), 
ρ: the density of the test fluid (g/cm2), 
51.6: a constant derived from the Bernoulli equation, and 
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Equation 2.  Root mean squared forward flow. 
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 (mL/s), where: 
Qi(t): flow data points (mL/s), 
i = 1: start of systole 
i = N: end systole 
 
2.6.2. Accelerated Fatigue Testing 
It becomes necessary to estimate valve longevity in order to evaluate the potential 
risks and failure modes associated with a prosthesis.  Durability testing of heart valve 
prostheses is used to assure that rigid heart valve substitutes remain functional for over 
400 million cycles (10 years) and flexible heart valve substitutes remain functional for 
over 200 million cycles (5 years).   
The FDA and ISO 5840:2005 standards require that a minimum peak pressure 
difference of 90 mmHg must be established across the closed aortic valves for at least 5% 
of each cycle, and this should be maintained for 95% or more of all test cycles.  The rate 
of cycling is dependent on two primary factors: (1) the potential for complete valve range 
of motion and (2) the time-dependent behavior of the particular valve materials.  Weekly 
checks are required to verify the transvalvular pressure and overall valve quality, and 
more quantitative assessment is required approximately every 50-75 million cycles to 
examine for wear, cracking, and general degradation of the valve in addition to 
hydrodynamic performance. 
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In a multi-station fatigue tester, it is critical that a comparative assessment of 
valve durability be carried out due to the sensitivity to testing conditions.  According to 
Iwasaki et al. [47], valve lifetime varies according to cycling rate, even when the 
maximum transvalvular pressure difference is constant; therefore, maintaining strict 
controls over test conditions is necessary for result correlation.  Specifying a pressure 
difference across a valve does not guarantee that tests are carried out under equivalent 
conditions [48]. 
 
2.7. Finite Element Analysis (FEA) 
Prior to the availability of computer modeling, knowledge of the failure modes 
associated with prosthetic valves was gained through in vitro and in vivo use, and 
changes to designs were made only after problems arose.  The downfall to this technique 
is that a prototype is required for testing, which can make development both time 
consuming and costly if numerous design iterations are required [49].  Finite element 
modeling (FEM) can provide a design tool to eradicate certain questionable designs 
without the need for rigorous prototyping and testing.  FEA incorporates a computer 
model of a material and/or design that is stressed and assessed for specific criteria.  It can 
be used to verify that a certain product meets specifications and can function without 
failure for the desired product life.    The finite element method is a numerical technique 
in which the governing differential equations can be approximated for solution; as a 
result it can be applied to multiple physical phenomena including stress, vibration, 
deflection, and heat conduction, to name a few [50, 51].  Discretization of the body into 
finite elements is performed, and approximations are carried out over each finite element.  
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The solution for each of the elements is summed to arrive at a solution for the entire 
body.    
Computational modeling provides a means to establish the structure-function 
relationships in valves: numerical simulations have provided a wealth of knowledge in 
the area of stress distribution and design optimization for trileaflet heart valves [52], 
where key features contributing to the stress concentrations in valve leaflets include valve 
geometry, leaflet anisotropy, and supporting stent structure.  Most models do not 
represent the behavior of the valve leaflet throughout the entire cardiac cycle as complex 
interactions between the flow and leaflets exist.  Loading of the valve can be achieved by 
either applying a differential pressure across the leaflets or by stretching the boundaries 
of the leaflets.   
FEM applied to bovine pericardial valves has shown that the primary stress 
concentrations occur at the commissure point close to the top of the stent post [51].  The 
extent of this stress is highly dependent on leaflet anisotropy, stent flexibility, and the 
angle that the free edge forms with the stent post.  In the aortic allograft and porcine 
xenograft on the other hand, the primary stress concentration is in the belly region, and 
stress at the coaptations and commissures are insignificant [51].  This phenomenon is 
believed to be as a result of the collagen fiber orientation.  In the aortic allograft, leaflet 
strains in the radial direction are four times greater than those in the circumferential 
direction, a fact consistent with the natural collagen and elastin fiber layout.  These 
strains are decreased in porcine xenografts, as glutaraldehyde fixation leads to leaflet 
stiffening. 
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Fiber/collagen reinforcement in trileaflet valves has been proven to contribute to 
the minimization of stress concentrations and improvement to the dynamic characteristics 
of leaflets [29, 30, 37-39, 44, 41, 52, 53], but the impact of varying fiber orientation has 
received only a cursory glance.  De Hart et al. [29] performed a three-dimensional FEA 
on a fiber-reinforced stented polymer trileaflet valve with either a sinusoidal or uniform 
circumferential fiber orientation. The leaflet was deformed from a stress-free open 
configuration to a closed configuration by the application of a uniform pressure load on 
the aortic side.  There was an overall decrease in stress concentrations in the primary high 
stress locations (commissures) when compared with non-reinforced samples, and the 
presence of fiber reinforcement created a more homogeneous stress distribution in the 
ventricular and aortic polymer layers.  Numerical instabilities required the use of non-
physiologic models in this evaluation.  FEA performed by Arcidiancono et al. [53] on the 
PericarbonTM aortic tricuspid valve revealed that pericardial orthotropy has a marked 
impact on leaflet dynamics, dependent on the particular orientation of the pericardium 
during valve manufacture.  The orientation of the pericardial tissue affects both leaflet 
dynamics and stress distribution and is presumed to significantly affect the durability and 
function of pericardial prostheses.  Load-pressure curves in conjunction with pericardial 
mechanical properties were applied in this dynamic model without the consideration of 
either the stent behavior or blood interaction.  In both de Hart’s and Arcidiancono’s 
model, a rigid stent body was considered.  Cacciola et al. [30] adapted de Hart’s model 
for a stentless fiber-reinforced polymer trileaflet valve.  A 75% reduction in stress when 
compared with the stented model was achieved.  Higher stress concentrations in the 
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stented valve were believed to be caused by the unphysiological flexure experienced by 
leaflets constrained in a rigid stent. 
For a material subjected to cyclic loading, the number of cycles to failure is 
controlled by the maximum stress level.  High stress concentrations are associated with 
the failure locations in trileaflet valves [51]; therefore, the knowledge of stress 
concentrations is imperative to the design of a trileaflet valve capable of withstanding 
cyclic fatigue.      
 
2.8. Fatigue Modeling 
Fatigue is referred to as the onset of failure as a result of cyclic loading [42, 54].  
During the design of heart valves, it is imperative to know the number of cycles to failure 
in order to ensure a device’s durability.  In vitro testing can be both time consuming and 
costly, and the particular cycling rate chosen for testing in accelerated heart valve testers 
and tensile testers is known to have a marked effect on the number of cycles to failure 
[47, 48, 42, 55].  As a result, more efficient fatigue predictive methods are needed, and 
fatigue life prediction models have been developed for this purpose. 
The most common approach and the first step in the prediction of fatigue failure 
involves stress-versus-life (S-N) curves [42, 54, 56].  In this method, the number of 
cycles required to induce fatigue failure of a specimen is estimated at multiple alternating 
(σa) and mean (σm) stress combinations, where the fatigue strength of the material refers 
to the stress on an S-N curve for a particular life of interest (Nf).  In some cases, the log-
linear plot of S-N data approximates a straight line that can be represented by the 
equation [42]: 
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Equation 3 
)log(* fa NmS +=σ , where: 
σa: amplitude of stress 
S & m: fitting constants, where S is the Y-intercept and m is the slope 
Nf: number of cycles to failure at a particular applied stress 
 
Mouritz [56] utilized this linear relationship in the development of a simple 
fatigue-life model for three-dimensional (3-D) fiber-polymer composites.  In this 
particular micromechanical model, the properties of 3-D composites were approximated 
from the knowledge of 2-D fatigue-life models, where three empirically determined 
constants were required: (1) the ultimate strength of the 3-D composite (σ3D), (2) the 
ultimate strength of the 2-D laminate (σ2D), and (3) the slope (m) parameter of the 
fatigue-life (S-logN) curve for the 2-D laminate.   The simplified relationship from 
Equation 3 was adjusted to account for the fact that the 2-D data was used for 
approximation of fatigue-life of 3-D composites, providing the following relationship: 
 
Equation 4 
( ))log(*2
2
3
3 fD
D
D
D NmS += σσ
σ  
 
Upon evaluation of the tensile fatigue properties of the 3-D composite, there was a good 
correlation between experimental data and model prediction for S-N, showing the validity 
of the method in this particular instance.  The model, however, is only applicable to 
materials that have linear S-logN curves, and it is only valid for comparison under 
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equivalent testing conditions.  Extrapolation of the model to varying cycling rates or 
loading conditions was not evaluated.  Many materials do not exhibit a linear S-logN 
relationship, instead the S-N curve begins to flatten and reaches a threshold stress 
amplitude, below which failure does not occur.  Materials that exhibit these tendencies 
cannot utilize the simplistic approach presented above. 
Cacciola [41] and Huang [55] utilized the theory of continuum damage 
mechanics, where the dynamic fatigue of the material results in progressive degradation, 
thereby affecting the sample’s response to stress and ultimately leading to failure.  
According to Cacciola, damage can be defined as: 
 
Equation 5 
a
aaD
~−= , where 
a: the area of a section through the element 
ã: the effective area for stress transfer (a - area occupied by microcracks and 
damage) 
 
When D = 1, the sample has failed, and when D = 0, the sample is undamaged.  With this 
definition of damage, the damage along a specimen is initially zero, but cyclic loading 
results in a progressive increase in damage that changes the material properties and 
affects the number of cycles the material can sustain until failure (Nf).  Iterative 
application of this in a finite element model was proposed for fatigue-life prediction of a 
polymer trileaflet valve, but thus far it has only been used to evaluate non-reinforced 
EPDM rubber.  In this particular evaluation, a hole was created in the isotropic EPDM 
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specimen, and it was exposed to cyclic fatigue.  The sample failed at 148 cycles in the 
experimental evaluation, while the simulation attained D = 1 after only 87 cycles.  Future 
work on this model involves program adaptation for the incorporation of large 
displacements, and the final implementation for a polymer trileaflet heart valve.   
Cacciola’s definition of damage or fatigue is reminiscent of the Palmgren-Miner 
Rule, which states that fatigue failure is expected when life fractions sum to unity: 
 
Equation 6 
∑ == 1Failure Fatigue
fj
j
N
N
, where 
Nj: number of cycles the stress amplitude, σaj, is applied 
Nfj: Number of cycles to failure when stress amplitude, σaj, is applied 
 
The Palmgren-Miner Rule is applicable when a device is subject to variable amplitude 
loading, and the effects of each are summed for the approximation of fatigue life.  For 
both Cacciola’s and the Palmgren-Miner approach, initial knowledge of the S-N 
relationship is required for the evaluation.   
Huang [55] adopted a more complex relationship for the prediction of fatigue in a 
fabric composite that was subjected to biaxial loads.  A Bridging micromechanics model 
was used for the simulation of fatigue strength and S-N data for a woven fiber-reinforced 
composite was used as input.  In this approach, the fiber and matrix properties were 
required in addition to the S-N data for the specific cyclic conditions evaluated.  In the 
model, the unit cell of the woven composite was subdivided into unidirectional slices, 
and the Bridging model was used to relate the internal stresses on the fiber and matrix 
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with the load on the unidirectional composite.  The stresses obtained from the Bridging 
model were evaluated against critical values from the S-N data, and when any constituent 
reached this critical parameter, the composite was considered to reach failure.  The 
Bridging model itself is complex, and discussion of the mathematical formulation serves 
no purpose in this present evaluation, suffice to say, the Bridging model was used to 
correlate the volume averaged stress increments in a unidirectional composite.  Once 
assembled, it can be applied in a fatigue-life model similar to Cacciola’s, where damage 
accumulation ultimately resulted in fatigue failure of the composite.  The total stress 
accumulation due to cyclic load was approximated as: 
 
Equation 7 [ ] [ ] [ ]ijKijKij σσσ +=+1 , where 
[σij](0): the initial residual stresses in the constituents 
 
Fatigue was defined when: 
Equation 8 [ ] ),,(),,(1 ωσωσσ NRNR uKij ≥=+ , where 
 R: ratio between the minimum and maximum stresses 
 N: cycle number 
 ω: frequency 
 σu: fatigue limit at R, N, and ω 
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The model was evaluated against experimental results obtained in literature, where the 
correlation between each was not convincing.  The true validity of this model can only be 
evaluated once a complete data set of experimental results is available for comparison. 
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3. SPECIFIC AIMS AND HYPOTHESES 
The two primary challenges preventing the commercial success of polymer 
trileaflet heart valves include polymer selection and valve design.  Many of the polymers 
chosen for previous designs of trileaflet valves have not been biostable, where oxidation 
led to embrittlement of the polymer, making it less resistant to cyclic fatigue [7].  
Materials that are more resistant to oxidation are said to be less vulnerable to enzymatic 
degradation and are, therefore, more biostable.  The adoption of SIBS for the polymer 
valve is proposed to overcome the problem of biostability, where preliminary testing has 
proven it to be stable in both in vitro [8] and in vivo [11, 14] oxidative environments.  
The high dynamic tensile and bending stresses acting on leaflets cause mechanical 
degradation, resulting in the formation of cracks and tears.  These cracks have been 
proven to be sites for calcification in polyurethane valves, but ultimately, propagation of 
these deformities causes catastrophic valve failure.  It is hypothesized that this problem 
can be overcome by an appropriate valve design, such as the adoption of a valve 
geometry and reinforcement that will effectively reduce the high stress concentrations in 
the leaflet polymer matrix, thereby reducing crack formation.  High stress is known to be 
a primer for degradation in materials exposed to cyclic fatigue [42].  It is this aspect of 
valve design that is still an issue for the SIBS valve; as a result, the focus of this work 
was the impact of design on both the acute valve function and long-term durability.   
Questions that were addressed included: 
A. What is the best possible leaflet design that will result in optimal acute and long-
term function of a polymer trileaflet valve? 
 
B. How important is stent flexibility to the function of a trileaflet valve? 
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C. Can a simplified fatigue-prediction model be incorporated into the development 
process for a polymer trileaflet valve; will it adequately predict the durability of 
such a complex device? 
 
In order to answer these questions, the following three specific aims were carried 
out: 
 
1. SIBS Valve Characterization:  This investigation characterized different valve 
prototypes in terms of leaflet and stent tensile properties, assembled valve 
hydrodynamic function, and overall valve quality. The tensile properties of the valve 
components were evaluated on an ElectroforceTM (ELF) 3200 materials tester (Bose 
Corporation, Electroforce Systems Group, Minnetonka, MN) by means of static 
tensile and Poisson’s ratio tests; hydrodynamic evaluation was performed on a 
Vivitro Systems Left Heart and Systemic Circulation Simulator; and SEM was used 
to assess leaflet quality.  The tensile, Poisson’s ratio, and hydrodynamic properties 
were required for input into both the FEM and, therefore, the fatigue lifetime 
prediction model. 
2. Finite Element Modeling:  Based on the literature review, it was determined that the 
three key parameters affecting leaflet stress concentrations include the supporting 
structure (stent) flexibility, the reinforcement alignment (leaflet anisotropy), and the 
geometry of the leaflet, especially in the region of coaptation.   Valve models 
including varying degrees of stent flexibility, coaptation and/or leaflet geometry, and 
fiber reinforcement were evaluated by means of a finite element model to determine 
their impact on leaflet stress concentrations.  By making iterative changes to the 
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parameters above, one can determine which has the greatest benefit in terms of stress 
reduction.   
3. Durability Assessment and Fatigue Prediction:  This investigation was used to 
characterize the valve components and completed valve prototypes from Aim 1 in 
terms of their durability.  The summation of this research was a mathematical model 
that is proposed as a tool for the fatigue lifetime prediction of polymer trileaflet 
valves.  Dynamic tensile fatigue tests of leaflet samples were characterized on the 
ELF tester, and the resultant S-N relationship were applied in the fatigue lifetime 
prediction model.  The final model was validated by both the S-N data and 
accelerated fatigue data for valves evaluated on the Vivitro Systems Hi-Cycle 
Accelerated Fatigue Tester.   
 
All three Specific Aims are interrelated, where the output of Aim 1 was necessary 
for input into Aim 2, and the output of both Aims was required for input into Aim 3.  The 
culmination of the research was a mathematical model from Aim 3 that has the potential 
to be implemented to predict the fatigue lifetime of the valve, negating the need for a 
slew of time-consuming durability tests.  Ultimately, in vitro accelerated fatigue testing is 
required for valves intended for clinical application as specified by the FDA and ISO 
standards. 
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4. METHODOLOGY 
As mentioned previously, the three primary aspects of the valve that were under 
investigation were the stent flexibility, leaflet anisotropy, and leaflet/coaptation 
geometry.  In order to investigate the impact that these parameters had on both the acute 
and long-term function of the valve, the variables in Table 2 were applied to different 
designs that were subject to experimentation and/or modeling (Specific Aims 1 – 3).  In 
the table below, the combination of leaflet reinforcement and manufacturing procedure 
manipulates the anisotropic properties of the leaflet, while the combination of stent 
geometry and polymer type manipulates the stent flexibility.   
 
Table 2.  Listing of all potential candidates for manufacture and testing of a trileaflet heart valve 
Leaflet Stent  
Reinforcement Manufacturing procedure 
Coaptation 
Geometry Material Geometry 
1 PET Knit 1 (JSI) Dip-Coating No Curvature 30% SIBS Low Profile
2 PET Knit 2 
(BARD) Hybrid 
Medium 
Curvature 
48.5% 
SIBS 
Medium 
Profile 
3 PET Weave Solvent Casting High Curvature  
High 
Profile 
4 PET Mesh 1 
(LARS) 
5 PET Mesh 2 
(XA-47) 
6 PET Mesh 3 
(NZ-11) 
7 PET Mesh 4 
(Athletic Mesh) 
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4.1. Valve Manufacturing Procedure 
A total of four distinct design prototypes were produced, incorporating the 
components listed in Table 2, in order to investigate the impact of variable stent 
flexibility and leaflet anisotropy on valvular function.  Finite element modeling was used 
to evaluate the affect of varying leaflet coaptation geometry on the valve stress 
concentrations; therefore, all the prototypes that were manufactured for the experimental 
evaluation incorporated the medium coaptation curvature.  A summary of the component 
parameters for the four valve designs is provided in Table 3, and descriptions of their 
manufacturing procedures are provided in the following sections.  The detailed 
manufacturing protocols are provided in Appendix I.    
4.1.1. Design 1: Pre-formed individual leaflets 
Design 1 prototype valves incorporated the polyester mesh, LARS® (Boston 
Scientific/Meadox Medical, Inc., Oakland, NJ), and a low profile, 30% styrene SIBS 
stent (refer to Figure 106, Appendix II).   The nominal thickness of the reinforcement 
mesh was 0.15 mm, and after coating with three dips in the SIBS solution, an average 
leaflet thickness of 0.21 mm was achieved.   
Leaflets were manufactured by dip-coating in a 15% SIBS (8.5% styrene) in 
toluene solution (Appendix I) as follows: Aluminum leaflet dipping molds were cleaned 
and buffed to remove any surface debris and scratches.  The aluminum molds were 
dipped into the SIBS/toluene solution and placed in an oven set to 75 ± 5°C for > 30 
minutes.  The LARS® mesh was cut into 2.5 inch square samples whose edges were 
parallel to the minimum and maximum elongation of the mesh.  The mesh was then 
secured over the coated mold with an o-ring so that the maximum elongation of the mesh 
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was oriented in the circumferential direction.  The whole assembly was then dipped two 
more times into the SIBS/toluene solution providing a three layer coating with the mesh 
sandwiched between the first and second layer.  On the second dip, the molds were 
allowed to dry at 75 ± 5 °C for > 30 minutes, but on the final dip, the molds were placed 
in the oven for > 2 hours to complete the drying process.  The leaflets were removed from 
their aluminum dipping molds and transferred to a holding fixture.   
The stent was manufactured by compression molding 30% styrene SIBS pellets at 
180°C and 7,000 lbs in a low profile stent compression mold (Appendix I and II).  The 
additional flash was trimmed from the stent, and the stent was now ready for attachment 
of the leaflets. 
A 15% SIBS (8.5% styrene) in toluene solution was painted onto the area of 
attachment of both the stent and leaflet, and the leaflet was properly aligned and adhered 
to the stent.  The bonding was repeated for all three leaflets in turn.  The leaflets were 
trimmed to allow the slightly curved coaptation geometry, and the valves were visually 
inspected:  (1) their thicknesses were measured with a Digimatic Outside Micrometer 
(Mitutoyo, Boca Raton, FL) and recorded, and (2) the leaflets were inspected for bubbles 
and flaws, their edges were inspected for ragged appearances, and adjacent leaflets were 
inspected for excessive glue and fusing.  
4.1.2. Design 2: Dip-Coated Cylinder 
The Design 2 prototype valves incorporated one of four polyester reinforcement 
fabrics and a high profile, 30% styrene SIBS stent (refer to Figure 106, Appendix II).  
The reinforcement materials included LARS®, an Athletic Mesh (Lot # 074-0837, JoAnn 
Fabric and Craft Stores, Miami, FL), a polyester weave (JoAnn Fabric and Craft Stores, 
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Miami, FL), and a Dacron (Jet Set Interlock (JSI), JoAnn Fabric and Craft Stores, Miami, 
FL).  By selecting various different materials for leaflet reinforcement, the impact of 
varying anisotropic properties could be investigated.  For the JSI-Dacron-reinforced 
leaflets, the impact of changing reinforcement orientation and polymer coating were 
assessed.  Valves were made where the JSI-Dacron was oriented so that the maximum 
elongation was in either the circumferential or radial direction, and the JSI-Dacron was 
dip-coated with either a 15% SIBS (8.5% styrene) in toluene solution or a porous 15% 
SIBS (16% styrene) in cyclopentane solution (refer to Appendix I).  For all other leaflet 
reinforcement materials, the maximum elongation was oriented circumferentially, and the 
fabric was coated with the 8.5% styrene SIBS.  By increasing the stent profile, greater 
stent flexibility was achieved when compared with that from Design 1. 
Leaflets were fabricated from one of the flat fabric reinforcement materials stated 
above.  The fabric was cut into 3 inch square samples whose edges were parallel to the 
minimum and maximum elongation of the fabric.  The flat sample was then heat sealed 
into a cylinder, with the maximum elongation oriented in either the circumferential or 
radial direction, dependent on the specific design.  The excess fabric was cut from the 
heat-sealed joint to allow a clean leaflet tube.  The leaflet tube was then dip-coated twice 
in either the SIBS in toluene or SIBS in cyclopentane solution, and after each dip, the 
leaflet was dried for 30 minutes in a 60°C oven.  Once dry, the edges were trimmed to 
allow a clean, flat edge.   
The stent was manufactured according to the same methods as that used for 
Design 1, except the high profile stent compression mold was used with the 30% styrene 
SIBS. 
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Table 3.  SIBS valve design summary 
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formed individual 
leaflets  
Design 2: Dip-
coated cylinder  
Design 3: 
Compression -
molded cylinder 
Design 4: Solvent 
Cast Cylinder 
St
en
t 
• 30% Styrene 
• Low profile 
 
 
 
 
 
 
• 30% Styrene 
• High profile 
 
 
. 
 
 
 
 
• 48.5% Styrene 
• Med profile 
 
• 48.5% Styrene 
• Med profile 
 
R
ei
nf
or
ce
m
en
t 
Fa
br
ic
 
 LARS 
 LARS 
 Athletic Mesh 
 PET Weave 
 JSI Dacron 
 
 JSI Dacron 
 PET Weave 
 JSI-Dacron 
 XA-47 
 NZ-11 
 BARD 
Po
ly
m
er
 
So
lu
tio
n 
 15% SIBS (8.5% 
styrene) in toluene 
 15% SIBS (8.5% 
styrene) in toluene 
 15% SIBS (16% 
styrene) in 
cyclopentane 
 15% SIBS (8.5% 
styrene) in toluene 
 Extruded SIBS 
(8.5% Styrene) 
 15% SIBS (8.5% 
styrene) in toluene 
Le
af
le
t 
Fa
br
ic
at
io
n 
M
et
ho
d 
 Dip-coat male 
mandrel 3x 
 Apply 
reinforcement 
between 1st and 2nd 
dip.  
 
 
 
 
 
 
 
 
 
 
 
 Heat-seal 
reinforcement 
fabric into cylinder 
 Apply 2-Dip 
coating to fabric  
 
 
 
 
 
 
 
 
Compression Mold 
 Compression-mold 
extruded SIBS-
Dacron cylinder 
laminate 
Hybrid 
 Dip coat as in 
design 2 and then 
compression mold 
 
 
 
 
 
 
 
 
 Solvent cast flat 
sheet 
 Heat seal into 
cylinder 
 
 
 
 
 
 
 
A
ss
em
bl
y  Solution-bond 
three individual 
leaflets to stent 
 Solution-bond then 
suture leaflet 
cylinder to stent 
 Thermal form 
leaflets 
 Solution-bond then 
suture leaflet 
cylinder to stent 
 Thermal form 
leaflets 
 Solution-bond then 
suture leaflet 
cylinder to stent 
 Thermal form 
leaflets 
M
os
t S
uc
ce
ss
fu
l 
Pr
ot
ot
yp
es
 
 
 
 
 
 
 
 
 
 
   
 
 54
For the leaflet/stent assembly, a 15% SIBS in toluene solution was painted onto 
the area of attachment of the stent base, and the leaflet was properly aligned and adhered 
so that half of the leaflet resided above the stent base and half resided below.  The leaflet 
was then sutured to the stent following the contour of the top edge of the stent, including 
the stent base and posts.  Ethibond Excel suture (5-0, Ethicon, inc., Piscataway, NJ) was 
used to suture through both the stent and leaflet to allow a tight junction between each.   
The excess material at the base of the stent was folded up and onto the stent to tightly 
cover the outer surface.  It was trimmed to mimic the outer geometry of the stent, and a 
coating of 15% SIBS (8.5% styrene) in toluene was applied to bond the two materials.  A 
reinforcement suture was added at the top of each stent post to secure the outer fabric to 
the stent.  The trileaflet geometry was obtained by thermal-forming the leaflets with 
aluminum leaflet forming mandrels for 1 hour at 80°C.  The leaflets were trimmed to 
allow the slightly curved coaptation geometry, and the valves were visually inspected as 
in Design 1. 
4.1.3. Design 3: Compression-Molded Cylinder 
Design 3 prototype valves incorporated a compression-molded JSI Dacron leaflet 
mounted on a 48.5% styrene SIBS, medium profile stent (refer to Figure 106, Appendix 
II).  The leaflet reinforcement was always oriented with the maximum elongation in the 
circumferential direction, but by applying one of two different compression-molding 
techniques, leaflets with variable mechanical properties were produced.  A medium 
profile stent consisting of a higher percentage styrene SIBS provided less stent flexibility 
than that of Design 2. 
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Leaflets were fabricated from 3 inch square JSI Dacron samples cut parallel to the 
minimum and maximum elongation.  As in Design 2, the flat fabric sample was heat 
sealed before the addition of the 8.5% styrene SIBS polymer.  For Design 3, one of two 
polymer coating techniques was applied (refer to Appendix I), namely: 1) Compression 
molded laminate or 2) Compression-molded hybrid.  For the compression-molded 
laminate, a true 3 layer laminate was produced by compression-molding two outer layers 
of 8.5% styrene SIBS into a cylinder and compressing the JSI cylinder between these two 
layers at 200°C and 30,000 lbs.  For the hybrid design, the JSI Dacron leaflet cylinder 
was dip-coated twice, as in Design 2, and this was then subjected to compression molding 
in a cylinder clam-shell mold at 200°C and 3,000 lbs. 
The stent was manufactured according to the same methods as that used for 
Designs 1 and 2, except the medium profile stent compression mold was used with the 
48.5% styrene SIBS.  After compression molding, the stent suture holes were drilled into 
the stent following a suture hole template.  Suture holes were required in the higher 
styrene content stent as it was too hard to suture through by hand. 
The leaflet/stent assembly was the same as that for Design 2. 
4.1.4. Design 4:  Solvent Cast Cylinder 
Design 4 prototype valves incorporated one of 4 leaflet reinforcement fabrics and 
the 48.5% styrene SIBS, medium profile stent from Design 3.  The reinforcement 
materials included a polyester weave (JoAnn Fabric and Craft Stores, Miami, FL), a 
Dacron (Jet Set Interlock (JSI), JoAnn Fabric and Craft Stores, Miami, FL), one of two 
polyester meshes (XA-47 or NZ-11, Apex Mills, Inwood, NY), and a polyester knit 
(P04081, BARD Peripheral Vascular, Inc., Tempe, AZ).  Once again, varying the leaflet 
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reinforcement allowed the evaluation of varying anisotropic leaflet properties on valvular 
function.  For the PET weave and the XA-47 reinforcement, the principal fiber directions 
were oriented 45° between the circumferential and radial directions; these two 
reinforcement types had the same mechanical properties in the orthotropic direction due 
to the orientation of the fibers.  For all other materials, the maximum elongation was 
oriented in the circumferential direction.  The JSI Dacron leaflet was manufactured by 
dip-coating, as in Design 2, but all other leaflets were manufactured by the solvent 
casting method. 
A casting plate was designed for the solvent casting technique (refer to Appendix 
I) that consisted of a bottom plate, a top plate, and a gasket (Figure 11).  The 
reinforcement fabric was secured between the top and bottom plates, above the gasket, 
and a controlled volume of 15% SIBS (8.5 % styrene) in toluene solution was poured into 
the plate to completely coat the fabric surface.  The gasket was used to lift the 
reinforcement fabric off the bottom plate, thereby allowing uniform coating on both sides 
of the material.  This fabrication technique was found to efficiently coat the fabric with a 
thin layer of SIBS.  The underlying fabric was completely coated with no exposed fibers, 
and the fabric was efficiently placed in the center of the polymer matrix, as can be seen 
from the SEM images (Figure 12).  The flat, SIBS-coated leaflet samples were then heat-
sealed into a leaflet tube as in Designs 2 and 3, with the exception that they were already 
coated with the polymer prior to heat-sealing.  The stent fabrication and valve assembly 
techniques remained the same as that for Design 3.    
All prototype valves and valve components were subjected to the testing outlined 
in Specific Aims 1 – 3. 
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Figure 11.  Casting plate for the uniform coating of leaflet reinforcement fabrics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.  SEM images of a solvent cast PET weave sample showing the cross-sectional and surface 
views.  It is apparent from the cross-sectional view that the fiber reinforcement is embedded in the center of 
the SIBS matrix, and that the exposed polymer surface is smooth with no fiber exposure. 
Top Plate
Bottom Plate Gasket
Cross-Section 
 
 
 
 
 
 
 
 
Surface 
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4.2. Specific Aim 1 – Valve characterization 
The purpose of this Aim is to characterize the valve and each of its components 
(leaflets and stent) to assess how the component tensile properties affect the function of 
the valve as a whole.  Iterative adjustments to valve geometry, reinforcement technique, 
and stent stiffness and design are characterized in terms of their impact on valve 
hydrodynamics.  In addition, the tensile properties and Poisson’s ratio measurements 
obtained were used to define the material properties in the finite element model of Aim 2, 
and the transvalvular pressure drop versus time curve obtained from the hydrodynamic 
analysis was used to specify the loading regimen for the finite element model. 
4.2.1. Tensile Testing 
When evaluating the impact of material properties on valvular function, the 
tensile properties of both the leaflets and stent are important.  During diastole, a 
backpressure of approximately 90 mmHg is acting on the valve, placing the leaflets in 
tension, and this tensile force is transferred to the stent at the commissure.  During 
systole, the outward flexion of the stent can aid in the opening of the leaflets.  For this 
reason, tensile testing of both the heart valve leaflets and stent is needed to fully 
characterize the impact of leaflet and stent design on valve function.    
The properties in both the radial and circumferential directions are important in 
determining valve integrity during diastole.  Radial compliance of the leaflets allows 
them to stretch in the radial direction and coapt to prevent regurgitation.  A valve that is 
too stiff radially will not seal properly, resulting in regurgitation.  The primary tensile 
load acting on the leaflets during diastole is oriented in the circumferential direction, so 
the tensile properties circumferentially verify whether or not a leaflet can withstand the 
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diastolic load.  As a result, leaflet samples were fabricated in the same manner as for 
valve fabrication (refer to Table 3), and circumferential and radial samples were cut and 
tested for comparison with each other leaflet prototype (listed in Table 4).  Stent samples 
were manufactured by compression molding, which is the same technique used to 
manufacture actual stents.   
 
Table 4.  Valve leaflet and stent components that were subjected to tensile testing (refer to section 4.1 for 
the valve manufacturing procedure). 
Valve 
Component 
Reinforcement 
Material Polymer 
Manufacturing 
Procedure 
PET Knit 1 (JSI) 8.5% Styrene SIBS Design 2: Dip-Coating 
PET Knit 1 (JSI) 8.5% Styrene SIBS Design 3: Hybrid 
PET Knit 2 (BARD) 8.5% Styrene SIBS Design 4: Solvent Casting 
PET Weave 8.5% Styrene SIBS Design 4: Solvent Casting 
PET Mesh 2 (XA-47) 8.5% Styrene SIBS Design 4: Solvent Casting 
PET Mesh 3 (NZ-11) 8.5% Styrene SIBS Design 4: Solvent Casting 
Leaflet 
 8.5% Styrene SIBS Compression Molding 
 30% Styrene SIBS Compression Molding Stent 
 48.5% Styrene SIBS Compression Molding 
 
Tensile testing was carried out on the ElectroforceTM (ELF) 3200 materials tester 
(Bose Corporation, Electroforce Systems Group, Minnetonka, MN), following ASTM 
standards D 638M – 89 (plastics), D 882 – 88 (thin plastic sheets), and D 3039 – 89 
(composites).  A crosshead speed of 5 mm/min was used in accordance with these 
standards.  Outcome measures included: Young’s Modulus (E), ultimate tensile stress 
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(UTS), and ultimate strain (US), where pertinent.  A minimum of five specimens was 
tested for each, and the standard deviation was provided. An analysis of variance 
(ANOVA) and subsequent post-hoc tests were carried out, and differences between 
samples were considered to be significant if p ≤ 0.05. 
4.2.2. Poisson’s Ratio 
Poisson’s ratio of the isotropic SIBS samples (Table 4) was assessed on the ELF 
tester following ASTM standard E 132-97.  A camera was mounted and focused in front 
of the test specimens to allow imaging of each test sample at exactly the same location 
and focal setting.  Longitudinal and transverse strain measurements were made as 
follows: 
Four fiducial points (0.2 mm in diameter) were marked with India ink at the 
center of each specimen in symmetry with the horizontal and vertical axes, forming a 
rectangle.  Once the sample was secured in the grips, prior to loading, an image was 
taken, showing the initial location of the points (Figure 13a).  The specimen was then 
loaded until it reached 15% strain, and a second image was immediately taken, showing 
the final location of the points (Figure 13b).  Care was taken to ensure that the second 
image occurred once the sample reached maximum elongation but before relaxation 
occurred.  In addition to imaging the samples, a 1 x 1 mm grid was secured in the same 
location as the samples, and an image was taken.  This image was used as a reference of 
known dimensions for quantification of Poisson’s ratio.  
In Photoshop®, the image of the grid was overlaid on each of the samples images, 
and the locations of the four fiducial points were measured with reference to the grid at 0 
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and 15% strain (Figure 13).   From this information, the horizontal and vertical distance 
between points was determined, and the Poisson’s ratio was calculated as follows:  
Equation 9. Poisson’s ratio 
l
t
ε
εμ = , where 
µ: Poisson’s ratio 
εt: transverse strain 
εl: longitudinal strain.  
 
Strain (ε) was defined as: 
Equation 10. Strain 
o
of
l
ll −=ε  , where 
lf: final length 
lo: initial length.   
 
 
 
 
 
 
Figure 13.  SIBS specimen (8.5% styrene) mounted on the ELF tester showing the location of the four 
fiducial points at (a) ε = 0 mm/mm and (b) ε = 0.15 mm/mm.  A 1 x 1 mm grid is shown overlaying the 
markers to quantify longitudinal and transverse strain.  In Photoshop® each one millimeter grid is 
subdivided into 5 segments, providing a measurement precision of 0.2mm.  A particularity of each point 
was used to identify its location at both strain locations. 
a) b) 
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To reduce measurement errors, a particularity of each point was used as a 
measurement reference.  At least five specimens were tested, taking into consideration 
that the standard deviation for each test was less than 10%. 
4.2.3. Hydrodynamic Testing 
The hydrodynamic function of a prototype valve is key to assessing its potential 
for development. This method determines whether a valve is either stenotic or 
regurgitant.  The hydrodynamic characteristics of the SIBS composite valves (listed in 
Table 5) were compared with two commercially available prosthetic valves: a St. Jude 
mechanical bileaflet valve and a Carpentier Edwards Magna pericardial prosthesis, both 
market leaders.  The St. Jude mechanical bileaflet valve is the most common choice for 
heart valve replacement when a mechanical valve is the valve of choice, whereas the 
pericardial bioprosthesis is one of the valves of choice for bioprosthetic valves.  The 
tissue annulus diameters for the SIBS and Magna valve were all 19 mm to allow a direct 
comparison between each; however, due to the lack of availability of a 19 mm 
mechanical valve, the St. Jude valve that was used had a 25 mm TAD. 
The nine SIBS valve designs represent the various designs outlined in Section 4.1.  
The various stent designs incorporate different geometries and SIBS grades, which allow 
one to determine the impact of stent flexibility on valve hydrodynamics.  By 
incorporating different leaflet manufacturing procedures and varying leaflet 
reinforcement fabrics, the orthotropic material properties of the leaflet can be 
manipulated, and their impact on valve hydrodynamics can be quantified.   
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Table 5.   Summary of valves subjected to hydrodynamic testing (refer to section 4.1 for the valve 
manufacturing procedure). 
Leaflet Stent 
Reinforcement 
Valve 
Design 
Type 
Orientation of 
Max 
Compliance 
Manufacturing 
Technique Geometry 
SIBS 
Grade 
1 Design 1 PET Mesh 1 (LARS) Circumferential Dip coating 
Low 
Profile 
30% 
Styrene
2 Design 2 PET Knit 1 (JSI) Circumferential Dip coating 
High 
Profile 
30% 
Styrene
3 Design 2 PET Knit 1 (JSI) Radial Dip coating 
High 
Profile 
30% 
Styrene
4 Design 3 PET Knit 1 (JSI) Circumferential Hybrid 
Medium 
Profile 
48.5% 
Styrene
5 Design 4 PET Knit 1 (JSI) Circumferential Dip coating 
Medium 
Profile 
48.5% 
Styrene
6 Design 4 PET Weave Circumferential Solvent Casting 
Medium 
Profile 
48.5% 
Styrene
7 Design 4 PET Mesh 2 (XA-47) Circumferential Solvent Casting 
Medium 
Profile 
48.5% 
Styrene
8 Design 4 PET Mesh 3 (NZ-11) Circumferential Solvent Casting 
Medium 
Profile 
48.5% 
Styrene
9 Design 4 PET Knit 2 (BARD) Circumferential Solvent Casting 
Medium 
Profile 
48.5% 
Styrene
10 Magna N/A N/A N/A N/A N/A 
11 St Jude Bileaflet N/A N/A N/A N/A N/A 
 
4.2.3.1. Vivitro Left Heart Simulator 
The valves were mounted in the aortic position of the Vivitro Systems 
(Vancouver, British Columbia) left heart and systemic circulation simulator (Figure 14).  
The system includes a processor-controlled stepper motor that drives a piston cylinder, 
resulting in contraction and relaxation of the left ventricular sac.  The flow loop consists 
of a mitral and aortic valve mounted in anatomical positions, an aortic outflow track 
including a sinus of valsalva, and models of characteristic and peripheral resistance and 
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compliance that allow the reproduction of systemic physiological flow and pressure 
waveforms (Figure 15).    
 
Table 6.  Specifications of cardiac outputs and heart rates for hydrodynamic testing of heart valves. 
Heart Rate 45 70 100 120 
Cardiac Output (L/min) 3.6 5.6 8.0 9.6 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14.  Schematic of the left heart and systemic circulation simulator: stroke volume 0-135 mL, aortic 
root compliance air volume 0-585 mL, characteristic compliance air volume 0-650 mL, valve mounting up 
to size 33 mm, blood analog fluid 2L 
 
 
4.2.3.2. Measurements and Outcome Measures 
Flow and pressure was measured for each of the valves at the combinations of 
cardiac outputs and heart rates presented in Table 6.  Aortic flow was measured with an 
electromagnetic flow probe and meter (Carolina Medical Electronics, King, NC) that is 
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mounted just below the aortic valve, as shown in Figure 14.  Ventricular and aortic 
pressures were measured with catheter-tipped piezoelectric pressure transducers (Millar 
Instruments, Houston, TX), and data acquisition and storage was carried out with an 
MP100 data acquisition system and software (Biopac Systems, Inc., Santa Barbara, CA).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15.  Typical pressure and flow waveforms showing (a) left ventricular pressure (mmHg), (b) aortic 
pressure (mmHg), (c) aortic flow (L/min), and camera trigger. 
 
Flow and pressure was recorded for each valve at the respective cardiac output 
and heart rate combinations.  Performance of the valves was assessed by measuring the 
mean transvalvular pressure drop during forward flow, the percent regurgitation during 
valve closure and while the valve was closed, and the effective orifice area (Equation 1).  
The values were averaged over 30 seconds of data acquisition, and three sets of 
measurements were taken for each valve and averaged.  An ANOVA and subsequent 
a 
b 
d 
c 
 66
post-hoc test was carried out, and any differences between each valve’s performance was 
considered to be of significance if p ≤ 0.05. 
As is evident from Figure 15, the pressure gradient across the valve is higher than 
what is expected for the natural valve; however, it is not high compared with other 19 
mm TAD prosthetic valves.  For example, Rosenhek et al. [76] reported the normal 
values of a variety of prosthetic valves through doppler echocardiographic measurements.  
For a 19 mm Bjork-Shiley tilting disk valve, the peak pressure gradient reported was 46.0 
mmHg and the mean pressure gradient was 26.67 mmHg.  For a Carpentier-Edwards 
stented bioprosthesis, the peak gradient was 43.48 mmHg, and the mean gradient was 
25.6 mmHg.  The 19 mm St. Jude Medical bileaflet valve was reported to have a peak 
gradient of 35.17 mmHg and a mean gradient of 18.96 mmHg.  The left heart and 
systemic circulation simulator cannot precisely match the natural system, but certain 
steps are taken to get the flow and pressure waves as close to the natural situation as 
possible.  For example, a physiological flow curve is produced that replicates the 
expected cardiac outputs in vivo, and a mean aortic pressure of approximately 90 – 95 
mmHg is established.  Not all left heart simulators can reproduce the same flow and 
pressure conditions.  As a result, a comparative test must be carried out, where 
commercially available valves are tested on the same system for comparison. 
4.2.4. SEM 
SEM images of the valve were used to assess the quality of surface coverage, the 
quality of the free edge, and the presence of defects.  Cyclic fatigue of the valve 
specimens can result in degradation of both the underlying fiber-reinforcement and the 
polymer itself.  These are not always visible to the naked eye, even with the use of a 
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microscope.  SEM will be used to provide a more thorough understanding of the fatigue 
mechanisms of the fiber-reinforced SIBS valve.   
The imaging technique is obviously a destructive one, so not all valves were made 
available for SEM analysis.  For the fatigued valves that were analyzed, a pre-fatigue 
valve was necessary to compare the quality of the leaflet surface and leaflet free edge 
prior to any cycling.  Particular attention was paid to surface smoothness and defects, 
such as cracks, holes, the presence of exposed reinforcement fibers, the presence of voids 
in cross-section, and the organization of reinforcement fibers (especially at the free edge).   
It must be noted that any exposed reinforcement fabric has been proven to have a 
devastating impact on in vivo valve function, as will be discussed in the Preliminary 
Results, Section 5.1.  For this reason, SEM can be used to evaluate the manufacturing 
process of the valve as well as how both the polymer and reinforcement fabric respond to 
cyclic fatigue.   
 
4.3. Specific Aim 2 – Finite Element Modeling 
Finite element modeling of the fiber reinforced heart valve was used to assess the 
affect of varying stent stiffness, fiber reinforcement, and leaflet geometry on the stress 
distributions in the leaflet.  According to previous studies, each of these three parameters 
has a large impact on the stress concentrations in the leaflet.  Vesely [21] reported that 
computational models have proven the advantage of flexible stent posts, a factor that has 
not been verified in vivo, and that the particular geometry of the coaptation region can 
have a large impact on leaflet stress concentrations, which was proven by a comparison 
of pericardial and porcine leaflets.  Pericardial leaflets, that tend to have a horizontal 
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coapting surface, have a higher concentration of stresses than do porcine leaflets.  By 
applying incremental changes to the finite element model for the properties of stent 
flexibility, valve geometry, and reinforcement architecture, one can illustrate which 
properties result in a stress minimization, and a valve prototype can be developed for 
testing and verification of whether these model properties are feasible for the production 
of a valve with suitable function and durability.  Ultimately, the objective was to find the 
best combination of these parameters in order to achieve a stress minimization, thereby 
increasing the potential for leaflet durability.   
4.3.1. Software 
Finite element modeling was carried out in ABAQUS (ABAQUS, Inc., 
Providence, RI), a simulation program capable of solving problems ranging from simple 
linear to complex nonlinear.  ABAQUS is capable of modeling structural 
(stress/displacement) analyses, heat transfer, mass diffusion, and acoustics, to name a 
few.   
All model geometry was designed in SolidWorks (SolidWorks Corporation, 
Concord, MA) and imported into ABAQUS/CAE (Complete ABAQUS Environment), 
where the complete model was created.  ABAQUS/CAE is a graphical environment 
which allows the creation of geometry, material properties, loads, boundary conditions, 
and meshes.  Once completed, the models can be submitted for analysis in either 
ABAQUS/Standard or ABAQUS/Explicit.  ABAQUS/Standard uses the implicit method 
to solve a system of equations at each increment, whereas ABAQUS/Explicit utilizes the 
explicit method, which steps the solution through time.  ABAQUS/Standard is a more 
general analysis tool that is capable of solving a variety of linear and nonlinear problems; 
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ABAQUS/Explicit is more specialized, and it can model transient dynamic problems, 
including nonlinear problems that involve changing contact conditions.  Once the 
analysis completes, results can be post-processed in ABAQUS/Viewer, a subset of 
ABAQUS/CAE. 
4.3.2. Model Description 
The models analyzed included those whose cylinder valve prototypes were tested 
in Aim 1 and additional theoretical models (refer to Table 7).  In total there were eight 
models that were analyzed, which accounted for three different stent varieties, four 
different leaflet varieties, and three different leaflet coaptation geometries.  The 
combination of the factors resulted in a total of four geometries, which are represented in  
Figure 16 - Figure 19. A full factorial was not run, as a total of 36 models would 
be required to accomplish this.  Instead, models were based on a selection of prototypes 
that were tested in both Aims 1 and 3, with the addition of four theoretical models that 
assessed the function of a non-reinforced leaflet, a valve mounted on a completely rigid 
stent, and various coaptation geometries.   
A schematic of the general valve prototype is provided in Figure 20, showing the 
locations of the leaflet commissure, coaptation, and belly; the stent; and the leaflet-stent 
junction.  Each valve consists of three identical leaflets that are securely attached to the 
supporting stent.  Each leaflet has a uniform thickness distribution that is defined by the 
particular reinforcement fabric and fabrication technique for the specific model.  
Although each third of the valve (including an individual leaflet and its corresponding 
stent third) is symmetrical and each individual leaflet has a symmetry plane, conditions of 
symmetry were not taken advantage of.  Instead, it was believed to be more beneficial to 
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model the valve as a whole in order to accurately represent the contact interactions 
between each coapting leaflet and to accurately represent the response of the stent to 
loading.   
 
Table 7.  Summary of valve models.  Refer to section 4.1 for the valve models that represent experimental 
prototypes, and refer to Figure 16 - Figure 19 for the specific valve geometries. 
Leaflet Stent 
Reinforcement 
Valve 
Type 
Orientation of 
Max 
Compliance 
Manufacturing 
Technique 
Coaptation 
Geometry Geometry 
SIBS 
Grade 
1 PET Knit 1 (JSI) Circumferential 
Design 2 
 8.5% SIBS 
Slight 
Curve 
High 
Profile 
30% 
Styrene 
2 PET Knit 1 (JSI) Radial 
Design 2 
 8.5% SIBS 
Slight 
Curve 
High 
Profile 
30% 
Styrene 
3 PET Knit 1 (JSI) Circumferential 
Design 4 
 8.5% SIBS 
Slight 
Curve 
Medium 
Profile 
48.5% 
Styrene 
4 None N/A 
Theoretical 
Isotropic 8.5% 
SIBS 
Slight 
Curve 
Medium 
Profile 
48.5% 
Styrene 
5 
PET Knit 
2 
(BARD) 
Circumferential Design 4 Slight Curve 
Medium 
Profile 
Theoretical, 
Rigid 
6 
PET Knit 
2 
(BARD) 
Circumferential Design 4 Slight Curve 
Medium 
Profile 
48.5% 
Styrene 
7 
PET Knit 
2 
(BARD) 
Circumferential Design 4 Theoretical, Flat 
Medium 
Profile 
48.5% 
Styrene 
8 
PET Knit 
2 
(BARD) 
Circumferential Design 4 
Theoretical, 
Larger 
Curve 
Medium 
Profile 
48.5% 
Styrene 
 
Previously, Liu et al. [44] modeled the SIBS valve leaflet as a laminated 
composite consisting of three layers: two isotropic, homogeneous outer layers and an 
inner fiber-reinforced composite. In Liu’s model, the SIBS leaflet was reinforced with 
individual polypropylene fibers.  In order to define the material properties, the individual 
properties of the SIBS and a polypropylene fiber were required.  The homogeneous, 
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isotropic properties of SIBS were used to define the homogeneous outer layers, whereas 
the Halpin-Tsai model was adopted to define the properties of the polypropylene-
reinforced inner layer by applying the properties of SIBS, polypropylene, and the volume 
percentage of polypropylene.  This method of establishing the material properties is not 
feasible for the particular model under investigation now because the reinforcement 
materials utilized are significantly more complex.  Commercially available multifilament 
polyester knits were used to reinforce the valve (refer to Table 7).  With these types of 
fabrics, fibers interact with each other, and when they are coated with SIBS, this 
interaction property changes.  As a result, the Halpin-Tsai model cannot predict the 
material properties of the fiber-reinforced layer from the knowledge of the individual 
properties of the knit and polymer.  Due to manufacturing constraints, it was impossible 
to separate the homogeneous outer layers of SIBS from the inner fiber reinforced layer 
for testing, so the material properties were determined, according to Sections 4.2.1 and 
4.2.2, for the full thickness of the material and input into the model.  For this reason, the 
leaflet was modeled as a homogeneous orthotropic shell instead of as a composite shell. 
 
 
 
 
 
 
 
Figure 16.  Geometry for models showing the a) top view and b) side view of the high profile stent with 
“slight curve” leaflet curvature. 
 
a) b) 
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Figure 17.  Geometry for models showing the a) top view and b) side view of the medium profile stent 
with “slight curve” leaflet curvature. 
 
 
 
 
 
 
 
 
Figure 18.  Geometry for models showing the a) top view and b) side view of the medium profile stent 
with “flat” leaflet curvature. 
 
 
 
 
 
 
 
Figure 19.  Geometry for models showing the a) top view and b) side view of the medium profile stent 
with “larger curve” leaflet curvature. 
a) b) 
a) b) 
a) b) 
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Figure 20.  Schematic of the (I) whole polymer trileaflet valve and (II) one third of the valve with interior 
detail.  Labeled segments represent the (a) stent, (b) area of coaptation, (c) commissure, (d) leaflet belly, e) 
stent-leaflet joint.  Embedded in the polymer is a reinforcement fabric. 
 
4.3.3. Boundary Conditions 
Generation of the geometrical model in SolidWorks was accomplished by 
designing one third of the valve, including the leaflet and attached stent, and creating a 
circular pattern to define the remaining two thirds.  In total, the model consisted of six 
individual parts (three leaflets and three stents), and the interactions between each 
component had to be specified.  ABAQUS does not recognize contact by the mere 
proximity of parts to one another, as a result, each individual contact and attachment 
constraint had to be specified by means of either a contact or tie condition, respectively.  
A summary of the boundary conditions is provided in Table 8, and a description of each 
condition is given below. 
Tie constraints can be used to tie two surfaces or node sets together so that each 
node on the slave surface is constrained to have the same motion as the node on the 
master surface that is in closest proximity.  This means that the translational and 
rotational degrees of freedom are constrained.  Tie constraints can effectively be used to 
a 
bc 
d
I 
e 
b
c 
II 
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model the attachment regions between adjacent stent thirds and between the stent and 
attached leaflet, thereby ensuring forces acting on the leaflet are transferred to the stent, 
and ensuring that the stent acts as one piece instead of individual thirds.  In the SIBS 
valve model, six tie constraints were defined in total: three to model the attachment 
between each leaflet and stent section (Figure 21a), and three to model the stent-to-stent 
connections along each individual post (Figure 21b). 
 
 
 
 
 
 
 
Figure 21.  Image showing the contact pairs between (a) a leaflet and its corresponding stent and (b) 
adjacent stents.  The tie constraint establishes a bond between adjacent stent thirds and between the 
contacting leaflet and stent sections.  This bond ensures that the nodes in closest proximity are restricted to 
move as one. 
 
In the SIBS valve model, contact interactions come into play during both diastole 
and systole.  During diastole the maximum pressure occurs on the aortic side of the 
leaflet, forcing the valve to close and the adjacent leaflets to coapt (Figure 22a).  During 
systole, the maximum pressure occurs on the ventricular side of the leaflets, forcing the 
leaflets to open.  When open, the leaflets are restricted from deforming past the stent, so a 
contact interaction develops between each corresponding leaflet and stent section (Figure 
22b).  In order to model contact in ABAQUS, the contact pairs and the constitutive 
a) b) 
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models governing the contact interactions had to be defined.  The finite-sliding contact 
formulation was instituted in the SIBS valve model as this formulation allows a 
continuous update during the simulation for the definition of which part of the master 
surface is in contact with the slave node.  The tangential frictional behavior between 
surfaces was defined according to the Penalty friction formulation, and a friction 
coefficient of 0.3 was selected as recommended by Sun et al. [62].  Sun et al. simulated 
the quasi-static loading of a bioprosthetic heart valve and experimented with friction 
coefficients ranging from 0.0 to 0.5.  As the friction coefficient was increased from 0.0 to 
0.3, an increase in the peak strain in the leaflet was observed; however, minimal increase 
in the peak strain was witnessed when the friction coefficient was increased from 0.3 to 
0.5.  As a result, the optimal friction coefficient was chosen to be 0.3.  The Penalty 
formulation was selected due to its ease of implementation for multiple contact 
formulations.  This method allows a small amount of elastic slip between contacting 
surfaces, and this slip is automatically calculated to be a small fraction of the 
characteristic element length. 
 
 
 
 
 
 
 
Figure 22.  Image showing the contact interaction pairs between a) coapting leaflet segments and b) leaflet-
stent contacting regions during systole.  The contact constraint alows the definition of the tangential 
frictional behavior between two contacting surfaces. 
a) b) 
 76
  
 
 
 
 
 
 
 
Figure 23.  Image showing the fixed boundary condition applied to the base of the stent.  A fixed boundary 
condition means that that base of the stent is restricted from either translating or rotating, making it a 
completely rigid restraint. 
 
Table 8.   A summary of the boundary conditions for all valve models.  A total of 13 boundary conditions 
was instituted. 
Type Location Description 
Tie Constraint Adjacent stent 
thirds (3 in 
total) 
This boundary condition constrains adjacent stent thirds so that 
they behave as one.  At the contact surface, nodes on the slave 
surface are constrained to move in the same manner as nodes on 
the master surface. 
Tie Constraint Contact point 
between leaflet 
and adjacent 
stent segment 
(3 in total) 
This boundary condition constrains the contact interaction 
between the nodes on the leaflet edge and the nodes on the 
surface of the contacting stent segment.  The nodes on the 
leaflet edge are constrained to move in the same manner as 
nodes on the stent surface. 
Contact 
Constraint 
Adjacent 
leaflets (3 in 
total) 
This contact constraint simulates leaflet coaptation during 
diastole.  Adjacent leaflets are restricted from moving past each 
other and tangential friction effects are specified to allow 
accurate simulation of contact. 
Contact 
Constraint 
Leaflet and 
adjacent stent 
segment (3 in 
total) 
This contact constraint prevents the leaflet from moving 
outward past the supporting stent, and once again tangential 
friction effects are specified to allow accurate simulation of 
contact. 
Fixed Boundary 
Condition 
Stent base (1 
in total) 
This boundary condition allows the simulation of valve restraint 
either in vitro or in vivo. 
 
During both in vitro testing and in vivo implantation of the SIBS valve, the valve 
is secured in place by an attachment at the stent base.  In vitro, a polycarbonate ring is 
bonded to the stent base, and this is secured in a silicone ring for placement in either the 
Vivitro hydrodynamic or fatigue tester; in vivo, a suture cuff is secured to the base of the 
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stent, and this is sutured into the aorta.  As a result, a fixed boundary condition was 
applied to the base of the stent to simulate its attachment criteria (Figure 23). 
4.3.4. Material Properties 
The material properties required for input into the FEM included the Young’s 
modulus (E), the Poisson’s ratio (ν), and the shear modulus (G).  The tensile and 
Poisson’s ratio properties for both the leaflets and stent were determined according to the 
procedures in Sections 4.2.1 and 4.2.2 and their resultant values are presented in Section 
5.  The specifics for each material model are discussed in detail below.   
The stent is fabricated from homogeneously isotropic compression molded SIBS 
of either 30 or 48.5% styrene content.  At the strain level experienced by the stent, these 
materials can be considered to be linearly elastic.  For linearly elastic materials, the 
properties can be completely defined by E and ν, and the shear modulus can be calculated 
as follows: 
Equation 11.  Shear modulus 
)1(2 ν+=
EG
 
 
The stress-strain relationship for the material is then given by: 
Equation 12.  Stress-Strain relationship for a linearly elastic isotropic material. 
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ABAQUS simply requires E and ν as input, and all other values specified in Equation 11 
and Equation 12 are calculated automatically.  For the theoretical, rigid stent (Table 7), 
the stent was also modeled as an isotropic, linearly elastic material instead of as a rigid 
body.  The main reason for this was ease of implementation.  Models already existed with 
the material definitions stated above, so it was easier to change the mechanical properties 
than to institute a rigid body definition.  In order to ensure the stent did perform as a rigid 
body, the Young’s modulus input was 10,000 times greater than the highest modulus 
input for any other model. 
The leaflet materials that were modeled included a polyester knit (Either JSI or 
BARD) that was either dip-coated or solvent cast with an 8.5% styrene SIBS.  When 
instituted as a valve leaflet, the primary directions of these orthotropic materials are 
oriented in the circumferential and radial directions.  The leaflet material response can be 
considered to be linearly elastic at the anticipated strain level, so the leaflet could be 
modeled as a linearly elastic orthotropic material.  In order to define the material 
properties, nine engineering constants were required, namely E1, E2, E3, ν12, ν13, ν23, G12, 
G13, and G23.  In the case of the valve leaflet, the 1- 2-, and 3-directions were considered 
to be the circumferential, radial, and through thickness directions respectively.  The 
Young’s moduli and Poisson’s ratio for the radial and circumferential directions were 
determined by the tests described in Section 4.2.1 and 4.2.2, but due to the fact that the 
through thickness properties could not be measured directly, the values were assumed to 
be that of pure 8.5% SIBS.  The shear modulus was defined according to Equation 11, 
and the stress-strain relationship is given by:     
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Equation 13.  Stress-strain relationship for orthotropic elasticity. 
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For the model evaluating the isotropic SIBS leaflets, the material was considered to be 
isotropic elastic, so the material was defined as outlined for the stent. 
4.3.4.1. Material Orientation and Coordinate System 
The valve was defined according to a rectangular coordinate system, and the 
origin of the global coordinate system was located at the exact center of the valve at its 
highest point (Figure 24).  For isotropic material components, directionality has no 
impact on the material properties, so no material orientation is required.  By default, the 
1-, 2-, and 3- directions refer to the global coordinate system. For orthotropic materials, 
however, the material properties are highly dependent on their orientation, so it became 
necessary to assign a local coordinate system for each individual leaflet and orient the 
material properties according to that system.  With this method, it was possible to orient 
the circumferential direction along local direction 1, the radial direction along local 
direction 2, and the through thickness or normal direction along local direction 3 (Figure 
25).  This allowed each leaflet to be defined according to their measured circumferential, 
radial, and through thickness properties.   
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Figure 24.  Model of valve showing the global coordinate system location at the highest central point of the 
valve. 
 
 
 
 
 
 
 
 
 
 
Figure 25.  Individual leaflet showing the location of the local coordinate system and the orientation of the 
1- , 2-, and 3(n)-directions. 
 
4.3.5. Loading Conditions 
A typical pressure waveform showing the ventricular, aortic, and transvalvular 
pressures obtained during the hydrodynamic testing of a SIBS valve is shown in Figure 
26.  From this figure, it is apparent that the pressure exerted on the valve is highly 
variable over time, and that the maximum transvalvular pressure acting on the valve 
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occurs during diastole, while the valve is closed.  With this knowledge in mind, a quasi-
static analysis procedure for leaflet stress evaluation was carried out.  The valve was 
loaded from a zero pressure state to the maximum diastolic load, where the transvalvular 
pressure load obtained from the hydrodynamic evaluation of the valve was applied to the 
aortic surface of the leaflets, resulting in a uniform pressure distribution.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26.  Characteristic aortic, ventricular, and transvalve pressure waveforms for a BARD reinforced 
SIBS trileaflet valve 
 
4.3.6. Elements and Mesh Optimization 
Heart valve leaflets, in general, are thin walled structures, and for the 19 mm 
TAD SIBS heart valves under investigation, the leaflet thickness ranged from 0.2 – 0.4 
mm.  The three types of elements that have been used to model heart valve leaflets in the 
past include continuum (solid) elements, membrane elements, and shell elements [63].  If 
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one were to model the leaflet with continuum elements, the element size would have to 
be very small due to the material thickness, resulting in the need for a high mesh density 
and, therefore, a computationally inefficient simulation.  In addition, to model the 
through-thickness stress distribution, several elements would be required through the 
thickness, resulting in an even higher mesh density.  As a result, characterizing the stress 
distribution through the leaflet with continuum elements is unlikely.  Membrane elements 
allow the simulation of a thin-walled structure such as a leaflet, but these elements have 
no bending stiffness; therefore, they are not appropriate for use in a heart valve leaflet 
that is being modeled through any bending criteria, such as those that occur during 
systole.  Shell elements also allow the modeling of thin structures; however, these 
elements can simulate bending events.  In addition, the shell element has multiple 
integration points through its thickness, so the stress variation through the thickness can 
be quantified.  As a result, shell elements were determined to be most appropriate for 
modeling the SIBS valve leaflets, resulting in the selection of an ABAQUS-type S4R 
element.  The S4R element is a general purpose shell element that allows transverse shear 
deformation.  It is a finite-membrane-strain, reduced integration, quadrilateral shell 
element that is suitable for modeling contact.   
The valve stent could not be considered as a thin-walled structure, so it was 
modeled with the C3D8R ABAQUS element type.  This is an eight node linear brick 
element with reduced integration and hourglass control.  The S4R and C3D8R element 
types are compatible when applying a tie constraint between shell and continuum 
elements. 
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Although ABAQUS is equipped with an adaptive remeshing capability where it 
can iteratively improve the mesh in order to achieve a more accurate solution, it was 
found to be more beneficial to perform a manual mesh optimization.  Upon using 
adaptive remeshing, an unrealistically fine mesh was developed that would result in a 
computational time on the order of days.  In order to perform the manual mesh 
optimization, four different models were run, and the mesh density was varied by 
changing the seeding density for the model.  The four different seeding densities that 
were applied included 0.25, 0.30, 0.40, and 0.50 accounting for a total mesh size of 
18,594, 13,407, 6,882, and 4,434 elements respectively.  A quasi-static diastolic load was 
applied to the leaflet, and the models that were generated were compared by qualitatively 
evaluating the stress distribution trends over the leaflet and quantitatively comparing the 
magnitude and location of the maximum stress.  On qualitative analysis, all four models 
had the same stress distribution trends over the leaflets and stent.  By comparing the 
percent difference between the maximum stresses, a 1.35% difference existed when the 
seeding density was changed from 0.25 to 0.3, a 7.3% difference existed when the 
seeding density was changed from 0.3 to 0.4, and a 6.24% difference existed when the 
seeding density was changed from 0.4 to 0.5.  The computational time ranged from 30 
minutes to 24 hrs for the minimum and maximum mesh densities, respectively.  As a 
result, a 0.35 seeding density was chosen to maximize computational efficiency while 
maintaining accuracy.  This was not one of the seeding densities analyzed, but the 0.3 – 
0.4 seeding density range was determined to be sufficient as it resulted in less than a 10% 
change to the maximum stress. 
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4.3.7. Solution Method 
A quasi-static analysis technique was implemented to model each valve type 
presented in Table 7.  The quasi-static analysis was carried out utilizing the implicit 
method, and the valve was subjected to diastolic loading from 0 MPa up to the maximum 
diastolic load, along the characteristic loading curve (Figure 26). 
4.3.8. Model Validation 
4.3.8.1. Transient Geometry Analysis 
The transient geometry of the PET Knit 2 (BARD) – reinforced valve prototype 
(listed in Table 5 and shown in Figure 27) was investigated using the Vivitro Left Heart 
Simulator, dual camera stereo photogrammetry (DCSP), and surface reconstruction.  The 
information obtained from the transient geometry analysis method was used to validate 
the corresponding finite element model.  The valve was mounted in the aortic position of 
the Vivitro Left Heart Simulator (refer to section 4.2.3), and leaflet motion was measured 
under normal physiological flow conditions, with a heart rate of 70 beats/min, a cardiac 
output of 5.6 liters/min, and a pulse pressure of 120/80 mmHg. A time series of 
photographs was taken during both the opening and closing phases, and image 
reconstruction allowed the quantification of leaflet displacement during the cardiac cycle.   
 
 
 
  
 
Figure 27.  BARD-reinforced SIBS valve with medium coaptation curvature and 48.5% styrene stent.  
Image shows (a) top and (b) oblique view including the leaflet marked with approximately 120 fiducial 
points. 
a b
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4.3.8.1.1. Image Acquisition 
Dynamic leaflet motion was monitored using the DCSP method described by Gao 
et al. [60] and Lee et al. [45, 61].  This is a two-phase procedure, where two identical 
cameras are focused on the same object to simultaneously acquire images from two 
different angles.  The 3-D coordinates of markers on the object were then calculated from 
each pair of simultaneous digital images. 
The aortic valve mounting chamber of the Vivitro was modified to obtain an 
optical window into the aortic channel.  An acrylic endoscope-mounting chamber was 
manufactured and attached to the exterior surface of the ventricular chamber to allow the 
endoscope tips to be bathed in the same blood-analog fluid that the valve was exposed to, 
thereby assuring the same refractive index in both the valve and endoscope environments 
for image acquisition (Figure 28a-c).  The leaflet was marked with approximately 120 
fiducial points of 0.2 mm diameter (Figure 27).  Two Sony ST30 CCD cameras (Sony, 
San Jose, CA, USA) with attached Slim 12 Hawkeye Borescopes (Hawkeye Gradient 
Lens Corporation, Rochester, NY, USA) acquired images of a single valve leaflet at an 
angle of 30° from the horizon and 30° between each other (Figure 28).  This orientation 
was chosen as it resulted in the best reconstruction of 3-D structures of known 
dimensions by Lee [61] and further verification by this researcher during reconstruction 
of gage blocks of known dimensions.   
The Vivitro Left Heart Simulator was set to run at the physiological heart rate and 
cardiac output combination stated above, and a function generator was used to trigger 
both cameras to allow image acquisition by the frame grabber (Coreco Viper-Quad) at a 
frame rate of 2 Hz.  Simultaneously, the pressure and flow data for the valve was 
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acquired with the MP100 data acquisition system and software (Biopac Systems, Inc., 
Santa Barbara, CA), and the trigger pulse was fed into this system via a pulse elongation 
circuit.  By collecting the trigger pulse in combination with the pressure and flow data, 
the exact location of image acquisition during the cardiac cycle can be known.  A pulse 
elongation circuit was required in order for the MP100 system to recognize the trigger 
signal.   A fiber-optic light was employed to illuminate the field.  A schematic of the 
image acquisition set-up is provided in Figure 29, and an example of the Biopac data, 
including the ventricular and aortic pressures, aortic flow, and trigger pulse, is provided 
in Figure 15. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28.  Image acquisition set-up showing (a) how the borescopes are inserted into the acrylic 
endoscope mounting chamber, (b) the orientation of each camera and associated borescope, (c) the location 
of the valve with respect to each borescope, and (c) the image generation on the imaging PC. 
a 
c 
b 
d 
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Figure 29.  Schematic of the image acquisition system for imaging valves undergoing hydrodynamic 
testing. 
 
4.3.8.1.1. Image Reconstruction and Analysis 
From the acquired image sequences, image pairs were selected that represented a 
total of 8 different locations during the cardiac cycle.  In addition, a baseline image pair 
was acquired, which represented the leaflet geometry under no load.  The 3-D 
coordinates of the marker matrix were derived using Photomodeler® (Eos Systems Inc., 
Vancouver, BC), and these were used to reconstruct the contour of a leaflet during the 
opening and closing phases of the cardiac cycle.  A MatLab code was employed to 
reconstruct the scatterplot of the marker matrices for qualitative comparison of the 
general leaflet geometry.  For quantitative validation of the model, three select points 
were chosen, and the distances between each pair was computed from the knowledge of 
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their x, y, and z coordinates (Figure 30).  The same approximate three nodes were 
selected from the finite element model, and the distances between each were computed.  
This was repeated at each time step corresponding to the 9 image pairs obtained 
experimentally, and the experimental and model values were compared.  The three 
particular points were selected to represent three different areas within the valve that 
produce different phenomena during cycling.  Distances between points were chosen to 
validate the model, rather than displacement of the points with respect to the unloaded 
case, as Photomodeler® lacked the capability of providing a uniform coordinate system 
from one image pair to the next.  As a result, there were slight variations between the 
coordinate systems of each consecutive image pair, and the coordinates of points 
obtained from one image pair could not be associated with those from a different time 
step.  Another short-coming of the procedure was that it was not always possibly to have 
the exact same time points represented for both the model and experimental data.  The 
closest time point available from the model results was used for comparison with the 
experimental. 
4.3.8.2. Stent Deflection 
To further validate the model, stent deformation during the cardiac cycle was 
measured by imaging the BARD valve from above.  Images were processed in Adobe® 
Photoshop®, where the distance between each adjacent stent post was quantified (Figure 
31).  Each image was overlaid with a grid, and the grid was scaled with the known 
dimensions of the valve in the horizontal and vertical directions.  Dimension lines were 
drawn between each adjacent stent post, and the horizontal and vertical offset from one 
post to the next was measured.  The distance between posts was then calculated using 
 89
Pythagorus’ theorem.  This dimension was then compared with that from the output of 
ABAQUS at the corresponding point in the cardiac cycle. 
 
 
 
 
 
 
 
 
Figure 30.  Quantitative validation of point-to-point distances between the experimental DCSP method and 
the finite element model. Points were selected on the image, and the distances between each was computed 
from the knowledge of their 3-D coordinates.  The corresponding points were selected on the 
corresponding finite element model (right), and the distances between each were computed for comparison. 
 
 
 
 
 
 
 
 
 
 
Figure 31.  Photoshop® image showing grid overlay and stent post dimension lines. 
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4.4. Specific Aim 3 – Durability Assessment 
The prediction and/or quantification of durability are vitally important for the 
development of devices exposed to cyclic fatigue as premature failure will have 
catastrophic results.  For heart valves, failure will certainly result in death to the patient if 
warning signs are not evident and failure is instantaneous.  Characterization of the 
durability of a valve is not simply a requirement established by the FDA, it is a necessity 
when developing a device for anticipated long-term fatigue.  Cyclic testing under 
simulated physiological conditions can provide a wealth of knowledge as to the failure 
modes and lifespan of a device, and can guide future design and development.  In vitro 
accelerated fatigue can provide evidence as to the anticipated durability of a device, but 
the only conclusive method to evaluate its true durability is to place it in the intended use 
environment, where mechanical and biological mechanisms work in collaboration.  
Nevertheless, comparative in vitro testing during device development can certainly guide 
design by indicating potential weaknesses in the design.  The downfall to in vitro testing 
is that it is time-consuming, so a modeling approach to fatigue prediction is proposed for 
incorporation into the design and development process of the SIBS trileaflet valve. 
4.4.1. Accelerated Fatigue Testing 
4.4.1.1. Cyclic Tensile Testing 
Tension fatigue tests were performed according to ASTM standard D 3479M – 
96, using the ELF materials tester.  The materials’ properties were evaluated in air and 
under load control, where loading amplitude was set at ± 10% of the mean load.  The 
load magnitude used for each specimen was progressively lowered from the static failure 
magnitude until a sufficient amount of data points existed to create an S-N curve.  A load 
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frequency of 100 Hz was adopted.  Cycling was continued until failure, which was 
defined as a strain of 0.5.  If a specimen reached 350 million cycles (equivalent to 8.75 
yrs) without failure, the test was stopped and the sample was considered to have an 
infinite life for that stress as it appeared to be below the endurance limit.  Although 
mechanical valves need to prove to be durable for an equivalent of 600 million cycles (15 
yrs), it will take 70 days to reach this point at a cycling rate of 100 Hz, so it was assumed 
that an equivalent of 8.75 yrs of fatigue was sufficient for this case.   
As with the static tensile tests, leaflets were fabricated in the same manner as for 
valve fabrication, and radial, circumferential, and samples 45° between those two were 
stamped out and tested.  The resultant S-N curves were fit to logarithmic trend lines for 
input into the fatigue model. 
4.4.1.2. Valve Durability Testing 
Accelerated fatigue testing of valves was carried out on a Vivitro Systems Hi-
Cycle accelerated fatigue tester (VSI HCS4991, Vancouver, British Columbia) (Figure 
32).  Prior to placement in the Hi-Cycle, valves were catalogued in terms of their lot 
number, design specifications, sterilization history, overall quality, and hydrodynamics.    
Valves underwent hydrodynamic evaluation, as per procedure 4.2.3.  This served as 
baseline data for comparison with incremental fatigue time-points. 
Valves were secured in the Vivitro Hi-Cycle in the orientation shown in Figure 
32.  Six valves can be tested simultaneously, but in order for the system to remain 
balanced and all of the valves to be subjected to the same testing conditions, the valves 
must be equivalent in both size and hydrodynamic properties.  Valves were cycled at 
1200 cycles/min (20 Hz) at a backpressure of 90 +20/-0 mmHg, which is specific for the 
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testing of aortic valves. The amplitude of the system was adjusted to provide complete 
valve opening and closing, which was verified with that during hydrodynamic testing at 
70 BPM and 5.6 L/min.  Incremental checkpoints for the valve included a 1-2 day 
evaluation of transvalvular pressure drop, a macroscopic evaluation every 25 million 
cycles, and a microscopic and hydrodynamic evaluation every 75 million cycles.  Valve 
failure was defined when during hydrodynamic testing, the transvalvular pressure drop 
and regurgitation increased to more than three times that of the pre-fatigue evaluation or 
if upon qualitative examination, the valve receives a rating of 5 as specified in Appendix 
III: Table 18.  Valves that failed were catalogued photographically, and their failure 
mechanism was reported. 
The Hi-Cycle system comes equipped with a temperature controller, which allows 
the working fluid (0.2 % glutaraldehyde/water solution:  glutaraldehyde is an effective 
bacteriostat) to be maintained at 37°C throughout the testing procedure.  Inline pressure 
transducers (Utah Medical 6069) allow for rapid transvalve pressure monitoring through 
the use of the monitoring software included with the test system (Vivitest Software, 
Vivitro Systems).  The FDA and ISO 5840 specifications state that the transvalve 
pressure drop must be maintained over 95% of the cycles.  A typical plot of a tuned 
chamber is provided in Figure 33, showing a peak pressure drop of 90 mmHg.  The peak 
mmHg, measurement on the lower left hand side shows the average pressure drop 
measured during the recording period.  When this value is in red, the specified pressure 
drop is not achieved over 95% of cycles.  When this value is in green, however, it is. 
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Figure 32.  Vivitro Systems Hi-Cycle including schematic of chamber where valve is seated. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33.  Vivitest software for the acquisition, analysis, and display of heart valve test data showing the 
inflow, outflow, and transvalve pressure, where the peak transvalve pressure is at 90 mmHg. 
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4.4.2. Fatigue Prediction 
An initial fatigue predictive model is proposed for the cyclic tensile fatigue of flat 
leaflet samples evaluated in section 4.4.1.1.  The initial production of an S-N curve is 
required to assess the relationship between mean stress and cycles to failure.  It is this 
relationship that can be incorporated into a predictive model to assess for the impact of 
varying stress conditions on the fatigue life of the sample.   
The heart valve leaflets undergo complex loading as the valve alternates between 
tension and flexion during one cardiac cycle.  The period in which these alternate loading 
conditions are applied is highly dependent on the heart rate: as the heart rate increases, 
the diastolic loading period decreases.  Initially, the model proposed above will be 
adapted for the trileaflet valve, where only loading during diastole will be accounted for.   
The stress history obtained in the finite element model (section 4.3.2) will be 
incorporated into the fatigue lifetime prediction model for solution, and the impact of 
tension fatigue will be examined.  The derived models will be validated by experimental 
results from the accelerated fatigue testing of valves in the Vivitro Hi-Cycle (section 
4.4.1.2).       
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5. RESULTS AND DISCUSSION 
This section is divided into three primary parts: the first involves the preliminary 
evaluation of valve design to assess the appropriate leaflet-stent attachment technique and 
leaflet reinforcement material properties; the second covers a rigorous assessment of 
potential reinforcement materials and design parameters for leaflet stress minimization 
and improved durability; and the third involves the implementation of a fatigue prediction 
model.  By separating this section into the above-mentioned parts, the motive behind 
extreme design changes can be made apparent, and the limitations of potential 
reinforcement materials can be understood. 
It should be noted that all valve and valve components were manufactured by the 
same technician.  In so doing, the manufacturing process could remain consistent, and 
differences could be attributed to design variations as opposed to technician-related 
changes. 
5.1. Preliminary Evaluation for Valve Design 
There were three preliminary valve design iterations that were evaluated for in 
vitro hydrodynamics and accelerated fatigue (Design 1 – Design 3 Table 3).  The most 
successful of each of these designs were utilized in simultaneous in vivo studies.  Each of 
the valves tested were the specified size for testing in an ovine model, that is, they all had 
a 19 mm tissue annulus diameter (TAD).  For design 2, a variety of leaflet reinforcement 
materials and manufacturing techniques were instituted to assess their impact on valve 
durability, thereby refining what characteristics for leaflet design are optimal.   
Accelerated fatigue testing of valves began with Design 1, which consisted of an 
open polyester (PET) mesh (LARS® mesh) that was sandwiched between SIBS (8.5% 
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styrene).  The failure mechanisms associated with Design 1 (refer to section 5.1.2) 
resulted in the need for a more dense reinforcement fabric and a more secure leaflet stent 
attachment technique.  As a result, a combination of different PET reinforcement fabrics 
and polymer coatings were selected for use in Design 2.  The reinforcement fabrics 
included the original LARS® mesh (as a baseline comparison), a more dense Athletic 
mesh, a weave, and a Dacron knit.  The polymer coatings included the original 8.5% 
styrene coating and a more porous 16% styrene coating.  It was hypothesized that the 
porous coating would provide less resistance to flexion, thereby improving valve 
hydrodynamics.  Design 2 leaflets were made by heat-sealing the flat fabric samples into 
a cylinder with the maximum stretch oriented circumferentially.  The fabric was dip-
coated twice in the particular polymer solution, and the leaflet cylinder was attached to 
the high-profile, flexible, 30% styrene stent by means of sutures.  The trileaflet geometry 
was attained by thermal forming with three spherically shaped mandrels. 
The Dacron reinforcement was found to provide the longest fatigue life (refer to 
section 5.1.3) in combination with the 8.5% styrene coating.  As a result, Design 3 was 
manufactured in much the same manner as Design 2, except that the leaflet surface was 
smoothed by the addition of a compression molding process, and the stent stiffness was 
increased through a combination of geometry changes and the use of a 48.5% styrene 
SIBS.  
Each of the valves underwent accelerated fatigue testing in the Vivitro Hi-Cycle, 
and the three most successful designs were selected for in vivo implantation [14].  
Although the in vivo studies are not a part of this particular investigation, it must be noted 
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that important findings during these studies have contributed to design changes, and they 
will be noted in the text.   
5.1.1. Hydrodynamic testing 
Hydrodynamic testing of the Design 1 – Design 3 valve iterations was carried out 
according to the methods presented in Section 4.2.3.  It is quite obvious from the results 
presented in Figure 34 and Figure 35 that a progressive improvement was made in the 
hydrodynamic function from one design to the next; there was a decrease in the 
transvalvular pressure drop and percent regurgitation with each new design.   
 
 
 
 
 
 
 
 
 
 
Figure 34.  Mean transvalvular pressure drop during forward flow for SIBS valve designs 1, 2, and 3. 
 
A decrease in the pressure drop from Design 1 to Design 2 can be explained by 
the initial valve geometry.  The unstressed valve geometry for Design 1 is spherical, so in 
order to open the valve, a complete inversion of curvature is required.  For the two 
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designs of cylinder valves, the curvature of the leaflet is not as extreme; therefore, less 
force would be required to invert this curvature during systole.   
As far as the regurgitation, design changes to the coaptation region can impact 
regurgitation, especially if these changes prevent efficient coaptation.  In the Design 1 
valve, the coaptation region is completely flat, and for Designs 2 and 3, a slight curvature 
is incorporated.  Design 2, however, has a more flexible stent; therefore, more internal 
flexion of the stent occurs during diastole, making coaptation different from that of 
Design 3.     
 
 
 
 
 
 
 
 
 
 
Figure 35.  Percent regurgitation measured while the valves are closed and closing for SIBS valve designs 
1, 2, and 3. 
 
5.1.2. Design 1 
Design 1 valves that were exposed to accelerated fatigue failed at an average of 
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between the mesh interstices (Figure 36).  The leaflets were bonded to the stent with the 
same polymer solution used for leaflet dip-coating, which proved to be insufficient.  Even 
if the bond was reinforced, the problem remained that the polymer between the mesh 
interstices that was unreinforced did not have the structural integrity to withstand the load 
acting on it, resulting in the polymer blowout that was seen. 
 
 
Figure 36.  Design 1 valve after an equivalent of 0.628 years of cycling.  Failure was as a result of leaflet-
stent detachment and polymer blowout from between the mesh interstices 
 
5.1.3. Design 2 
Based on the failure mechanisms of Design 1, two major design changes were 
made to the polymer valve.  Firstly, the use of polymer bonding between the leaflet and 
stent was replaced with sutures to allow a more secure attachment.  Secondly, varying 
reinforcement fabrics were investigated for use in this design.  The first prototype valve 
incorporated the original LARS® reinforcement.  Failure occurred at an equivalent of 
0.908 years of cycling as a result of polymer blowout from between the mesh interstices 
(Figure 37a).  This design adjustment did result in an increase in valve durability, but the 
reinforcement mesh was insufficient.  As a result, a more dense reinforcement fabric was 
required, and this prompted the simultaneous testing of a dense mesh (Athletic mesh), a 
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weave, and a knit (Dacron).  The processing technique for each was the same, but 
accelerated fatigue of these samples resulted in failure due to varying mechanisms.  The 
weave-reinforced valve failed at an equivalent of 0.943 years as a result of fraying at the 
free edge and fabric separation at the leaflet base (Figure 37b); the Athletic mesh-
reinforced valve failed at an equivalent of 1.38 years due to polymer degradation from 
between the larger interstices and actual mesh fracture at the leaflet belly (Figure 37c); 
and the Dacron reinforced valve failed at an equivalent of 10.35 years as a result of a 3-
fold increase in transvalvular pressure drop when compared with pre-fatigue 
hydrodynamic testing (Figure 38).  It must be noted that the weave was oriented so that 
the fibers ran in the circumferential and radial directions, so along the free edge, 
individual fibers had nothing but the polymer matrix to hold them in place.  From Figure 
38, distinct deposits are seen on the Dacron leaflet surface, so the valve was dissected and 
sent for SEM (Figure 39).  Non-fatigued samples (Figure 39a), fatigued samples (Figure 
39b), and samples that had been fatigued and then processed in toluene were evaluated 
(Figure 39c).  The toluene effectively dissolved the polymer coating, but even when the 
polymer was removed, the deposits still remained.  An elemental analysis performed by 
SEM-EDS revealed that the deposits were in fact silicone, which is not a constituent of 
the valve itself; therefore, it was concluded that valve failure was as a result of silicone 
deposits that had leached from the testing system and was not design related. 
The natural heart valve leaflet is more compliant in the radial direction than in the 
circumferential direction (Figure 40a), but the particular orientation that was used for 
each of the valves thus far showed opposite trends (Figure 40b).  Further Dacron valves 
were manufactured where the fabric orientation was switched to allow greater 
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compliance in the radial direction.  These valves failed at an equivalent of 2.72 (Figure 
41a) and 6.12 years (Figure 41b) as a result of stent fracture and hole formation in the 
mid-leaflet region, respectively.  It was concluded that the increased stiffness in the 
circumferential direction resulted in higher stress concentrations in both the stent and 
leaflet, resulting in the modes of failure seen. 
 
   
 
 
 
 
 
 
 
Figure 37.  Varying iterations of the dip-coated thermal-formed design 2 valves including different 
polyester reinforcement fabric: (a) LARS® reinforcement mesh failure mode was polymer blowout from 
between mesh interstices at an equivalent of 0.908 yrs, (b) PET weave failure mode was weave degradation 
at an equivalent of 0.943 years, and (c) athletic mesh failure mode was polymer and mesh degradation at an 
equivalent of 1.38 years. 
 
 
 
Figure 38.  Dacron reinforced valve with maximum stretch oriented circumferentially.  Note the surface 
deposits on the leaflet that resulted in a 3-fold increase in transvalvular pressure drop at 10.35 years. 
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Figure 39.  SEM images of the Dacron-reinforced valve shown (a) prior to cycling, (b) after cycling an 
equivalent 10.35 years, and (c) after cycling an equivalent 10.35 years and subsequent polymer dissolution.  
The silicone deposits are denoted by the white arrows. 
 
 
 
 
 
 
 
 
 
Figure 40.  Stress-strain relationship in the radial and circumferential direction for (a) natural porcine valve 
leaflets (adapted from Li et al. [50]) and (b) dip-coated JSI leaflets with maximum elongation oriented 
circumferentially. 
 
 
Figure 41.  Dacron-reinforced valve with maximum stretch oriented in the radial direction.  The failure 
mode was a combination of stent fracture (equivalent 2.72 years) and hole formation (equivalent 6.12 
years) in the belly of the leaflet as a result of unphysiologically high stress in the circumferential direction. 
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A further assumption was made that by switching from the non-porous coating 
with an 8.5% styrene SIBS to a porous coating with a 16% styrene SIBS, an 
improvement in the hydrodynamic function of the valve could be achieved due to greater 
leaflet flexibility.  While the change in polymer had minimal impact on the 
hydrodynamic function of the valve, the increase in SIBS stiffness due to the increased 
styrene content resulted in the premature formation of cracks as shown in Figure 42.  The 
increased styrene content appeared to result in crack formation orthogonal to leaflet 
bending. 
 
 
Figure 42.  SEM image of aortic leaflet surface of a Dacron cylinder valve dip-coated in a porous 16% 
styrene SIBS solution.  On the right image, cracking is seen after cycling an equivalent of 5.06 years. The 
sketch identifies the location of the crack formation.   A white arrow points to some instances of crack 
formation. 
 
 104
Based on these results, the dip-coated SIBS (8.5% styrene) with circumferential 
stretch appeared to have the most promising durability, and it was this valve that was 
chosen for in vivo evaluation.  Valve failure in vivo was as a result of excessive stent 
flexure and severe tissue overgrowth.  The tissue overgrowth was originally hypothesized 
to be as a result of the surface roughness: the dip-coating procedure results in a polymer 
surface that follows the topology of the underlying Dacron, and it is for this reason that 
Design 3 incorporated a compression-molding technique to smooth the leaflet surface.  In 
addition, the stent stiffness was increased and the profile reduced to minimize stent 
flexibility. 
5.1.4. Design 3 
The manufacturing procedure adopted for Design 3 initially included the pure 
compression molding of a 3-D laminate.  Accelerated fatigue of this design showed 
failure at 0.635 years as a result of tear formation at the center of coaptation (Figure 43).  
An SEM image of the leaflet cross section (Figure 44) showed that the Dacron mesh was 
highly compressed between the two polymer layers, potentially resulting in increased 
residual stress in the leaflet fabric that could have contributed to premature failure.  The 
compression molding process resulted in a decrease in the circumferential compliance of 
the leaflets as determined through qualitative stretching. 
Further developments to smooth the surface of the leaflet involved a fusing of the 
dip-coating and compression-molding techniques, referred to as a hybrid.  This hybrid 
technique incorporated the initial dip-coating of the leaflet and then compression-molding 
at a reduced pressure when compared with the purely compression-molded valve.  This 
hybrid valve had favorable hydrodynamics as reported above, but failure of the valve 
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occurred at an equivalent of 1.5 years due to tear initiation at the heat-sealed joint (Figure 
45).  The heat sealed joint at this stage had been reduced in cross-sectional area when 
compared with Design 2 for aesthetic reasons, but the failure mode resulted in the return 
to the original heat-seal geometry. 
 
 
 
 
 
Figure 43.  Dacron-reinforced compression molded valve showing failure due to tear formation at the 
center of coaptation at an equivalent of 0.635 years. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 44.  SEM of cross section of compression-molded leaflets.  Note how the reinforcement fabric is 
crushed between two layers of polymer. 
 
 
 
 
 
 
 
 
Figure 45.  Dacron reinforced hybrid valve showing failure due to tear initiation at the heat sealed joint at 
an equivalent of 1.5 years. 
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Figure 46.  SEM images of the leaflet free edge and aortic surface of SIBS valve designs 1, 2, and 3.  
Samples were excised from freshly manufactured valves.  The white arrows denote exposed polyester 
fibers.  At the leaflet free edge, exposed fibers are expected due to how the edge is cut and exposed, but the 
leaflet surface should not have exposed fibers. 
 
5.1.5. SEM 
In vivo studies carried out on the three valve designs showed an inflammatory 
reaction due to Designs 2 and 3, but none due to Design 1.  So the question one might ask 
is: why did the second two designs cause an inflammatory response but the first did not?  
Dacron is known to elicit an inflammatory response in vivo [71], but the assumption was 
that if it was sufficiently coated, it would not do this.  The problem arose when the 
Dacron was not sufficiently coated.  It can be seen from the SEM images (Figure 46) that 
both the cross section and leaflet surface of Design 1 have good fabric covering when 
compared with Designs 2 and 3.  The present manufacturing technique for the valve 
SEM Stage 
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means that there is going to be uncoated Dacron at the free edge, but in Designs 2 and 3, 
uncoated Dacron fibers escape on both the free edge and the surface.  These uncoated 
fibers could have triggered the immune response witnessed. 
An even more noticeable finding was seen after fatigue of the samples:  The 
underlying Dacron from Designs 2 and 3 appears to have unraveled at the free edge and 
crept to the surface along the body of the leaflet.  This increase in fiber exposure due to 
fatigue could have further contributed to the inflammatory response seen in vivo. 
 
 
Figure 47.  SEM images of the leaflet free edge and aortic surface of SIBS valve designs 2, and 3.  
Samples were excised from valves subjected to accelerated fatigue testing for an equivalent of 1.25 years. 
The white arrows denote exposed polyester fibers.  Note the increase in fiber exposure on both leaflet 
surfaces and the fraying of fibers at the free edge. 
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5.2. Design Refinement and Quantification for Improved Durability 
Based on these results, it was determined that the best combination of features for 
the trileaflet valve included: 
 The stiffer, medium profile stent from Design 3 
 The cylinder valve design from Designs 2 and 3 
 The more dense leaflet reinforcement fabric from Designs 2 and 3 
 The thinner leaflet reinforcement fabric from Design 1 
 A leaflet manufacturing process that resulted in complete coverage of the underlying 
reinforcement fabric like what was achieved in Design 1 
 The lower styrene content leaflet matrix polymer. 
A stronger supporting stent is required to prevent the excessive deformations seen in vivo 
for the 30 % styrene, high profile stents; the cylinder valve design allows a more secure 
leaflet-stent attachment technique and a better leaflet curvature in terms of reduced 
pressure drop; a more dense leaflet reinforcement fabric is needed to provide adequate 
structural support for the SIBS matrix; the lower styrene content (8.5%) leaflet polymer is 
preferred to prevent polymer cracking and fiber exposure; and a thinner leaflet 
reinforcement fabric in combination with a new polymer coating technique is preferred to 
allow adequate coating of the reinforcement with SIBS without resulting in excessive 
leaflet thickness.  It should be noted that the nominal thickness of the Dacron 
reinforcement is 0.3 mm, while the LARS® reinforcement is only 0.15 mm, and the dip-
coated thicknesses are 0.40 mm and 0.21 mm respectively.  
Based on these results and the preliminary in vitro and in vivo experiments 
presented by Gallocher, Schoephoerster, and Wang et al. [7, 10, 11, 12, 13, 14], it was 
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determined that the preferred reinforcement mesh would be one with a maximum 
thickness of approximately 0.20 mm and a density sufficient to prevent the visual 
exposure of non-reinforced SIBS.  The materials chosen for leaflet reinforcement were 
restricted by what was commercially available.  Materials with suitable mechanical and 
biological properties included polyester (PET) and polypropylene, but only PET fabrics 
were found that met the above criteria. 
5.2.1. Leaflet Design and Manufacture 
Due to the unsatisfactory results obtained with the dip-coating and compression 
molding manufacturing techniques from Design 2 and Design 3, a solvent casting 
procedure was developed to ensure the uniform and complete coating of the 
reinforcement fabrics.   The solvent casting technique in combination with the new fabric 
reinforcements allowed the production of leaflets whose overall thickness was less than 
0.25 mm (Table 9).   
 
Table 9.  Summary of uncoated and coated thicknesses of the dip coated Dacron and all samples 
manufactured by solvent casting.  The precision of the digital calipers is provided.   
Reinforcement 
Fabric 
Uncoated 
Thickness 
(± 0.005 mm)
Coated 
Thickness 
(± 0.005 mm) 
Leaflet 
Manufacturing 
Technique 
PET Knit 1 (JSI) 0.30 mm 0.45 mm Dip-coating 
PET Weave 0.15 mm 0.20 mm Solvent casting 
PET Mesh 3 (NZ 11) 0.21 mm 0.26 mm Solvent casting 
PET Mesh 1 (XA 47) 0.16 mm 0.20 mm Solvent casting 
PET Knit 2 (BARD) 0.15 mm 0.20 mm Solvent casting 
 
5.2.2. Experimental Evaluation 
The material formulations presented in Table 9 were used for the production of 
trileaflet valves, and their material properties were assessed according to the procedures 
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outlined in Section 4.2 to determine how their properties impact valve function and 
durability.  The valves were of the preferred cylinder-valve design, and the leaflets were 
mounted on the medium profile, 48.5% styrene stent.  Even though the dip-coated, PET 
knit type 2 (JSI) had been eliminated as a prospective leaflet material, it was still tested in 
this configuration because: 1) In terms of durability, it has been the most successful 
reinforcement to date when mounted on a high-profile, flexible stent, so it is a good 
gauge of ideal durability; and 2) by mounting it on a less flexible stent, the impact of 
changing stent design could be assessed. 
5.2.2.1. Tensile Testing 
Tensile tests were carried out on the reinforced leaflet materials, the isotropic 
polymer used in leaflet fabrication, and the isotropic polymers used in the stent.  The 
reinforced leaflet materials were tested primarily along their circumferential and radial 
directions, but a selection were also tested at 45° between the circumferential and radial 
directions. 
As can be seen from the stress-strain plots (Figure 48 - Figure 51), a vast array of 
material properties existed for the fiber-reinforced leaflet materials, where differences 
between materials became more prevalent at the higher strain levels.  For the polyester 
weave and the XA-47 polyester mesh materials, the properties in the radial and 
circumferential directions were identical due to the make-up of the fabric, whose 
properties were the same in the orthotropic directions.  In both of these reinforcement 
materials, the fabric was oriented so that their fibers ran 45° between the radial and 
circumferential directions, so it was in this orientation that the higher stiffness in the 
material existed.  This phenomenon becomes more evident in Table 10, where the 
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engineering and true Young’s moduli are presented for all three directions.  For these 
materials, the properties in the circumferential and radial directions were predominated 
by the matrix properties (Figure 52); however, their overall properties did deviate from 
that of the underlying polymer due to the presence of the fibers (Figure 53).  It is well 
known that for composites in which the applied stress is parallel to the direction of the 
reinforcement fibers, the modulus of elasticity approaches that of the fibers as the fiber 
volume fraction increases. If the applied stress is perpendicular to the fibers, the modulus 
of elasticity tends to mimic that of the matrix material [66], so when the applied stress is 
between those two orientations, the Young’s modulus falls between that of the fibers and 
the polymer matrix.  
   
 
 
 
 
 
 
 
 
 
 
 
Figure 48.  Circumferential stress versus strain curve for all fiber-reinforced leaflet materials  N = 5 for all 
samples. 
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Figure 49.  Radial stress versus strain curves for all fiber-reinforced leaflet materials. N = 5 for all samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 50.  Circumferential stress versus strain curves for all fiber-reinforced materials up to 10% strain. N 
= 5 for all samples. 
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Figure 51.  Radial stress versus strain curves for all fiber-reinforced materials up to 10% strain. N = 5 for 
all samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 52.  Stress versus strain curve for isotropic, non-reinforced 8.5% SIBS i.e. the version of SIBS used 
in leaflet production. N = 5 for all samples. 
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Figure 53.  Stress versus strain curve for isotropic, non-reinforced 8.5% SIBS, PET weave-reinforced 8.5% 
SIBS, and XA-47 – reinforced 8.5% SIBS.  N = 5 for all samples. 
 
The stress-strain curves for the two polymers used to fabricate the valve stent are 
provided in Figure 54.  By increasing the styrene percent from 30 to 48.5%, a large 
change in the material response can be seen.  For the 30% styrene SIBS, the material 
yields at a stress (σy) of approximately 2,900 kPa and a 6% strain (εy), whereas, the 
48.5% styrene SIBS has a σy of 10,585 kPa and a εy of 4%.  There is a 323 MPA 
difference in the Young’s Moduli of the two formulations (Table 10).  An ANOVA was 
run comparing the engineering and true Young’s moduli of these materials, and they were 
found to be significantly different with p = 0.001 for both values. 
It is apparent from the stress-strain curves that not all materials exhibited a linear 
relationship.  In fact, many displayed a similar tendency to the natural valve properties 
(Figure 40), where an increase in the slope of the curve occurred at higher strain levels. 
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Nevertheless, Young’s moduli for all materials were determined based on the initial slope 
of the stress-strain curve from 0 to 5% strain (Table 10), and an ANOVA and subsequent 
post hoc test was carried out to assess for significant difference between materials.  When 
comparing the properties for the leaflet materials (including the 8.5% SIBS) in the 
circumferential direction, the NZ-11 mesh and the JSI hybrid formulations were found to 
be significantly different from each other and all other leaflet formulations.  The 8.5% 
SIBS, XA-47 mesh, and dip-coated JSI knit were not found to be significantly different 
(p = 0.079), as were the XA-47 mesh, dip-coated JSI knit, BARD knit, and PET weave (p 
= 0.078).  When an ANOVA and subsequent post hoc test was run for the radial samples, 
the 8.5% SIBS, XA-47 mesh, and PET weave were not significantly different (p = 0.169), 
the dip-coated JSI knit and BARD knit were not significantly different (p = 0.984), and 
the hybrid JSI knit and NZ-11 mesh were not significantly different (p = 0.916). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 54.  Stress versus strain curves for isotropic, non-reinforced 30% and 48.5% SIBS i.e. the versions 
of SIBS used stent production.  N = 5 for all samples. 
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Table 10.   Engineering and true Young's moduli for fiber-reinforced leaflet materials, isotropic leaflet 
material, and isotropic stent materials in the circumferential direction, radial direction, and 45° in between. 
Circumferential Radial 45° Material 
Eeng (kPa) Etrue (kPa) Eeng (kPa) Etrue (kPa) Eeng (kPa) Etrue (kPa)
BARD 3669 
#
 3953 15351 
@
 16508 5835 6272 
PET Weave 3797 
#
 4055 3797 
+
 4055 79312 84921 
JSI Dip 2973
*,#
 3220 14504 
@
 15622   
JSI Hybrid 12651  13699 33034 
&
 35502   
XA-47 1884 
*,# 
 2034 1884 
+
 2034 32214 34525 
NZ-11 21837  23420 34229 
@
 36798 13399 14388 
8.5% SIBS 1064 
* 
 1151 1064 
+
  1151 1064 1151 
30% SIBS 62429  66935 62429  66935 62429 66935 
48.5% SIBS 385372  395969 385372  395969 385372 395969 
Note: N = 5; and *, #, +, @, & denote groups that are not significantly different, i.e. p < 0.05 
 
5.2.2.2. Hydrodynamics 
The fiber-reinforced leaflet materials whose mechanical properties were assessed 
in Section 5.2.2.1 were used to fabricate valves mounted on a 48.5%, medium profile 
stent, and these valves were subjected to both hydrodynamic and fatigue testing.  For 
each valve, the measurement was repeated three times, and the results are represented as 
averages and standard deviations.  By taking repetitive measures, the variations in data 
acquisition can be accounted for.    
  The transvalvular pressure drop results presented in Figure 55 appear to be 
divided into three subsets, where the dip-coated JSI leaflets resulted in a consistently 
higher pressure drop, the hybrid JSI and PET weave leaflets resulted in a medium 
pressure drop, and the Magna, BARD, XA-47, and NZ-11 leaflets had the lowest 
pressure drop. 
In terms of percent regurgitation (Figure 56), the data again appeared to be 
divided into three subsets, where the NZ-11 reinforced valve exhibited the highest 
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regurgitation, the dip-coated JSI (48.5% styrene stent) and XA-47 valves showed 
regurgitation in the medium range, and the remaining valves had an average regurgitation 
under 5%.   
   
 
 
 
 
 
 
 
 
 
Figure 55.  Transvalvular pressure drop during forward flow for all prototype valves mounted on the 
48.5% styrene stent.  The results for the 19 mm TAD Magna® valve are provided for comparison.  Error 
bars denote standard deviation between the three repeated measures. 
 
A summary of the pressure drop, percentage regurgitation, effective orifice area, 
and leaflet thickness is provided for all of the valves that have been tested (Table 11).  
The transvalvular pressure drop and percent regurgitation values were averaged over all 
cardiac output – heart rate combinations, while the values for AEO were calculated at a 
heart rate of 70 BPM and a cardiac output of 5.6 L/min.  From this summary, it is 
apparent that the St. Jude bileaflet valve had a considerably lower pressure drop than all 
other valves, and the Magna valve had the lowest percentage regurgitation.  An ANOVA 
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and subsequent post hoc test was run to assess for significance between the pressure drop 
and regurgitation results.   
 
 
 
 
 
 
 
 
 
 
 
Figure 56.  Percentage regurgitation flow for all prototype valves mounted on the 48.5% styrene stent.  The 
results for the 19 mm TAD Magna® valve are provided for comparison.  Error bars denote standard 
deviation between the three repeated measures. 
 
Tukey’s post hoc tests comparing transvalvular pressure drops between valves 
determined that: the pressure drops for the Magna and XA-47 valves were not 
significantly different (p = 0.195), the pressure drops for the Magna and NZ-11 valves 
were not significantly different (p = 0.793), the pressure drops for the PET weave and 
hybrid JSI valves were not significantly different (p = 0.937), the pressure drops for the 
dip-coated JSI (48.5% styrene stent) and LARS® valves were not significantly different 
(p = 0.956), and all other combinations of valves not mentioned are significantly different 
from each other.  A summary of the significant results is provided in Table 11. 
 
0
5
10
15
20
25
30
35
40
0 2 4 6 8 10 12
Cardiac Output (L/min)
Pe
rc
en
t R
eg
ur
gi
ta
tio
n
JSI Hybrid JSI Dip-coat PET Weave NZ-11 XA-47 BARD Magna
 119
Table 11.  Summary of mean transvalvular pressure drop during forward flow, percentage regurgitation, 
effective orifice area (AEO), and leaflet thickness for all valves subjected to hydrodynamic testing.  Values 
for the pressure and regurgitation were averaged over all cardiac output and heart rate combinations, and 
AEO was measured at 70 BPM, 5.6 L/min. 
Valve 
Mean ΔP during 
forward flow 
(mmHg) 
Regurgitation 
% 
AEO 
(cm2) 
Leaflet 
Thickness 
(mm) 
1 LARS 3-Leaflet Valve, Implant 1 42.85
 @
  7.35
+,@
  0.90 0.21 
2 JSI: High Profile, 30% Styrene, Dip, Implant 2 38.02  4.23
#,+
  1.03 0.45 
3 
JSI: Medium Profile, 
48.5% Styrene, 
Hybrid, Implant 3 
25.71 
+
  1.01 
*
  1.15 0.30 
4 JSI: Medium Profile, 48.5% Styrene, Dip 42.05
@
  10.76
&
  0.93 0.45 
5 PET Weave: Medium Profile, 48.5% Styrene 24.86 
+
  4.50
#,+
  1.21 0.20 
6 NZ-11: Medium Profile, 48.5% Styrene 18.97 
#
  18.30  1.57 0.26 
7 XA47: Medium Profile, 48.5% Styrene 16.22 
*
  8.62
@,&
  1.59 0.20 
8 BARD: Med Profile, 48.5% Styrene 13.16  2.82 
*,#
  1.60 0.20 
9 Magna 17.90 
*,#
  0.41 
*
 1.42 NA 
10 St Jude 0.16  3.23 
*,#
  7.51 NA 
Note: , N = 3; and  *, #, +, @, & denote groups that are not significantly different, i.e. p < 0.05 
 
Tukey’s post hoc tests comparing percentage regurgitation between valves 
determined that: the Magna, hybrid JSI, BARD, and St. Jude valves were not 
significantly different (p = 0.126), the BARD, St. Jude, dip-coated JSI (30% styrene 
stent), and PET weave valves were not significantly different (p = 0.787), the dip-coated 
JSI (30% styrene stent), PET weave, and LARS® valves were not significantly different 
(p = 0.059), the LARS® and XA-47 valves were not significantly different (p = 0.952), 
the XA-47 and dip-coated JSI (48.5% styrene stent) valves were not significantly 
different (p = 0.482), and all other combinations not mentioned were considered to be 
significantly different.   
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It should be noted at this time that statistical significance does not always imply 
clinical significance.  For example, the dip-coated JSI (30% styrene stent) valve was 
determined to be significantly different from the hybrid JSI valve in terms of percent 
regurgitation, even though the difference between the average regurgitation was only 
3.22% (calculated from Table 11).  In the clinical setting, this would not be considered a 
regurgitation difference significant enough to take action, so in reality, these two valves 
cannot be suggested to be clinically different.  If one were to classify the pressure 
difference as being clinically significant if it were greater than 10.0 mmHg and the 
regurgitation difference to be clinically significant if it were more than 5%, then a 
broader tolerance range could be provided for assessment of significant difference.  
Under all conditions of flow, the St. Jude bileaflet valve had a pressure gradient 
that was significantly lower than any other valve (both clinically and statistically).  This 
decreased pressure gradient is a characteristic of this market-leading valve; however, the 
difference between results from all other valves is accentuated by the fact that this valve 
has a 25 mm TAD compared with the 19 mm TAD for all other valves.  A larger TAD 
means a larger AEO, and the AEO is inversely proportional to the square root of the 
transvalvular pressure drop (refer to Equation 1).  As a result, one can conclude that if a 
19 mm TAD St. Jude valve were available for comparison, its pressure drop would not be 
as significantly different from the prototype valves as what is shown here.  The minimum 
performance for a 19 mm TAD valve (as stated by ISO 5840:2004) requires that AEO ≥ 
0.70, and all prototype valves fulfilled this requirement (Table 11). 
When manufacturing prosthetic trileaflet heart valves, it is assumed that they 
function like the natural heart valve and replicate the same opening and closing 
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characteristics, but according to Thubrikar et al. [75], bioprosthetic leaflets and synthetic 
polymer leaflets that have an increased stiffness when compared with the natural valve 
leaflet result in an increased transvalvular pressure drop during systole.  The natural heart 
valve includes a ground substance of glycosaminoglycans that allow movement of 
collagen fibers with respect to one another.  At the same time, the glycosaminoglycans 
are capable of moving with minimal force, so they provide an environment conducive to 
bending and shear, thereby allowing valve opening at transvalvular pressures as low as 5 
mmHg [75].  Bioprosthetic valves and polymer trileaflet valves have been said to display 
elevated bending stresses and an increase in stored bending energy.  This promotes valve 
closure back to its neutral geometry at lower pressure gradients.  As a result, an increase 
in the transvalvular pressure gradient is needed to open these types of valves and keep 
them open [75]. 
Rosenhek et al. [76] provided a summary of a selection of prosthetic valve’s peak 
pressure gradient, mean pressure gradient, and AEO.  The pertinent information for a 
selection of 19 mm TAD commercial valves has been assembled for comparison with the 
BARD-reinforced valve mounted on the 48.5% styrene stent (Table 12).  This valve was 
selected for comparison as it represents the most successful SIBS prototype valve to date 
in terms of its hydrodynamics.  As is apparent from the data, the mean pressure gradient 
for the BARD valve is lower than that of the selected mechanical and bioprosthetic 
prostheses, and the AEO is higher.  The peak pressure drop, on the other hand, is the 
highest out of the selection.  From this information, it can be assumed that the BARD-
reinforced SIBS trileaflet valve performs at least as well as the selection of prostheses. 
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Table 12.  Summary of peak pressure gradient, mean pressure gradient, and AEO for the BARD reinforced 
valve and a selection of commercially available aortic valve prostheses [76] 
Valve Peak pressure gradient (mmHg) 
Mean pressure 
gradient (mmHg) AEO (cm
2) 
BARD 47.28 13.16 1.60 
Bjork-Shiley Tilting 
Disc 46.0 26.67 0.94 
Carpentier-Edwards 
Stented Bioprosthesis 43.48 25.6 0.85 
Carpentier-Edwards 
Pericardial Stented 
Bioprosthesis 
32.13 24.19 1.21 
St. Jude Medical 
Bileaflet 35.17 18.96 1.01 
 
 
Both leaflet thickness and modulus are proposed to have a large impact on the 
hydrodynamic function and durability of polymer valves [64].  Leaflets derived from low 
modulus materials are expected to have good hydrodynamic function as the low modulus 
materials provide little resistance to opening, thereby allowing a decreased transvalvular 
pressure drop.  Low modulus materials, however, are subject to larger strains than higher 
modulus materials exposed to the same loading conditions.  This strain accumulation 
results in decreased durability for those materials, so in terms of durability, a higher 
modulus material that results in a reduction in strain accumulation is more favorable.  
These higher modulus, stiffer materials are believed to restrict valve opening and are less 
likely to close fully, so a stiffer leaflet material is predicted to result in less favorable 
hydrodynamic function.  These conflicting phenomena have to, therefore, be considered 
when designing a polymer valve.   
According to Bernacca et al. [65], leaflet thickness is a better predictor of 
hydrodynamic function than modulus.  From a theoretical point of view [65], the bending 
stiffness of a material is proportional to t3E, where t is the thickness of the material and E 
is the Young’s modulus.  Stiffness is then proportional to the cube of the thickness, 
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showing the higher dependence on thickness than material modulus.  Bernacca evaluated 
this theory with polyurethane trileaflet valves, where he varied the leaflet thickness from 
62 – 238 μm, and the Young’s modulus from 5.0 – 32.5 MPa.  What he found was that 
leaflet thickness had a direct correlation to transvalvular pressure drop, while leaflet 
modulus appeared to have no significant impact on hydrodynamic function.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 57. Leaflet thickness versus mean transvalvular pressure drop for all prototype valves.  
 
The dependence of leaflet thickness on pressure drop was examined for all 
prototype SIBS valves.  A strong correlation between the two was seen, as is apparent in 
Figure 57, but some deviations were evident.  The issue with assessing the dependence of 
leaflet thickness on pressure drop for the SIBS valves is that not all valve designs were 
equivalent.  The LARS® design had a completely different geometry, and many of the 
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valves had different fiber reinforcements.  While the LARS® valve had a thickness of 
0.20 mm, its leaflet geometry prevented the leaflets from opening completely to allow a 
cylindrical orifice and reduced pressure drop.  The cylinder valve designs, on the other 
hand, did allow this circular orifice upon opening.  From this, one can conclude that the 
design of the leaflets had a greater impact on pressure drop than the leaflet thickness did.  
As far as the cylinder valves are concerned, a general trend did exist, where the leaflet 
thickness was inversely proportional to the transvalvular pressure drop.  Even though 
varying leaflet reinforcements were compared, one can conclude that thickness is still an 
important factor.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 58.  Circumferential and radial Young’s modulus versus mean percent regurgitation for all 
prototype valves 
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The dependence of leaflet modulus on valve hydrodynamics was assessed for all 
SIBS cylinder valves.  It is apparent that no correlation existed for either regurgitation or 
pressure drop (Figure 58 and Figure 59 respectively).  Due to the fact that the SIBS valve 
leaflets are composite structures, each with the same matrix polymer, the simple 
correlation between leaflet stiffness and Young’s modulus cannot be applied.  Due to the 
complexity of the material properties, there is not a simple and obvious relation to their 
hydrodynamic function. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 59.  Circumferential and radial Young’s modulus versus mean transvalvular pressure drop for all 
prototype valves 
 
5.2.2.3. Valve Fatigue 
The valves whose hydrodynamics were assessed in Section 5.2.2.2 were 
subsequently placed on the Vivitro HiCycle fatigue tester to evaluate their long-term 
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fatigue response.  The two most successful valve designs, in terms of their durability, 
included the BARD-reinforced valve and the JSI-reinforced valve.  A comparison of all 
valves, including those already discussed in Section 5.1, is provided in Table 13, with a 
short description of their failure modes.  The preliminary evaluation from Section 5.1 
already established that the optimal design included the cylinder valve design and a 
48.5% styrene, medium profile stent, so the purpose of this evaluation was to determine 
what leaflet properties are most favorable for the development of a fiber-reinforced 
polymer trileaflet valve.   
 
Table 13.  Summary of the primary valve designs subjected to fatigue evaluation. 
Valve 
Orientation of 
Max 
Compliance 
Years To 
Failure Failure Mode 
1 LARS 3-Leaflet Valve, Implant 1 Circumferential 0.628 
 Leaflet/Stent detachment 
 Polymer degradation / blowout 
2 JSI: High Profile, 30% Styrene, Dip, Implant 2 Circumferential 10.35 
 3-fold increase in pressure drop 
 NOT VALVE RELATED 
3 JSI: High Profile, 30% Styrene, Dip Radial 
 2.72, 
6.20 
 Stent fracture 
 Hole formation in leaflet belly 
4 
JSI: Medium Profile, 
48.5% Styrene, 
Hybrid, Implant 3 
Circumferential 1.50  Heat seal joint failure 
5 JSI: Medium Profile, 48.5% Styrene, Dip Circumferential N/A N/A - 4.19 yrs to date 
6 PET Weave: Medium Profile, 48.5% Styrene Circumferential 2.94 
 Tear formation at all coaptation 
regions 
 Free edge fraying 
7 NZ-11: Medium Profile, 48.5% Styrene Circumferential 0.20  Catastrophic mesh failure 
8 XA47: Medium Profile, 48.5% Styrene Circumferential 
2.34, 
2.39 
 Polymer degradation 
 Mesh degradation 
 Stent fracture 
9 BARD: Med Profile, 48.5% Styrene Circumferential 4.19 
 Degradation of the heat-sealed 
joint 
 
The failure mode descriptions for valves 1 – 3 have already been discussed in 
detail, so results from valves 4 – 9 will be compared.  Valves 4 – 9 include those cylinder 
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valve designs that are mounted on a 48.5% styrene stent.  The NZ-11 PET mesh valve 
suffered from very early catastrophic failure.  After cycling for an equivalent of 0.20 
years, a tear initiated and propagated along the leaflet-stent attachment zone of one leaflet 
(Figure 60).  It should be noted that this location was not the location of the heat-sealed 
joint, as has been the case with other designs.  On that same leaflet, a tear developed at 
the central region of the coaptation zone (Figure 61).  This catastrophic breakdown of the 
reinforcement fabric after such a short period of cycling ruled it out as a potential 
reinforcement fabric for the polymer valve design.  Suturing of the fabric to the stent was 
assumed to contribute to the premature failure of the valve.  During the manufacturing 
process, it was noted that hole formation and mesh separation developed at the suture 
locations; nevertheless, the tear at the center of the coaptation could not be attributed to 
suturing, so even if a new leaflet-stent attachment technique were developed, the 
reinforcement would still be considered inappropriate for use.     
 
 
 
 
 
 
 
 
Figure 60.  NZ-11 valve showing tear formation along the leaflet-stent zone after an equivalent of 0.20 
years of cycling.  Tear viewed from the a) aortic and b) ventricular orientation 
 
 
a) b) 
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Figure 61.  NZ-11 valve showing tear formation at the center of coaptation of the same leaflet as above. 
 
Two XA-47 PET mesh valves were manufactured for testing of valve fatigue.  
The first valve lasted an equivalent of 2.34 years before one of the supporting stent posts 
fractured completely (Figure 62a).  In addition, tear formation at the center of coaptation 
of two of the leaflets (Figure 62b), and polymer blowout at the center of coaptation for 
the third leaflet was evident (Figure 62c).  The second of the XA-47 valves failed at an 
equivalent of 2.39 years of cycling.  It had very similar leaflet failure characteristics, with 
the addition of degradation of the heat-sealed joint.  The stent on this valve did, however, 
maintain its integrity.  Both valves appeared to have problems related to delamination 
between the leaflet polymer and reinforcement (Figure 62d).  While using the solvent-
casting technique to manufacture these samples, problems arose with bubble formation 
and reinforcement wetting.  The fabric appeared to be resistant to wetting by the 
SIBS/toluene solution.  This was assumed to result in mainly surface coating by the 
polymer, leaving entrapped air within the mesh and contributing to the delamination.  
Ignoring the delaminations seen, the underlying mesh itself did not have the structural 
integrity to maintain long-term cycling, so this reinforcement type was also determined to 
be insufficient for use in a trileaflet valve.     
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Figure 62.  XA-47 valve showing a) stent fracture, b) tear formation at the coaptation, c) polymer blowout 
and d) delamination at the coaptation. 
 
One of the downfalls of the PET weave reinforced valve is that the weave is a 
non-locking weave, so fibers are free to move around.  The weave valve discussed in the 
preliminary testing incorporated the same weave that has been tested here, but a different 
orientation was applied.  In the previous study, the weave was oriented so that the fibers 
were oriented along the radial and circumferential directions.  This led to an 
uncharacteristically high modulus in these two directions, and it promoted free edge 
fraying by not securing the fibers located right at the free edge.  By rotating the 
orientation 45°, greater radial and circumferential compliance could be achieved, and the 
fibers could be held more securely within the polymer matrix.  An increase in valve 
durability was seen (from 0.943 years to 2.94 years), but the reinforcement fabric was 
a) b) 
d) c) 
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again determined to be inappropriate.  Valve failure for the PET weave valve that 
allowed circumferential and radial compliance was as a result of tear formation of the 
leaflet along two of the three commissures (Figure 63).  The actual weave fibers 
fractured, causing valve prolapse.  Even with this new fiber orientation, fraying at the 
free edge of the leaflet was still evident (Figure 63b). 
 
 
 
 
 
 
 
 
Figure 63.  PET Weave valve showing a) tear formation at the commissure and b) leaflet prolapse and free 
edge fraying. 
 
The two remaining valves were both PET knit reinforced valves that differed with 
respect to leaflet thickness.  The JSI valve had a leaflet thickness of 0.40 mm, while the 
BARD valve had a 0.20 mm thickness.  The tensile tests of these materials and 
subsequent statistical analyses (Section 5.2.2.1) revealed that the Young’s moduli in both 
the circumferential and radial directions were not significantly different.  Upon in vitro 
fatigue analysis of the two valves, failure of the BARD-reinforced valve occurred at an 
equivalent of 4.19 years as a result of heat seal deterioration.  The actual reinforcement 
fabric, and even the valve as a whole, was still in good working condition, but the 
fabrication method used to seal the flat solvent cast BARD sheet into a cylinder proved to 
a) b) 
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once again be insufficient.  The JSI-reinforced valve showed no deterioration at this stage 
of cycling; however, the Vivitro HiCycle has to always be balanced, so it needs a 
minimum of 2 valves to be run simultaneously.  Due to the lack of a replacement valve 
after the BARD valve failed, the cyclic fatigue of the JSI valve had to be halted.  The JSI 
valve had also been cycled an equivalent of 4.19 years at this stage.  Both the JSI and 
BARD valves were subjected to a hydrodynamic evaluation after 66 million cycles (1.65 
years).  Less than a 1 mmHg change in transvalvular pressure drop and a 2 % changed in 
percent regurgitation was seen for both valves when results were compared with their 
baseline, pre-fatigue data.  It was concluded that fatigue to this point had not impacted 
the acute function of the valves.  The failure mode experienced by the BARD valve was 
not sufficient to eliminate it as a potential leaflet reinforcement material.  In fact, it is the 
only viable reinforcement material out of all of the versions that have been tested.  The 
dip-coated JSI reinforcement had previously been eliminated due to unfavorable in vivo 
response.   
 
 
 
 
 
 
 
 
Figure 64.  BARD valve showing deterioration of the heat-sealed joint. 
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It has been proposed by Bernacca et al. [64] that a high modulus material could be 
more resistant to fatigue.  A plot of the circumferential and radial moduli versus fatigue 
life (Figure 65) shows no distinct pattern exists for the fiber-reinforced SIBS valves.  
Once again, the complex interaction within each orthotropic material invalidates such a 
simplistic interaction between fatigue life and leaflet modulus.  Interactions within the 
material exist, and a finite element analysis could provide a better predictor of fatigue life 
based on an analysis of the stress concentrations within a leaflet subjected to a 
physiological load.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 65.  Plot of fatigue life versus the radial and circumferential moduli. 
 
No SIBS trileaflet valve has thus far made it to an equivalent of 15 years of 
fatigue.  The BARD-reinforced valve appears to be the most promising, but a design 
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modification for the leaflet cylinder sealing technique is required for this to be a 
possibility.  
5.2.3. Finite Element Model 
Eight separate combinations of valve geometry and material properties were 
compared to assess the impact of 1) stent flexibility and geometry, 2) leaflet anisotropy, 
and 3) leaflet coaptation geometry on the stress concentrations in the leaflet as a result of 
pressure loading.  One particular valve, the BARD-reinforced valve mounted on a 
medium profile, 48.5% styrene stent, was manufactured and its stent deflection and 
transient geometry were quantified for comparison and validation of the finite element 
model.  Each valve was subjected to a quasi-static diastolic loading regimen to assess the 
resultant stress concentrations when the valve was subjected to its maximum pressure 
load.   
For the quasi-static analysis, it was the initial intention to subject the valve to the 
incremental loading steps representing the entire cardiac cycle, i.e. diastolic and systolic 
loading.  What was found was that the static, implicit solution technique was not 
equipped to deal with the numerical instabilities that occurred when a complete inversion 
of curvature or buckling occurred, such as what happens during systole.  For all quasi-
static models, the analysis terminated during systole.  As per a discussion with Michel 
Labrosse (University of Ottawa, Department of Mechanical Engineering, Ottawa, 
Ontario, Canada), it was recommended that the dynamic explicit solution procedure in 
ABAQUS was more suitable for analysis of heart valve leaflets subject to buckling, so 
analysis of the full cardiac loading cycle is proposed for future analyses with this method. 
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Figure 66.  Hydrodynamic data showing the flow and pressure waveforms.  The dashed lines (1 – 8) 
represent the specific locations during the cardiac cycle where each image pair was triggered. 
 
5.2.3.1. Model Validation 
5.2.3.1.1. Transient Geometry Analysis 
During the DCSP procedure, the eight images that were taken during the cardiac 
cycle corresponded to points 1 through 8 on Figure 66.  An additional image was taken 
with the hydrodynamic tester switched off, thereby allowing imaging of the valve under a 
0 mmHg transvalvular pressure load.  The 3-D coordinates of the fiducial points were 
derived in Photomodeler®, and the generated scatterplots in addition to the raw image 
pairs are shown in Figure 67 - Figure 72 and in Appendix IV: Figure 107 - Figure 118.   
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Figure 67.  Photogrammetry image pairs corresponding to the baseline image where the valve was under a 
no load condition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 68.  MatLab regeneration of fiducial points from the x, y, and z coordinated generated in 
Photomodeler® from Figure 67. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 69.  Photogrammetry image pairs corresponding to Frame 5 in Figure 66. 
 
 136
 
 
 
 
 
 
 
 
Figure 70.  MatLab regeneration of fiducial points from the x, y, and z coordinated generated in 
Photomodeler® from Figure 69. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 71.  Photogrammetry image pairs corresponding to Frame 7 in Figure 66. 
 
 
 
 
 
 
 
 
 
Figure 72.  MatLab regeneration of fiducial points from the x, y, and z coordinated generated in 
Photomodeler® from Figure 71. 
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Table 14.  Validation of the quasi-static FEM.  The particular valve included the BARD-reinforced leaflets 
with slight coaptation curvature.  These leaflets were mounted on the medium profile, 48.5% styrene stent. 
Frame 
Equivalent 
ABAQUS 
Time (s) 
Actual 
ABAQUS 
Time (s) 
Points 
DCSP 
Measure 
(mm) 
ABAQUS 
Measure 
(mm) 
Percentage 
Error 
1-2 6.39 5.60 14.12 
1-3 9.15 7.81 17.05 Baseline 0.0 0.0 
2-3 5.01 4.61 8.68 
1-2 7.16 5.65 26.76 
1-3 9.11 8.00 13.86 7 0.5 0.4802 
2-3 5.29 4.63 14.17 
1-2 4.22 9.96 57.57 
1-3 12.01 13.27 9.49 5 0.6 0.5714 
2-3 10.19 4.63 120.13 
 
As is apparent in Figure 66, no images were taken during the diastolic “loading” 
of the valve (between images 4 and 5); images were only available for the diastolic 
“unloading”.  As a result, the quasi-static model had to be evaluated using the image pairs 
taken during the diastolic “unloading”, with the assumption that the leaflet will maintain 
the same geometry at a given pressure load, regardless as to whether the pressure is 
increasing or decreasing.  The image pairs from frames 5 (Figure 69 and Figure 70) and 7 
(Figure 71 and Figure 72) were used and the equivalent time for the image sequence was 
calculated for comparison with the finite element model.  The distances between each of 
the three points selected for quantitative valve validation were computed, and the results 
from the DCSP and finite element model are compared below (Table 14).   
The percentage error obtained between the two measurements was very large, 
ranging from 8.68% to 120.13%.  Even when no load was applied on the valve (i.e. the 
baseline measure), the percentage error between experimental and model data was high.  
This high error was not sufficient to rule out the model as being a feasible representation 
of the real case for the following reasons: 1) The model represents the optimal case where 
the valve is completely symmetrical and each of the three leaflet’s opening and closing 
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geometries are identical.  In the real case, manufacturing restrictions prevent this perfect 
leaflet symmetry, so leaflets do not behave exactly the same. 2)  The set-up for the DCSP 
was not the most favorable as it was impossible to calibrate the cameras in the exact same 
environment as that in which the images were taken.  Calibration of the cameras requires 
a minimum of eight separate images from eight separate angles, including from above the 
image plane, and the Vivitro tester restricts the views from all of the eight angles.  As a 
result, the cameras had to be calibrated in the blood analog fluid without the presence of 
the acrylic walls and glass sinus of the Vivitro.  These objects are capable of distorting 
the image and providing a less than optimal image regeneration. 3) Due to the high rate 
of diastolic leaflet loading, it was difficult to capture an image during this phase, and 
images during diastolic “unloading” had to be substituted.  The combination of all three 
of these factors are believed to have contributed to the high percentage error between the 
experimental and model data, and it was concluded that this method neither proves nor 
disproves the validity of the model.  It is believed that this method is feasible for the 
validation of the model if a more ideal experimental set-up is instituted.  The poor 
correlation between these results prompted the second validation, where stent deflection 
was quantified and compared with the model.    
5.2.3.1.2. Stent Deflection 
Stent deflection of the same experimental valve examined by DCSP was 
quantified during the hydrodynamic evaluation at 70 BPM and 5.6 L/min.  The valve was 
imaged from above, and the maximum deformation at peak diastole and peak systole was 
quantified by measuring the post-to-post distances.  For the quasi-static model, the 
maximum deflection at peak diastole was compared with that for the finite element 
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model.  The finite element model predicted an average post-to post distance of 12.21 mm, 
while the experimental set-up predicted an average deflection of 13.26 mm.  This resulted 
in an 8.58% error, which was determined to be sufficient to prove the validity of the finite 
element model.   
5.2.3.2. Material Properties 
The material properties needed for input into the quasi-static models are provided 
in Table 15 and Table 16.  The through thickness modulus (E3) could not me measured, 
so it was assumed to be that of the isotropic polymer.  According to Skinner [66] this is a 
valid assumption because, when the applied stress is perpendicular to the reinforcement 
fibers, the modulus of elasticity mimics that of the surrounding matrix.   
     
Table 15.    Orthotropic material engineering constants used as input into the quasi-static FEM.  Note all 
Poisson's ratio values were assumed to be zero. 
 E1 
(N/mm2) 
E2 
(N/mm2) 
E3 
(N/mm2) υ12 υ13 υ23 
G12 
(N/mm2) 
G13 
(N/mm2) 
G23 
(N/mm2)
JSI -  
Circumferential 2.972 14.504 1.064 0 0 0 1.486 1.486 7.252 
JSI -  Radial 14.504 2.973 1.064 0 0 0 7.252 7.252 1.486 
BARD - 
Circumferential 3.670 15.351 1.064 0 0 0 1.835 1.835 7.675 
 
Table 16.    Isotropic material constants used as input into both the quasi-static and dynamic FEMs. 
 E 
(N/mm2) υ 
8.5% SIBS 1.064 0.4 
30% SIBS 62.429 0.4 
48.5% SIBS 385.372 0.4 
 
Please note that for the orthotropic leaflet materials, the Poisson’s ratio had to be 
assumed to be zero in all cases.  This was found to be necessary when running these 
models because, when a non-zero number was instituted, the simulation was unable to 
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converge.  By assuming the Poisson’s ratios to be zero, a comparison between all cases 
was achieved, and the impact of changing Young’s modulus and leaflet thickness could 
be assessed.  For the isotropic materials, a non-zero Poisson’s ratio did not present a 
problem, so the measured value was input in these cases. 
5.2.3.3. Quasi-Static Model 
For the quasi-static model, the transvalvular pressure load was ramped over time 
according to the curve shown in Figure 73.  The resultant stress concentrations at the 
maximum load for all eight models are shown in Figure 74 - Figure 81.  For the leaflets, 
images of the stress concentration on both the aortic and ventricular surfaces are provided 
for comparison.  For all models, a high stress point occurred on the inner surface of the 
stent where the stent post joined the stent base, which is consistent with a failure mode 
seen in vitro.  During dynamic fatigue of the XA-47 reinforced valve and the high-profile 
JSI-reinforced valve with radial compliance, the stent post failed in this region.   
 
 
 
 
 
 
 
 
Figure 73.  Diastolic pressure loading regimen for the quasi-static model 
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When evaluating the top views of all models (Figure 74 - Figure 81), twisting in 
the coaptation area was noted for all valves except that with the rigid stent.  The twisting 
is symmetrical from one leaflet to the next, and it is believed to be as a consequence of 
the contact definition.  Contact is defined as a pure master-slave interaction, where the 
slave cannot cross the master surface.  Based on how each master-slave pair was defined, 
the master surface is always the surface that pushes the slave surface and causes the 
twisting at the valve center.  For an actual valve, this twisting does not necessarily occur, 
as one leaflet may be pushed by both of the adjacent leaflets, forcing these leaflets past 
the 120° coaptation zone, such as in the case shown in Figure 82a.  Nevertheless, this 
model interaction was believed to be satisfactory as a similar deformation was shown 
during hydrodynamic testing of a bioprosthetic valve by Labrosse et al. [65] (Figure 
82b).  The inward flexion of the posts is believed to contribute to the twisting 
phenomenon, as it does not occur in the rigid stent case (Figure 75). 
The non-reinforced SIBS valve leaflets (Figure 78) were modeled with the same 
0.20 mm thickness as that of the BARD-reinforced leaflets.  The SIBS leaflets 
experienced significantly more deformation than any of the reinforced valve leaflets, 
proving the insufficiency of the polymer alone. Given the lower Young’s modulus, it 
makes sense that more deformation is seen when the valve is subject to the same loading 
conditions.  From this, it can be concluded that fiber reinforcement is necessary for the 
normal functioning of the SIBS trileaflet valve when the 8.5% styrene SIBS is used in the 
leaflet.  Preliminary studies of the SIBS valve comparing isotropic leaflets and reinforced 
leaflets of the same thickness showed severe leaflet insufficiency due to prolapse, further 
verifying the need for leaflet reinforcement [9]. 
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Figure 74.  BARD-reinforced leaflets with slight coaptation curvature mounted on a 48.5% styrene, 
medium profile stent (BARD-Reg). Views include (a) top view of aortic surface stresses, (b) top view of 
ventricular surface stresses, (c) front view of one third of the valve showing aortic surface stresses, and (d) 
front view of one third of the valve showing the ventricular surface stresses. 
 
 
 
 
 
 
 
 
 
 
 
Figure 75.  BARD-reinforced leaflets with slight coaptation curvature mounted on a rigid, medium profile 
stent (BARD-Reg-Rigid).  Views include (a) top view of aortic surface stresses, (b) top view of ventricular 
surface stresses, (c) front view of one third of the valve showing aortic surface stresses, and (d) front view 
of one third of the valve showing the ventricular surface stresses. 
a b
c d
a b
c d
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Figure 76.  BARD-reinforced leaflet with flat coaptation curvature mounted on a 48.5% styrene, medium 
profile stent (BARD-Flat).  Views include (a) top view of aortic surface stresses, (b) top view of 
ventricular surface stresses, (c) front view of one third of the valve showing aortic surface stresses, and (d) 
front view of one third of the valve showing the ventricular surface stresses. 
 
 
 
 
 
 
 
 
 
 
 
Figure 77.  BARD- reinforced leaflet with large coaptation curvature, mounted on a 48.5% styrene, 
medium profile stent (BARD-Lrg).  Views include (a) top view of aortic surface stresses, (b) top view of 
ventricular surface stresses, (c) front view of one third of the valve showing aortic surface stresses, and (d) 
front view of one third of the valve showing the ventricular surface stresses. 
a b
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Figure 78.  SIBS-leaflet with slight coaptation curvature mounted on a 48.5% styrene, medium profile 
stent (SIBS-Reg).  Views include (a) top view of aortic surface stresses, (b) top view of ventricular surface 
stresses, (c) front view of one third of the valve showing aortic surface stresses, and (d) front view of one 
third of the valve showing the ventricular surface stresses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 79.  JSI-reinforced valve with slight coaptation curvature mounted on a 48.5% styrene, medium 
profile stent (JSI-Reg).  Views include (a) top view of aortic surface stresses, (b) top view of ventricular 
surface stresses, (c) front view of one third of the valve showing aortic surface stresses, and (d) front view 
of one third of the valve showing the ventricular surface stresses. 
a b
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Figure 80.  JSI-reinforced leaflet (max compliance oriented circumferentially) with slight coaptation 
curvature mounted on a 30% styrene, high profile stent (JSI-HiP-Circ).  Views include (a) top view of 
aortic surface stresses, (b) top view of ventricular surface stresses, (c) front view of one third of the valve 
showing aortic surface stresses, and (d) front view of one third of the valve showing the ventricular surface 
stresses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 81.  JSI-reinforced leaflet (max compliance oriented radially) with slight coaptation curvature 
mounted on a 30% styrene, high profile stent (JSI-HiP-Rad).  Views include (a) top view of aortic surface 
stresses, (b) top view of ventricular surface stresses, (c) front view of one third of the valve showing aortic 
surface stresses, and (d) front view of one third of the valve showing the ventricular surface stresses. 
a b
c d
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Figure 82.  Images showing the coaptation interaction during diastole for a (a) BARD-reinforced leaflet 
mounted on a 48.5% styrene stent and a (b) bioprosthetic valve adapted from Labrosse et al. [65]. 
 
The high profile JSI valves (Figure 80 and Figure 81) appeared to have an 
increase in leaflet stress concentrations when compared with the lower profile version 
(Figure 79).  Not only was the valve geometry different in this case, but a lower 
percentage styrene SIBS was used to manufacture the stents.  The combination of a 
higher stent profile and a polymer with decreased stiffness resulted in more stent 
deformation.    When the orientation of the dip-coated JSI fabric was switched to allow 
more radial compliance, a large difference to the leaflet and stent stress concentrations 
occurred.  With more radial compliance, the leaflet stress increased, and a peak stress was 
evident in the mid-leaflet region, denoted by the red color (Figure 81).  For all other valve 
models, the peak stress always occurred on the stent itself, and not the leaflet. When 
comparing the two high profile valves, the valve with the circumferential compliance had 
greater stent deformation than that of the valve with the radial compliance.  This 
occurrence can be attributed to the fact that greater circumferential stiffness results in 
reduced leaflet deformation that is translated to the stent; therefore, the load on the stent 
is reduced.  The resultant reduction in stress on the stent is not sufficient to warrant a 
a b
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change in the preferred reinforcement orientation (i.e. more circumferential compliance) 
as the large increase in stress that occurred in the leaflet itself ultimately led to the valve 
failure during in vitro fatigue. The location of the peak stress in the model is consistent 
with the location of hole formation in the same valve subjected to in vitro fatigue (Figure 
83). 
Based on the results presented above, the primary regions of concern in terms of 
elevated stress concentrations in the leaflets include the top of the commissure, lower 
commissure, center of coaptation, and belly region (Figure 84).  For the higher profile 
valve, an additional region of high stress arose between the center of coaptation and belly 
region.  The peak stresses in these five areas were compared between valves to assess 
how the different designs affect the overall stress concentrations within the valve.  It 
should be noted that the peak stresses for the fiber-reinforced orthotropic models were 
compared with their experimental stress-strain curves, and each was determined to be 
within the elastic range of the material.  The assumption of a purely elastic model is, 
therefore, valid for this analysis.   
 
 
 
 
 
 
Figure 83.  Dip-coated JSI-reinforced, high profile valve showing hole formation at the mid-valve region 
of cycling equivalent to 6.12 years 
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Figure 84.  Critical areas of interest when comparing the leaflet stress concentrations, where (1) is the top 
of the commissure, (2) is the lower commissure, (3) is the center of coaptation, and (4) is the belly.  For the 
higher profile valves, a fifth region defined as the mid valve was added between regions 3 and 4. 
 
A summary of the peak stresses for the four primary leaflet regions is presented in 
Figure 85.  An ANOVA was run for each of these regions to assess whether any 
particular design resulted in a significantly larger stress concentration.  For the top of the 
commissure, the three JSI-reinforced models were found to result in a significantly lower 
stress concentration than any of the other valve models, but they were not significantly 
different from each other (p = 0.907).  The BARD-reinforced design mounted on the rigid 
stent was found to result in a significantly larger stress concentration than any of the 
other models.  What was interesting to note was that the three different BARD-reinforced 
valves with varying coaptation geometry were not found to result in significantly 
different stress concentration at the top of the commissure (p = 0.979).  This is contrary to 
what has been presented in the literature, where stress concentrations at the commissure 
are believed to be affected by leaflet anisotropy, stent flexibility, and the angle the free 
edge forms with the stent post [21, 29, 30, 37-39, 44, 41, 52, 53].  By changing the leaflet 
1
2
4 
3
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coaptation geometry, the angle between the free edge and stent post is varied, but in the 
case of the BARD-reinforced leaflet, it did not have any impact on the stress 
concentrations.  Changing the stent flexibility did have a large impact, where increased 
flexibility resulted in a decreased stress for the BARD-reinforced valve.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 85.  Peak stress concentrations for regions 1 – 4 of all models at the (a) aortic and (b) ventricular 
surface. 
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when the values on the aortic surface are compared (Figure 85), but both the aortic and 
ventricular values were input into SPSS, and for some models, a large difference between 
the two existed.  This would have resulted in a larger standard deviation, so when 
different models were compared, significance was not established. 
On comparison of the stresses at the center of coaptation, the radially compliant, 
JSI-reinforced valve mounted on the high profile stent was found to have a significantly 
larger peak stress than any of the other models.  The rest of the models were not found to 
be significantly different (p = 0.60).  It should be noted that all of the other models, 
excluding the isotropic SIBS model, had a lower circumferential modulus than radial 
modulus.  The radially compliant valve mimics the general tendencies of the natural 
valve in which the circumferential modulus is higher than in the radial direction (refer to 
Figure 40); however, the circumferential modulus for the JSI-reinforced valve with radial 
compliance is significantly higher than that of the natural valve (EJSI = 14.5 MPa, Enatural = 
5.79 MPa) [53].  The elevated stress in the radially compliant valve can be attributed to 
the fact that the increased modulus along the circumferential direction resulted in 
elevated stresses on the valve in order to achieve valve coaptation.  For the JSI-reinforced 
valve with circumferential compliance, the circumferential modulus was closer to that of 
the natural valve (EJSI = 2.97 MPa, Enatural = 5.79 MPa ), even though the radial moduli 
were considerably different (EJSI = 14.5 MPa, Enatural = 0.966 MPa).  Orienting the JSI 
reinforcement in order to have closer matching of circumferential modulus with the 
natural valve appeared to be more beneficial in terms of stress reduction than replicating 
the circumferential versus radial compliance tendencies.    
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In terms of the stress concentrations in the belly region, once again the three JSI-
reinforced valves were not found to be significantly different from each other (p = 0.136), 
but the JSI-reinforced leaflets mounted on the 48.5% styrene stent were found to have a 
significantly lower stress concentration than any of the other valves mounted on the 
48.5% styrene stent.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 86.  Peak stress concentrations for regions 1 – 4 for all BARD valve models at the (a) aortic and (b) 
ventricular surface.  
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In order to further investigate the impact of varying valve designs on leaflet stress 
concentrations, the results were grouped in terms of leaflet reinforcement fabric and stent 
design. When comparing the output for the three BARD-reinforced valves with varying 
coaptation geometries, the statistical analysis stated that none of the stress concentrations 
could be considered to be significantly different, and this is made more apparent in 
Figure 86. One can then conclude that the coaptation geometry in the range of what was 
tested does not significantly affect the stress concentrations in the leaflet, so the most 
favorable geometry would be that which results in the least percent regurgitation during 
hydrodynamic evaluation.   
For the BARD-reinforced valve, increasing the stiffness of the supporting stent 
led to a significant increase in the stress concentration at the top of the commissure (refer 
to Figure 86).  It did not, however, have a large impact on the stresses in other regions of 
the leaflet.  From this, one can conclude that a more flexible stent is favorable for reduced 
commissure stresses, but based on previous in vivo studies, a balance must be found.  If 
the stent is too flexible, it can be susceptible to excessive buckling, and if it is too stiff, it 
can cause increased leaflet stress and a resultant decrease in leaflet durability.  According 
to Cacciola et al. [31], rigid supporting stents increase the degree of leaflet flexure, and 
this can cause an increase in the leaflet stress concentrations.  In order to investigate this, 
Cacciola et al. [31] performed an evaluation of stentless versus stented valves, including 
leaflets with identical material properties, and what was found was that the stentless 
formulation did in fact result in a 75% reduction of stress.  Stentless valves do differ from 
flexible stented valves, but the allowance of leaflet boundary displacement is similar, 
thereby reiterating the benefits to supporting structure flexibility.     
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Figure 87.  Peak stress concentrations for regions 1 – 4 for all valve models including a 48.5% styrene at 
the (a) aortic and (b) ventricular surface.  
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leaflet is double the thickness of the BARD leaflet (0.40 mm to 0.20 mm, respectively).  
One can conclude that a thicker leaflet material aids in the reduction of stress during 
diastolic loading; however, the hydrodynamic evaluation already established that the 
thicker JSI leaflet resulted in a significantly higher transvalvular pressure drop during 
forward flow, so a thinner leaflet is more favorable for hydrodynamic function. 
According to Deck and Thubrikar et al. [73, 75] a decrease in the leaflet thickness results 
in an increase in the tensile stresses within the leaflet.  In their evaluation of natural, 
bioprosthetic, and synthetic leaflet valves, they calculated membrane stress according to 
the equation: membrane stress = PR/t, where P was the pressure difference across the 
leaflet, R was the radius of the leaflet, and t was the leaflet thickness.  It can be seen in 
this formulation that leaflet thickness and tensile stress were inversely proportional, 
resulting in an increased stress with a decrease in leaflet thickness.   
During comparison of the different JSI-reinforced valve designs, statistical 
significance was only established for the radially oriented version mounted on the high 
profile, 30% styrene stent.  On comparison of the two different circumferentially oriented 
designs (Figure 88), the valve mounted on the more flexible stent appeared to have a 
reduced stress concentration at the top of the commissure and the center of coaptation, 
and it had a higher stress concentration in the belly region.  At the lower commissure, 
there was a different trend on the ventricular surface when compared with the aortic 
surface.  Significance was not established between these designs, so one cannot conclude 
that there is any benefit, in terms of stress minimization, to a higher profile and more 
flexible stent.  This is somewhat contradictory to what was established for the BARD-
reinforced valve; therefore, it can be concluded that an increase in flexibility does have 
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its limitations.  An increase from completely rigid to partially flexible is beneficial, but 
when the flexibility increases to the point of resulting in large stent post deformation 
(Figure 80), the positive effects are reduced.  When the highly flexible valve was 
implanted in an in vivo sheep model, severe stent deformation occurred resulting in valve 
incompetence [12, 15].  There is, therefore, no added benefit to highly flexible stents.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 88.  Peak stress concentrations for regions 1 – 4 for all JSI-reinforced valve models at the (a) aortic 
and (b) ventricular surface.  
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With the quasi-static loading of the leaflet, the change in stress with time was of 
interest.  The plots of stress versus time for the four primary leaflet regions of interest 
(Figure 89 -Figure 92) reaffirm what is already known about which valves result in a 
significantly higher or lower stress concentration.  Interesting points of note occur at the 
lower commissure, center of coaptation, belly region, and at the mid-valve.  At the lower 
commissure, the JSI-reinforced valve with radial compliance and a highly flexible stent 
has a stress concentration in the region of all the other valves at a low pressure load, but 
after 0.03 seconds, an abrupt increase in the stress concentration occurs, resulting in it 
having the highest peak stress at the maximum diastolic load.  At the center of coaptation, 
this same valve displays an abrupt increase in stress, and then the stress appears to 
plateau until the maximum pressure load is reached.  When the two high profile valves 
are compared in terms of their stress concentrations in the mid-valve region, the radially 
oriented JSI valve starts out with a lower stress concentration in this region, but once 
again, after approximately 0.03 seconds, a sharp increase in the stress is seen.  All other 
valves show a more gradual increase in their stress state over time. 
 
 
 
 
 
 
 
 
Figure 89.  Peak stress concentrations for the aortic surface of all valves at the top of the commissure. 
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Figure 90.  Peak stress concentrations for the aortic surface of all valves at the lower commissure. 
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responses along the circumferential direction of the leaflet as more critical to the valve’s 
function and longevity.  Based on this information, an additional three high stent profile 
models were run to investigate this phenomenon.  Two models included isotropic leaflets 
of either the high (E = 14.5 MPa) or low (E = 2.97 MPa) moduli of the JSI reinforcement, 
and the third model assumed the orthotropic moduli of a porcine heart valve (Ecirc = 5.79 
MPa, Erad = 0.966 MPa) obtained from Li et al. [53].  The graphical representations of the 
surface stress concentrations for the additional three models are provided in Figure 94 - 
Figure 96.  It is apparent that the higher modulus isotropic leaflet (Figure 94) displayed 
the same peak stress concentration in the center of the leaflet that the radially oriented 
JSI-reinforced valve (Figure 81) did.  Both of these valves had the same circumferential 
modulus (E = 14.5 MPa), but the radial modulus for the JSI valve was much lower (E = 
2.97 MPa) than that of the isotropic valve.  The low modulus isotropic valve and the 
valve with the natural valve orthotropic material properties had a marked reduction in the 
peak stress concentration when compared with the high modulus isotropic valve.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 91.  Peak stress concentrations for the aortic surface of all valves at the center of coaptation. 
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Figure 92.  Peak stress concentrations for the aortic surface of all valves in the belly region. 
 
On comparison of the peak stress concentrations between the three new models 
and the original three JSI-reinforced models (Figure 97) it is apparent that at the lower 
commissure and the center of coaptation, the two valves with increased circumferential 
modulus (radially oriented JSI and high modulus isotropic) show elevated stress 
concentrations.   
 
 
 
 
 
 
 
 
 
Figure 93.  Peak stress concentrations for the high profile JSI-reinforced valves at the mid-valve region. 
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Figure 94.  Isotropic leaflet with mechanical property mimicking that of higher modulus JSI-reinforced 
orientation (E = 14.5 MPa) with slight coaptation curvature mounted on a 30% styrene, high profile stent 
(IsoHi-HiP).  Views include (a) top view of aortic surface stresses, (b) top view of ventricular surface 
stresses, (c) front view of one third of the valve showing aortic surface stresses, and (d) front view of one 
third of the valve showing the ventricular surface stresses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 95.  Isotropic leaflet with mechanical property mimicking that of lower modulus JSI-reinforced 
orientation (E = 2.97 MPa) with slight coaptation curvature mounted on a 30% styrene, high profile stent 
(IsoLo-HiP).  Views include (a) top view of aortic surface stresses, (b) top view of ventricular surface 
stresses, (c) front view of one third of the valve showing aortic surface stresses, and (d) front view of one 
third of the valve showing the ventricular surface stresses. 
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An ANOVA comparing the peak stress concentrations of the original eight 
models and the additional three established no significance at the top and lower 
commissure; however, at the center of coaptation, the low modulus isotropic valve, the 
circumferentially oriented high profile JSI valve, the circumferentially oriented medium 
profile JSI valve, and the natural orthotropic high profile valve were not significantly 
different.  Both the isotropic high modulus valve and the radially oriented high profile JSI 
valve were found to have a significantly higher stress concentration than all other valves.  
In the belly region, the low modulus isotropic valve and the radially oriented JSI valve 
were found to be significantly different from each other, but they were not found to be 
different from any of the other valves.   
 
 
 
 
 
 
 
 
 
 
Figure 96.  Orthotropic leaflet with mechanical property mimicking that the natural valve (Ecirc = 5.79 
MPa, Erad = 0.966 MPa) with slight coaptation curvature mounted on a 30% styrene, high profile stent 
(Natural-HiP).  Views include (a) top view of aortic surface stresses, (b) top view of ventricular surface 
stresses, (c) front view of one third of the valve showing aortic surface stresses, and (d) front view of one 
third of the valve showing the ventricular surface stresses. 
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Figure 97.  Peak stress concentrations for regions 1 – 4 on the aortic surface for all JSI-reinforced valve 
models and the high profile models including the orthotropic natural valve properties and the isotropic (E = 
2.97 MPa and E = 14.5 MPa) properties. 
 
Based on this analysis, it appears that the two valves with the highest 
circumferential moduli resulted in the highest leaflet stress concentration.  The 
circumferential modulus for both of these valves was identical, and it was markedly 
higher than that of the natural valve.  This knowledge and the belief of Thubrikar et al. 
[75], that the valve is subjected to flexural and tensile stresses predominantly in the 
circumferential direction, prompted an evaluation of the component stresses in the 
circumferential and radial directions (Figure 98 - Figure 100).  It is apparent from these 
figures that the stress along the circumferential direction is higher than that in the radial 
direction, across the board; therefore, one can conclude that the peak loads are oriented 
along the circumferential direction, and the properties in this direction are more critical 
for the minimization of stress in combination with increased valve longevity.  What was 
found was that by reducing the circumferential modulus to provide a closer match to that 
of the natural valve, a reduction in the leaflet stress concentration could be obtained.     
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Figure 98.  Component stress concentrations in the circumferential (S11) and radial (S22) directions for all 
models at the top of commissure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 99.  Component stress concentrations in the circumferential (S11) and radial (S22) directions for all 
models at the center of coaptation. 
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SIBS valve models and the natural valve leaflet as they represented the same orthotropic 
nature.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 100.  Component stress concentrations in the circumferential (S11) and radial (S22) directions for 
all models at the belly 
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the circumferentially oriented JSI-reinforced leaflet mounted on the high profile stent 
(Figure 80) and the isotropic low modulus leaflet mounted on the high profile stent 
(Figure 95) the circumferential moduli were identical (E = 2.97 MPa), but their radial 
moduli differed by 11.53 MPa; nevertheless, minimal impact to the leaflet stress 
concentration occurred.  For the circumferentially oriented JSI leaflet, the radial modulus 
was higher than the circumferential modulus.  In the natural valve (Figure 96), the radial 
modulus is approximately three times less than that of the circumferential modulus [73], 
and yet no significant change in the leaflet stress concentrations was witnessed.  Based on 
these results, one can conclude that changing the radial modulus from six times as small 
to twice as large as the circumferential modulus has limited effect on the leaflet stress 
concentrations as long as the circumferential modulus is in the vicinity of that of the 
natural valve.   
 
5.3. Fatigue Model 
All previous experimentation ruled out all but the BARD PET knit as a feasible 
material for leaflet reinforcement.  As a result, tension-tension fatigue was only carried 
out on these specific samples.  Samples were manufactured by solvent casting, and S/N 
curves were generated for the circumferential direction, radial direction, and 45° in 
between (Figure 101).  If a sample reached 350 million cycles, the test was stopped, and 
the load was assumed to be below the endurance limit for the material.  One such case 
occurred for testing in the 45° direction, and it is represented by an open triangle in 
Figure 101.  Each S/N curve was fit to a log-linear equation, represented in the figure 
below, and this was used for input into the fatigue prediction model.    
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Figure 101.  Cyclic tension-tension fatigue results for solvent-cast BARD reinforced leaflet samples along 
the circumferential, radial, and 45° between the circumferential and radial directions.  Each data set was 
fitted to a log-linear curve whose equation is provided in the figure. 
 
The S/N equations were used to predict the fatigue stress after 1 – 400 million 
cycles when a sample was subjected to any of the three separate loading conditions used 
for tensile fatigue testing (Table 17).  The radial, circumferential, and 45° components 
were broken into their σ11 and σ22 components (refer to Figure 102) corresponding to the 
1 and 2 directions in the finite element model.  From this information, the σ11 versus σ22 
stress interactions could be plotted, and a failure envelope could be defined by the three 
distinct points that were generated.  Figure 103 will be used to describe the process of 
defining failure envelopes for specific lifetimes.  Firstly, the coordinates of the three 
points defined for a specific lifetime (in this example, 1 million cycles), were plotted.  A 
curve was then fit to this data to represent the interaction between the stresses in the 1 
(circumferential) and 2 (radial) directions with respect to their impact on fatigue life.  A 
curve linking all three points represents an equivalent fatigue life for all points along that 
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curve.  A quadratic equation was found to be sufficient to describe the failure curve for 
all cases represented in Table 17, where 
 
Equation 14 .  General failure curve equation. 
DCB +⋅+⋅= )()()model( 2222211 σσσ  
 
In this case, the constants (B, C, and D) are specific to each failure curve, and the solver 
tool in Excel was used to define these three constants for each distinct case represented in 
Table 17 by minimizing the sum squared error between the model and experimentally 
predicted values.  Once all curves were generated, the stress components predicted during 
finite element modeling could be input to assess what fatigue range could be expected. 
 
Table 17.  Predicted failure stresses in the circumferential and radial directions for specific cyclic intervals 
from 1 to 400 million cycles. 
σ45° = -0.1125ln(N) +3.1728 # Cycles 
(N) 
σ11 = -0.0481ln(N) 
+1.3005 
σ22 = -0.3814ln(N) 
+8.4761 σ45° 
σ11 =  
σ45°(sin45°) 
σ22 =  
σ45°(sin45°)
1.00E+00 1.300 8.476 3.173 2.244 2.244 
1.00E+02 1.079 6.720 2.655 1.877 1.877 
1.00E+03 0.968 5.841 2.396 1.694 1.694 
1.00E+04 0.857 4.963 2.137 1.511 1.511 
1.00E+05 0.746 4.085 1.878 1.328 1.328 
1.00E+06 0.636 3.207 1.619 1.144 1.144 
1.00E+07 0.525 2.329 1.360 0.961 0.961 
1.00E+08 0.414 1.450 1.100 0.778 0.778 
4.00E+08 0.347 0.922 0.945 0.668 0.668 
 
The same four regions used to compare the overall stress concentrations in the 
leaflet were used to determine the potential fatigue life of a BARD-reinforced valve.  
When the circumferential and radial stress components are represented for the whole 
leaflet (Figure 104), it is apparent that elevated stress areas exist at the top of the 
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commissure, lower commissure, and center of coaptation for the circumferential 
component, and elevated stresses occur in the belly region and lower coaptation for the 
radial component.  The numerical values of the peak stresses in the four critical regions at 
0.0298, 0.0571, and 0.090 seconds were plotted together with the failure curves for 
assessment of fatigue life (Figure 105).  It is apparent that the results for the lower 
commissure and belly region fall well within the 400 million cycle failure envelope.  The 
peak load occurring at 0.090 seconds for the center of coaptation falls just inside the 400 
million cycle failure envelope, but the 0.0571 and 0.090 second results for the top of the 
commissure both fall outside the 400 million failure envelope.  As a result, one can 
conclude that the top of the commissure is the weak point during valve fatigue, and with 
the present design, failure can be expected before 400 million cycles.  During valve 
fatigue testing, this particular design did fail at the top of the commissure (refer to Figure 
64) at an equivalent of 4.19 years (approximately 168 million cycles).  The valve 
happened to fail at a heat sealed joint, which is a well-known weak point on the valve that 
was not taken into account in the finite element model.  As a result, the anticipated 
fatigue life for the BARD valve is closer to 400 million cycles (10 years) if a design 
change can effectively strengthen the weak joint in the leaflet. 
According to Deck et al. [73] and Thubrikar et al. [74], the primary location of 
elevated stresses in both the natural valve and bioprosthetic valves occurs at the leaflet 
attachment zone, corresponding to the top of the commissure in the SIBS valve.  Upon 
evaluation of the stresses and strains in the natural valve during both systole and diastole, 
Deck et al. [73] found that total stresses were elevated during diastole, and they were 
negligible during systole; therefore, the diastolic loading of the leaflet resulted in high 
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tensile stresses, especially in the commissural region, where these high stresses are 
proposed to result in wear of the tissue that can ultimately lead to the valve’s failure.   
 
 
 
 
 
 
 
 
Figure 102.  Representation of the principal directions subjected to tension-tension fatigue.  The stresses 
along the 45° orientation were broken up into their circumferential and radial components.   
 
 
 
 
 
 
 
 
 
 
 
Figure 103.  Representation of the method used to define a failure envelope for leaflet fatigue at 1 million 
cycles. 
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Figure 104.  BARD-reinforced leaflet model mounted on a 48.5% styrene, medium profile stent.  Images 
show the circumferential (σ11) and radial (σ11) stress components at 0.0298 seconds, 0.0571 seconds, and 
0.090 seconds during the quasi-static diastolic loading.  Note: stress shown in MPa.  
 
The stresses occurring within the leaflet during diastole are as a result of the 
transvalvular pressure load that the leaflet is being subjected to.  The leaflet deforms 
under the tensile load; therefore load controlled tensile fatigue testing is justified for 
fatigue analysis of polymeric leaflets.  The affect of creep, on the other hand, was not 
taken into account as load controlled fatigue testing subjected a leaflet sample to a 
constant load until failure (50% strain) occurred, and the S/N curve results were reported 
as engineering stress versus number of cycles.  According to Deck et al. [73], a reduction 
t =
 0
.0
29
8 
se
c 
t =
 0
.0
57
1 
se
c 
t =
 0
.0
90
 se
c 
σ11 σ22 
 171
in the leaflet thickness causes a decrease in the bending strain and stress in a leaflet; 
however, an increase in the membrane or tensile stress occurs.  The pressure load during 
diastole results in a decrease in the leaflet thickness due to an increase in its length [75].  
Continual cycling of the leaflet will lead to a progressive decrease in its thickness due to 
creep.  This decrease in thickness will cause an increase in stress, so failure of the leaflet 
can potentially occur before the predicted 400 million cycles.  Due to this, it is 
recommended that a factor of safety (FOS) be applied to ensure that catastrophic valve 
failure does not occur before the valve’s predicted lifespan.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 105.  Failure envelopes predicted for the BARD-reinforced leaflets, showing the 1 million, 10 
million, and 350 million cycle failure envelope.  The model-predicted stress components for the top of the 
commissure, the lower commissure, the center of coaptation, and the belly region are plotted for 0.0298 
seconds, 0.0571 seconds, and 0.090 seconds for assessment of fatigue life.   
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The natural valve is endowed with the capacity to regenerate.  Studies performed 
by Deck et al. [73] showed an increase in glycosaminoglycan and collagenous protein 
synthesis in a rat valve when compared with other organs within its body.  This elevated 
rate of tissue replacement was proposed to be as a result of the high stresses, thereby 
allowing the valve to maintain its function without degeneration.  In bioprosthetic valves, 
regeneration of the collagenous network obviously cannot occur, and breakdown of the 
collagenous fibers has been noted as one of the failure modes [73].  Another interesting 
point to note is the presence of glycosaminoglycans: glycosaminoglycans are believed to 
contribute to a reduction in the stresses within the leaflet as these molecules allow 
slippage between the fibrous elements, thereby increasing the durability of the leaflets.  
Glutaraldehyde fixation of bioprosthetic valves has been linked to a reduction in the 
presence of glycosaminoglycans.  Considering the rapid production of these molecules in 
the natural valve, they obviously play an important function in the mechanics and 
longevity of the natural valve.  The lack of this friction-reducing molecule in both 
bioprosthetic valves and polymeric valves put them at a disadvantage in terms of fatigue 
life when compared with the natural valve; nevertheless, implementing materials and 
geometries that can minimize the stresses in a valve can have a marked impact on their 
longevity. 
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6. SUMMARY AND CONCLUSIONS 
Polymer trileaflet heart valves have been under investigation since the 1960’s, but 
they have met with limited success due to poor material and design choices [4-6, 22-30].  
Many materials investigated for use in leaflets were not biostable, and chemical 
degradation of these materials, in combination with mechanical fatigue, accelerated their 
failure.  Leaflets are subjected to alternating tension and compression during the cardiac 
cycle; these alternating stresses result in the mechanical degradation of the leaflet 
materials and the formation of cracks and tears, ultimately leading to the catastrophic 
failure of the valve.  Designs that aid in the reduction of stress concentrations in the 
leaflet are proposed to increase the valve’s overall durability [29].  Design aspects that 
are believed to reduce leaflet stress concentrations include stent flexibility, parabolic 
coaptation curvature, and leaflet anisotropy [28-30, 37, 38, 41, 44, 49, 51, 52].  It is with 
these concepts in mind that a fiber-reinforced SIBS trileaflet valve was developed. 
SIBS is a triblock copolymer that has been proven to be stable in oxidative 
environments [8].  Being a block copolymer, its hard and soft segment chemistry can be 
manipulated to produce polymers with a large variety of mechanical properties.  By 
increasing the styrene percentage in the polymer, the stiffness of the material can be 
increased.  This property of the polymer was exploited in the valve, where a low 
percentage styrene SIBS was used for the leaflet matrix, and a high percentage styrene 
SIBS was used for the supporting stent.  Prior studies have proven the feasibility of a 
SIBS trileaflet valve in terms of its biocompatibility and acute function [7, 9-14], and it 
was the intention of this investigation to refine the design in order to optimize valve 
durability while improving the hydrodynamic function.   
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An extensive literature review of the natural heart valve and bioprosthetic valves 
revealed that it is not necessary to replicate all of the properties of the natural valve in 
order to achieve sufficient durability [21, 31-36, 39, 40, 49, 51-53, 58, 60, 62-65].  One 
of the most critical features of the natural valve is its collagen network.  The layout of the 
collagen network throughout the leaflet allows the valve to withstand high tensile loads 
while not preventing extensibility and bending.  Radial extensibility of leaflets is 
important during diastole as it promotes leaflet coaptation and reduces regurgitation.  
Low resistance to bending allows the leaflets to open freely during systole, thereby 
allowing favorably low pressure drops.  The collagen network was simulated in the SIBS 
valve through the incorporation of a commercially available reinforcement fabric.  The 
exact mechanical properties of the natural valve could not be matched, so a combination 
of experimentation and modeling was used to evaluate what reinforcement type and 
orientation provided the best possible combination of acute and long-term valve function.  
Seven different polyester reinforcement materials were tested using four different 
processing methods to maximize the material property combinations.   
The flexibility of the supporting stent is also believed to have a large impact on 
valve function and durability [28, 30, 41, 52].  In the natural valve, the leaflets join the 
aortic wall at the commissures, and the aortic wall dilation and contraction has been 
linked to improved hemodynamic function and reduced stress load in the area.  During 
systole, the aortic wall dilates, pulling the commissures apart and aiding in leaflet 
opening.  During diastole, the inward flexion of the commissure helps reduce stress 
concentrations in that area.  A combination of three stent geometries and two SIBS 
grades were used during the experimental evaluation, and a combination of two stent 
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geometries and three different material properties were used during finite element 
modeling to verify the importance of stent flexibility.  
The coaptation geometry is believed to play an important role in commissure 
stress concentrations and regurgitation.  A more parabolic coaptation geometry is 
believed to reduce the load on the leaflet, but a leaflet that does not have sufficient radial 
extensibility will not close completely if it has a parabolic coaptation geometry.  For 
example, pericardial valves have reduced radial extensibility due to glutaraldehyde 
fixation, and these valves require a flat coaptation geometry in combination with a 
spherical leaflet shape in order to achieve valve closure.  The geometry of the pericardial 
valve has proven to result in increased stress concentrations when compared with the 
natural and porcine valve leaflets [21].  In order to verify this phenomenon for the SIBS 
valve, three different coaptation geometries were evaluated by finite element modeling. 
The two primary experimental methods used to evaluate the feasibility of the 
composite leaflet materials included valve hydrodynamic testing and durability testing.  
The preliminary valve design included three individually placed spherical leaflets, but 
this valve failed prematurely due to leaflet-stent detachment and polymer degradation.  
The valve incorporated an open PET knit which allowed exposed polymer.  The 
individually placed spherical leaflets were replaced by a continuous cylinder of leaflet 
material that was sutured to the supporting stent.  The curved leaflet geometry was 
obtained by thermal-forming techniques, and this new design eliminated the problem of 
leaflet-stent detachment.  Upon fatigue testing, it was immediately obvious that a dense 
reinforcement fabric was required to sufficiently support the SIBS matrix, as the PET 
mesh reinforcement that had large enough interstices to see visibly unsupported matrix 
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material failed prematurely (after 0.908 years) due to polymer blowout from between the 
interstices.   
The first cylinder valve design incorporated a high profile, 30% styrene stent, 
resulting in increased flexibility when compared with the original three leaflet, low 
profile valve.  In vitro testing showed improved hydrodynamic function and significantly 
increased durability (failure after 10.35 years due to system-related problems), but when 
this valve was implanted in the aortic position of an ovine model, severe stent distortion 
rendered the valve incompetent.  It was concluded that the increased flexibility and 
design changes were beneficial to the in vitro function; however, the stent was now too 
flexible for in vivo use.  In addition, an inflammatory response was seen in vivo, and it 
was concluded to be as a result of exposed Dacron fibers.  Dacron is a well-known cause 
of inflammation [71].  As a result, the stent design was changed to a medium profile, 
48.5% styrene SIBS formulation, and the processing technique used for the leaflets was 
changed to improve coating.  The hydrodynamic function of this valve once again 
improved, but failure in vivo due to an inflammatory response was still a problem.  SEM 
analysis of a fatigued valve sample showed that the exposure of Dacron fibers persisted 
with this new leaflet manufacturing technique.  The nominal thickness of the uncoated 
Dacron used in these cases was 0.30 mm, but in order to achieve preferential 
hydrodynamic function, a thin leaflet was required.  By attempting to maintain as thin a 
leaflet as possible, insufficient polymer coating was applied to the underlying Dacron.  
From this, it was concluded that a significantly thinner fiber reinforcement was necessary 
in order to obtain complete coverage while not creating a thick, stiff leaflet that is 
resistant to bending.   
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In vitro and in vivo testing found no fault with the 48.5% styrene, medium profile 
stent, so this design was continued with the application of varying polymer 
reinforcements.  Two new mesh designs, one weave, and one new knit design were 
evaluated for use as leaflet reinforcement.  Each had a nominal thickness of 
approximately 0.15 mm, and a solvent casting technique was instituted to ensure 
complete coverage.  The coated thickness of these materials was approximately 0.20 mm.  
Hydrodynamic testing of these materials showed a decreased pressure drop when 
compared with the original designs, and variable regurgitation.  The valve design with the 
highest regurgitation (the NZ-11 mesh-reinforced design) coincidentally had the highest 
modulus in both the circumferential and radial directions, but upon comparison of the 
modulus versus both percent regurgitation and pressure drop, no distinct correlation 
between these properties was found.  There was, however, a correlation between leaflet 
thickness and transvalvular pressure drop, where thinner leaflets generally resulted in 
lower pressure drops.   
Due to the fact that the Dacron-reinforced valve with the highly flexible stent 
posts showed the best results in terms of durability, a valve including Dacron-reinforced 
leaflets mounted on the medium profile, 48.5% styrene stent was manufactured for 
comparison.  Fatigue analysis of the two new mesh-reinforced valves (NZ-11 and XA-
47), the weave-reinforced valve (fibers rotated 45° from the circumferential direction), 
and the two PET knit/Dacron-reinforced valves (JSI (original) and BARD) revealed that 
the two Dacron-reinforced valves had the most promising fatigue results.  Upon analysis 
of the modulus of these two knits, neither the properties in the circumferential nor radial 
directions were found to be significantly different, so the only difference was their 
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thickness.  The JSI-reinforced leaflet had an overall thickness of 0.40 mm, and the 
BARD-reinforced leaflet had a thickness of 0.20 mm.  Hydrodynamic comparison of 
these two valves showed a 28.9 mmHg difference in mean transvalvular pressure drop, 
providing a stronger argument for the importance of thin leaflets when considering a 
valve’s hydrodynamic function. Fatigue failure of the BARD valve at an equivalent of 
4.19 years was as a result of the heat-seal degradation and not actual reinforcement 
failure.  The cylinder valves were all manufactured from flat sheets, and they were 
formed into a cylinder by heat-sealing the edges.  This particular joint has proven to be a 
weak point in the valve design, and future work involves the replacement of the heat-seal 
with a reinforced suture line to provide a stronger attachment point.  The actual BARD-
reinforced fabric showed no signs of degradation, so the improvement of the leaflet seal 
is hypothesized to significantly increase its durability.  An analysis of the leaflet modulus 
versus fatigue life once again showed no correlation between the two properties. 
The premature fatigue of all but the knit-reinforced samples prompted the finite 
element analysis of only these two reinforcement types.  A total of eleven different 
models were run, which investigated the impact of stent flexibility and geometry, leaflet 
thickness and anisotropy, and coaptation geometry on leaflet stress concentrations.  A 
uniform transvalvular pressure load was enforced on the aortic surface of the leaflets, and 
the amplitude was varied according to the loading curve obtained during hydrodynamic 
testing of the BARD-reinforced valve (slight coaptation curvature and 48.5% styrene 
stent).    It was only possible to establish the effect of diastolic loading during quasi-static 
analysis as numerical instabilities resulted in premature termination of all static analyses 
of systolic valvular loading.  Diastolic loading was believed to provide sufficient insight 
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as to the effects of the different parameters on the leaflet stress concentration as Deck et 
al. [73] reported that stresses during systole were negligible, and diastolic stresses were 
critical for the understanding of natural valve leaflet remodeling and fatigue. 
The four primary areas in the valve that were of concern in terms of elevated 
stress concentrations included the top of the commissures, the lower commissure, the 
center of coaptation, and the belly region.  Leaflet stress concentrations on both the aortic 
and ventricular surfaces were computed, and for the fiber reinforced valves, the lower 
commissure was the only region that displayed a large difference between the stress 
concentrations on the aortic and ventricular surfaces, where the aortic surface consistently 
showed higher stress levels than the ventricular surface.   
Increasing stent flexibility from completely rigid to marginally flexible (385 MPa) 
for the BARD-reinforced valve resulted in a significant decrease in the peak stress 
concentrations at the top of the commissure, which is consistent with reports in the 
literature [21].  A further decrease in stent stiffness (to 68 MPa), however, did not present 
any additional benefit to the stress concentration.  For the JSI-reinforced valve, the stress 
concentrations were compared between the medium profile, 48.5% stent and the high 
profile, 30% stent.  No significant difference between stress concentrations was 
established, so it can be concluded that reducing stent rigidity does initially lead to a 
reduction in the stress concentration at the top of the commissure, but the rate of 
improvement of stress concentration plateaus with a further reduction of stent modulus.  
From this, it can be concluded that a balance needs to be found where the stent should be 
flexible enough to help reduce high stress concentrations, but it should not be so flexible 
that it cannot maintain its integrity in vivo.   
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The two experimental JSI valves mounted on the high profile, 30% styrene stent 
were evaluated to determine the affect of varying reinforcement orientation.  Fatigue 
analysis proved the valve with the radially oriented maximum compliance to have a 
significantly lower fatigue life (4.42 years) compared with the circumferentially oriented 
leaflets (10.35 years).  Finite element modeling of these two designs revealed increased 
stress concentration in the region of the lower commissure, center of coaptation, and the 
mid valve for the radially oriented leaflets.  The peak stress location on the radially 
oriented leaflets coincided with a failure point seen during dynamic fatigue, further 
corroborating the relationship between stress concentrations and durability.  The natural 
heart valve has increased compliance in the radial direction when compared with the 
circumferential direction, but the actual modulus is markedly lower than any of the 
materials incorporated for use in the synthetic valve.  As a result, maintaining the 
circumferential compliance is believed to be more important in terms of reduced stress 
concentrations and increased valve durability than mimicking the natural valve trends.  In 
order to further verify this statement, three additional models of the high profile, 30% 
styrene stent were evaluated incorporating either a low (E = 2.97 MPa) or high (E = 14.5 
MPa) modulus isotropic leaflet or an orthotropic leaflet mimicking the properties of the 
natural valve (Ecirc = 5.79 MPa, Erad = 0.966 MPa).   The low and high modulus 
properties were obtained from the two orthotropic directions of the dip-coated JSI 
Dacron.  What was found was that the high modulus isotropic valve replicated the 
elevated stress concentrations of the radially oriented JSI-reinforced valve, and the low 
modulus and natural valve model replicated the more optimal results from the 
circumferentially oriented valve.  Thubrikar et al. [75] believed that the valve leaflets are 
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subjected to flexural and tensile stresses predominantly in the circumferential direction, 
and when the stress concentrations for all eleven models were divided into their 
circumferential and radial components, it was evident that the circumferential stress 
levels were consistently higher than the radial.  Based on these results, it was concluded 
that matching the circumferential modulus of the natural valve was more important in 
terms of the reduction in leaflet stresses than mimicking the radial versus circumferential 
modulus trends.  Moreover, the results proved that changing the radial modulus from six 
times as small to twice as large as the circumferential modulus had limited impact on the 
leaflet stress concentrations as long as the circumferential modulus was in the vicinity of 
that of the natural valve.   
A literature review of the effect of coaptation geometry has consistently revealed 
that a parabolic geometry is better than a flat geometry for reduced leaflet stress 
concentrations [21, 49, 51].  Three models of the BARD valve incorporating three 
different coaptation geometries showed no change in the leaflet stress concentrations, so 
it was concluded that the choice of coaptation geometry should be dependent on valve 
regurgitation.  Too large a coaptation curvature can prevent complete valve closure, 
leading to regurgitation.   
It was interesting to note that increasing leaflet thickness resulted in an overall 
decrease in leaflet stress concentrations.  Models of BARD- and JSI-reinforced valves 
mounted on a 48.5% styrene stent were compared, and the thicker, JSI leaflet led to a 
consistently lower leaflet stress concentration during diastolic loading.  According to 
Deck et al. [73], an increase in the leaflet thickness causes an increase in bending strain 
and stress in a leaflet and a decrease in tensile stress.  What this means is that, although 
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the leaflet stress is reduced, the increased bending stress and strain results in an increase 
in the transvalvular pressure drop during hydrodynamic testing of the valve, as was seen 
for the two valve types.   
From the combination of experimental and model evaluations, it can therefore be 
concluded that the BARD-reinforced leaflet with medium coaptation curvature and 
48.5%, medium profile stents presents the most promising combination of results.  
Although the thicker, JSI reinforcement has a proven durability and a reduction in stress 
concentrations during modeled diastolic loading, in vivo evaluation ruled it out as a 
potential candidate.  The thinner BARD-reinforced leaflets showed excellent 
hemodynamics when compared with the Magna bioprosthesis and other SIBS valve 
prototypes.  Due to this, the BARD-reinforced valve was selected for analysis of fatigue 
life using a method reminiscent of that developed by Hashin [67 - 70].  
An empirical fatigue failure criterion was developed to represent failure curves at 
select cyclic intervals.  BARD-reinforced leaflet samples were subjected to dynamic 
tensile fatigue along their circumferential direction, radial direction, and 45° in between.  
The S/N curves that were generated were fit to log-linear equations, each representing the 
characteristic mean stress versus number of cycles to failure for each of the three 
principal directions.  The equations generated were used to predict the characteristic 
failure stress for specific cyclic intervals ranging from 1 – 400 million cycles, and these 
stress components were broken into their characteristic circumferential and radial 
components. A plot of the circumferential versus radial failure stress components was 
made, and an independent failure curve was defined for each set of three points 
corresponding to one lifespan.  A quadratic approximation was found to be the most 
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appropriate fitting curve for the three experimental points.  Once the fatigue failure 
criteria had been established, the model-generated results for the circumferential and 
radial components for the same four critical regions specified for stress concentrations 
were plotted on the generated figure.  Each location output three separate coordinate pairs 
corresponding to 0.0298, 0.0517, and 0.090 seconds on the diastolic loading curve.  
Based on the location of the points in the fatigue limit region or envelope, the fatigue life 
of the valve was predicted.  What was found was that the top of the commissure 
represented the critical region in predicting fatigue failure, similar to what has been 
witnessed in both the natural valve and bioprosthetic valves [73 - 75].  Based on the 
maximum diastolic loading conditions, the valve is predicted to fail prior to 400 million 
cycles (10 years).  Experimental fatigue of this valve revealed that failure did occur at the 
top of the commissure at an equivalent of 4.19 years (167 million cycles), but failure was 
as a result of degradation of the heat-sealed joint, a design specification not taken into 
account during modeling.  The fatigue prediction model is in its very early stages, so 
additional experimental validation is required to refine the characteristics contributing to 
leaflet failure.  In this model, the shear stress and shell normal stress were neglected.  
DCSP was applied for validation of the finite element model in this research.  It 
proved to be unsuccessful for the accurate prediction of leaflet deformation during the 
cardiac cycle; nevertheless, the methodology and results were presented in this discussion 
because the method is still believed to be a potentially useful one for model validation.  
Issues relating to the experimental set-up reduced measurement accuracy, but if these 
problems can be corrected, it could prove to be a valuable tool. 
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In order to conclusively prove the potential of the BARD-reinforced leaflet 
mounted on the 48.5% styrene stent, continued in vitro testing is needed to determine the 
best coaptation geometry for improved hydrodynamics, and the long-term fatigue of the 
valve needs investigation through a combination of in vitro fatigue and in vivo 
implantation.  Concern as to the lack of fatigue resistance at the top of the commissure 
may warrant further reinforcement in that area, with the understanding that reinforcement 
should not inhibit bending in this critical region.  
In reference to the questions from the specific aims, the best possible valve design 
for the SIBS trileaflet valve incorporates the Design 4 valve including the BARD-
reinforced leaflet and medium profile, 48.5% styrene stent.  A limited amount of stent 
flexibility does lead to a reduction in leaflet stress concentrations; however, excessive 
flexibility has no added benefit.  Exact replication of the natural heart valve properties is 
not necessary when designing a prosthetic heart valve; however, the circumferential 
properties of the leaflet have proven to be more important than the radial properties.  
Replication of the circumferential properties of the natural heart valve can produce a 
prosthetic valve with reduced leaflet stress concentrations and increased durability, while 
a large variation in radial modulus has minimal effect.  Increased leaflet thickness results 
in a decrease in leaflet stress concentrations but an increase in transvalvular pressure 
drop; therefore leaflet design is required to optimize these two contradicting 
characteristics.  A simplified fatigue prediction model, such as that produced herein, can 
be used to identify the weak points in the valve design; however, additional investigation 
is required to evaluate the accuracy of the model.   
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APPENDIX 
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Appendix I – Valve Manufacturing Protocols 
 194
A. Chemical Solution Preparation 
1. Preparation of 15% SIBS (8.5% styrene) in toluene solution 
a. Set up mixer with stirring plate, 250 mL glass jar with black top and Teflon or 
foil lid, and stirring magnet. 
b. Remove glass bottle and weigh in: 
i. 30g of 8.5% SIBS 
ii. Toluene 170g 
c. Mix with or without heat (75°C) with lid secured until dissolved  
2. Preparation of 15% SIBS (16% styrene) in cyclopentane solution 
a. Set up mixer with stirring plate, 60 mL glass jar with black top and Teflon or 
foil lid, and stirring magnet. 
b. Remove glass bottle and weigh in: 
i. 2.1 g of 16% SIBS 
ii. 11.9 g of cyclopentane 
c. Mix without heat (75°C) with lid secured until dissolved. 
d. Remove from mixer and weigh in 5.2g of isopropanol (95% titration). 
i. Mix without heat until dissolved. 
B. Fabricating Compression-molded SIBS Stent 
1. Select stent design and SIBS polymer combination for particular valve prototype 
to be manufactured (Figure 106), and identify specific compression mold.   
a. Low profile geometry with 30% styrene SIBS 
b. High profile geometry with 30% styrene SIBS 
c. Medium profile geometry with 48.5% styrene SIBS 
2. Examine all components of compression mold to ensure that they are clean. As 
needed, smooth mold parts with 320 or finer grit wet/dry sand paper, flush with 
water, and clean well with isopropyl alcohol and allow to dry completely. 
3. Spray all mold parts with Teflon mold release. 
4. Block hole at the bottom of the female mold with a piece of rolled-up paper towel 
and half-fill the mold with SIBS. Material used to block the hole in the female 
mold should not protrude out of either end of the hole. 
5. Set temperature of plates on Pasadena Hydraulic Press to 220˚C. 
6. Attach thermocouple to temperature output on the female mold. 
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7. Place separated male and female molds on center of compression platform. Do 
not allow the top platen to touch the mold. 
8. Heat molds until temperature output reads 135˚C. 
9. Place the male portion of the mold inside the female portion. 
10. Close press until it touches, but does not apply pressure on the mold (note: the 
male portion of the mold will compress into the female portion, but no pressure 
increase will register on the pressure gauge). 
11. Hold in place until the mold reaches 150ºC. 
12. Compress to 7000 lb. 
13. Hold pressure until the mold reaches 180ºC. 
14. Remove from press and clamp in hydraulic press or vice. Apply compressive 
force until resistance is felt. Allow assembly to cool (approximately 15 min). 
15. Remove the stent from the mold as follows: 
a. Invert the assembly in the hydraulic press so that the male portion is facing 
downwards and the female portion is secure in place preventing any 
movement. 
b. Place a small diameter pin in the hole in the female base (facing up). Apply 
pressure until the female part separates from the male part. 
c. Using a razor blade, trim any flash from the external surface of the male mold, 
and trim along the edge of the stent to release it from the mold edges for ease 
of removal. 
d. The stent remains attached to the male mold.  Ease the stent gently off the 
mold with forceps making sure not to distort it.  Application of isopropanol 
can aid in this process. 
16. Use a razor blade to cut any excess flash from stent and examine stent for 
imperfections.  If imperfections exist, discard stent. 
17. Prepare suture holes in the stent as follows: 
a. Place the stent on the Delrin mandril of the stent hole alignment tool, aligning 
the posts with the grooves in the fixture. 
b. Place the mandril in the template, aligning the divot in the mandrel with the 
set screw in the template. 
c. Hand-tighten the set screw to lock the mandril in position. 
d. Mount a 0.027” diameter drill bit in the drill press. Set the drill press stop to 
where the bit touches the Delrin. 
e. Place the alignment tool on a V-block for support. 
f. Turn on the drill press. 
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g. Carefully align the alignment tool under the drill bit and drill through a hole in 
the template. Use of magnifying loops may help maintain accuracy. Press 
until the stop. 
h. Repeat the previous step, repositioning the alignment tool on the V-block, 
until all holes are drilled. 
i. Turn off the drill. Remove the stent from the alignment tool and inspect to 
ensure all holes are drilled in the proper positions and are through the entire 
stent wall. Repeat drilling process as needed. 
18. Rinse stent with IPA and allow it to dry. 
C. Leaflet Fabrication 
1. Pre-formed Individual Leaflets: Design 1 
a. Dip dipping mold into 15% SIBS (8.5% styrene)/toluene solution and place in 
oven at 75°C for 30 minutes, then remove and cool. 
b. Once mold has cooled to room temperature, place PET mesh (LARS®) over 
coated mold with maximum elongation oriented circumferentially. 
c. Use O-ring to secure knit to dipping mold, making sure that mesh does not 
bunch. 
d. Dip assembly in 15% SIBS (8.5% styrene)/toluene solution. 
e. Place in oven and dry at 75°C for 30 min, then remove and cool. 
f. Once mold has cooled, dip again in the same solution and dry for > 2 hours. 
g. Cool and dip in soapy water (makes it less tacky). 
h. Remove from mold (use soapy water where necessary). 
i. Wash off soap and dry 
2. Dip-Coated Cylinder Leaflets: Design 2 
a. Select particular fabric for use. 
b. Identify direction of minimum and maximum elongation on fabric, and cut 
into a 3” x 3” square parallel to the max and min elongation respectively 
c. Wrap the cut fabric tightly around the mandril made for heat sealing with the 
maximum stretch oriented in either the circumferential or radial direction, 
dependent on the specific prototype. 
d. Heat-seal the fabric into its cylindrical form and cut of any excess. 
e. Secure one free edge of the fabric to a cylindrical dipping mandril. 
f. Slowly dip the fabric into the SIBS solution specific for the valve prototype 
(A.1 or A.2) making sure not to entrap air bubbles or collapse the cylinder. 
g. Dry in an oven set to approximately 60˚C for 30 minutes 
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h. Repeat steps C.2.f - C.2.g once more to form a 2-dip coated cylinder 
i. Neaten the edges of the cylinder by cutting off any excess or uncoated 
material. 
3. Compression-Molded Cylinder Leaflets: Design 3a 
a. Manufacture of isotropic SIBS cylinder 1: 
i. Using an 8.5% styrene extruded SIBS ring, slide a cut portion 
(approximately 3 – 5 mm in length) onto the center of the cylinder insert 
(component of the leaflet compression mold). 
ii. Place the cylinder insert into the small female clam shell, and 
compression mold it on the Pasadena Press (set to 200ºC). 
 Close the press until it is at its tightest, un-pressurized point, and hold 
for 1 min. 
 Add 30,000 lbs of pressure, and hold for 30 sec. 
 Remove from press and clamp in vice until cool. 
iii. Very delicately separate the two sides of the clam shell so as not to 
disturb the underlying polymer. 
 Ensure that the polymer is only attached to one side of the clam shell. 
iv. Under a microscope, trim the cylinder to size by removing all flash at the 
top, bottom, and both sides of the cylinder insert. 
v. Do not remove the polymer from the cylinder insert, but remove the caps 
on the insert to clean out any flash trapped inside. 
b. Forming First Laminate with the Dacron Cylinder: 
i. Only circumferentially oriented JSI Dacron knit leaflets were 
manufactured using this method. 
ii. Identify direction of minimum and maximum elongation on Dacron, and 
cut into a 3” x 3” square parallel to the max and min elongation 
respectively 
iii. Wrap the cut fabric tightly around the mandril made for heat sealing with 
the maximum stretch oriented in the circumferential direction. 
iv. Heat-seal the fabric into its cylindrical form and cut of any excess. 
v. Slide heat sealed Dacron on top of the SIBS cylinder manufactured in 
procedure C.3.a. 
 Orient heat seal along one of the flash/joint lines. 
vi. Slide Teflon® shrink tubing over the top, and use a heat gun to shrink it 
to size. 
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vii. Place the assembly in the larger clam shell and compression mold it on 
the Pasadena Press set to 200ºC. 
 Close the press until it is at its tightest, un-pressurized point, and hold 
for 1.5 min. 
 Add 30,000 lbs of pressure, and hold for 30 sec. 
 Remove from press and clamp in vice until cool. 
viii. Separate the two sides of the clam shell. 
ix. Remove the shrink tubing. 
x. Remove the first Dacron/SIBS laminate by liberally applying 
isopropanol, and ease the cylinder off by rolling it inside-out. 
xi. Dry in an oven at 80ºC for 15 mins. 
c.  Manufacture of individual SIBS cylinder 2: 
i. Repeat procedure C.3.a. 
d. Forming Final Compression-Molded SIBS/Dacron  Laminate: 
i. Ease first laminate manufactured in procedure C.3.b onto the top of the 
individual SIBS cylinder manufactured in procedure C.3.c. 
 IPA may be required in this process.  If used, dry for 15 mins in an 
oven set to 80°C. 
ii. Repeat procedures C.3.b.v - C.3.b.xi. 
4. Hybrid Cylinder Leaflets: Design 3b 
a. Only circumferentially oriented JSI Dacron knit leaflets were manufactured 
using this method. 
b. Identify direction of minimum and maximum elongation of fabric. 
c. Cut fabric into 3.0” x 3.0” rectangle parallel to min and max elongation 
respectively. 
d. Place one edge of the fabric (the direction of minimum elongation) between 
the Delrin heat seal mandrils. Wrap the fabric tightly around the mandrils 
ensuring that the maximum stretch is oriented circumferentially. 
i. Make sure not to stretch the fabric, simply ensure that it is a tight fit. 
e. Place the fabric on the heat sealer platform with the region to be sealed 
adjacent to the ribbon. 
f. Confirm the variable autotransformer is set to the correct position (an ink line 
on the transformer indicates the proper setting). Do not exceed this voltage or 
the fabric will burn. 
g. Lower the upper portion of the heat sealer to compress the fabric against the 
wire. 
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h. Press the red button on the timer control to heat-seal the fabric (set to 7 s). 
i. Cut off excess fabric on both the outside and inside of the heat-sealed cylinder 
(note: requires inverting it). 
j. Dip coat the fabric cylinder 
i. Stir 15% SIBS (8.5% styrene)/toluene solution for five minutes on 
magnetic stirrer. 
ii. Secure one edge of the heat-sealed Dacron cylinder to the 
Dipping/Attachment Mandril with scotch tape. 
iii. Slowly dip approximately 2/3rds of the length of the fabric into the SIBS 
solution. Retract slowly from the solution. Do not allow the fabric to 
touch either the sides or bottom of the solution container. Prevent any air 
bubbles from coming into contact with the dipped fabric. If the opening at 
the bottom of the tube closes, discard this sample and start again. 
iv. Leave dipped fabric on mandril in the fume hood for 10 minutes. 
v. Transfer to and dry in an oven set to approximately 80ºC for 20 minutes. 
vi. Remove cylinder from Dipping/Attachment Mandril, invert it, and secure 
it to the mandrel as before. It may be helpful to place the cylinder on the 
mandrel to facilitate inversion. 
vii. Repeat step C.4.j.i - C.4.j.v. 
viii. Trim the edges of the cylinder using the circular razor so as to remove 
any rough edges and uncoated fabric. 
k. Compression-mold the coated fabric cylinder. 
i. Slide the cylinder onto the cylinder insert of the leaflet compression-
molding tool. 
ii. Slide Teflon® shrink tubing over the assembly, and use heat gun (set to 
#4 on dial) to shrink the tubing onto the cylinder. Mount the assembly on 
a drill and rotate the assembly at low speed while shrinking the tubing. 
iii. Place the assembly in the clam shell mold and compress it on the 
Pasadena Press set to 200ºC. 
 Close the press to its tightest, un-pressurized point for 1.5 min. 
 Compress to 3,000 lb for 30 s. 
 Remove the assembly from the press and clamp it in a vice until cool 
(~ 15 mins). 
iv. Separate the two sides of the clam shell. 
v. Remove the shrink tubing. This is most easily accomplished by making a 
small, diagonal slit, gripping the free segment, and peeling the tubing off 
in a spiral. 
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5. Solvent-Cast Cylinder leaflets: Design 4 
a. Clean the solvent casting plate to ensure no polymer residue is present. 
i. Wash in warm soapy water. 
ii. Rinse with deionized water and allow to dry 
b. Cut an aluminum foil gasket following the dimensions of the top plate of the 
solvent casting plate and secure it in place on the bottom plate of the solvent 
casting plate. 
c. Cut reinforcement fabric into a 3” by 3” square parallel to the max and min 
elongation respectively 
d. Place reinforcement fabric in position on top of the bottom casting plate and 
gasket and secure with tape along the outside edges. 
e. Secure the top plate with the 10-32 bolts to clamp the reinforcement fabric 
between the two plates. 
i. Make sure there is no rippling in the fabric. 
f. Level the plate on a flat surface by adjusting the four corner ¼-20 bolts. 
g. Using a pipette, slowly dispense 11 mL of the 15% SIBS (8.5% styrene) in 
toluene solution into the solvent casting plate 
i. Make sure no bubbles form on pouring and make sure the entire surface 
of the reinforcement fabric is coated. 
h. Cover the casting plate with a glass bowl for 24 hours to reduce air flow over 
the SIBS solution and reduce the rate of evaporation 
i. After 24 hours lift one edge of the glass bowl 1 cm to allow minor exchange 
of air for an additional 24 hours 
j. Transfer solvent casting plate to oven and dry for 24 hours at 60°C. 
k. Remove plate from oven and allow to cool to room temperature. 
l. Dismantle solvent casting plate and remove composite SIBS/reinforcement 
sheet. 
m. Heat seal sheet into cylinder: 
i. Place one edge of the fabric (the direction of minimum elongation) 
between the Delrin heat seal mandrils. Wrap the fabric tightly around the 
mandrils ensuring that the maximum stretch is oriented circumferentially. 
 Make sure not to stretch the fabric, simply ensure that it is a tight fit. 
ii. Place the fabric on the heat sealer platform with the region to be sealed 
adjacent to the ribbon. 
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iii. Confirm the variable autotransformer is set to the correct position (an ink 
line on the transformer indicates the proper setting). Do not exceed this 
voltage or the fabric will burn. 
iv. Lower the upper portion of the heat sealer to compress the fabric against 
the wire. 
v. Press the red button on the timer control to heat-seal the fabric (set to 7 s). 
vi. Cut off excess fabric on both the outside and inside of the heat-sealed 
cylinder (note: requires inverting it). 
D. Valve Assembly 
1. Preformed Individual Leaflets: Design 1 
a. Position leaflet on placement mandril 
b. Using syringe filled with 15% SIBS in Toluene, paint area of contact on both 
the leaflet and the stent with SIBS solution. 
c. Bond leaflet to stent making sure to orient correctly 
d. Dry in oven for 15 min at 75°C. 
e. Repeat with other 2 leaflets  
i. In order to prevent leaflets bonding together, separate each with 
aluminum foil. 
f. Ensure leaflets touch as required  
g. Trim leaflet coaptation area such that slope ends halfway down flats. 
h. Thermoform leaflets closed, if necessary. 
i. Store in the labeled zip-lock bag that contained the stents 
i. Record lot numbers of leaflets and stents 
2. Cylinder Valve: Designs 2-4 
a. This procedure is used for the manufacture of all cylinder valves, including 
the leaflet cylinders produced in C.2 - C.5 attached to either the high profile 
geometry (30% styrene SIBS) or medium profile geometry (48.5% styrene 
SIBS). 
b. Preliminary attachment of the leaflet cylinder to the internal surface of the 
stent. 
i. Slide the SIBS-coated valve cylinder over the Dipping/Attachment 
mandril. Place enough fabric onto the mandrel to cover the entire height 
of the stent. 
ii. Position the stent over the fabric (top of the posts first), aligning one stent 
post with the heat-seal joint. 
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iii. Using the 15% SIBS (8.5% styrene)/toluene solution, bond the cylinder to 
the stent. 
 Place a small volume of the solution (approximately 0.1 mL) into a 
1ml syringe with a blunt 20 gage needle. 
 Dispense a thin coat of the solution on the leaflet cylinder along the 
curves of the stent base between the stent posts (but not up the edges 
of the stent posts themselves). 
 Slide the stent over the coated fabric, orienting it so that the heat-
sealed joint runs along one stent post. Leave a gap of approximately 1 
mm between the top of the posts and the exposed fabric above. 
 Dispense a thin coat of the solution along the bottom ring of the stent. 
 Dry in the oven set to 80˚C for 15 minutes. 
c. Suturing the fabric to the stent 
i. Sew the cylinder to the stent using the 5-0 Ethibond Excel green braided 
polyester suture. Start at the bottom of a post and suture in through the 
assembly and back out through the next hole up the post. 
ii. Knot the suture at the base of the stent post, on the outside of the 
assembly, using a square knot (black arrows). Do not trim the suture ends 
at this point. 
 
 
Suturing Pattern 
i. With the free end of the suture line, continue suturing all the way up the 
post by sewing in and out the stent at each successive hole (blue arrow). 
ii. Once the top hole is reached, suture up and over the post, looping around 
the top of the post and entering through the leaflet fabric (red arrow). 
 
Starting 
knot 
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iii. Suture back though the post through the top hole.  Repeat this procedure a 
second time.   
iv. Reverse the suturing direction and come back down the post through the 
same holes in the stent (blue arrow). 
v. At base of post, suture out through leaflet (green arrow) adjacent to the 
first hole along the curve. Suture in (orange arrow) through the adjacent 
hole. 
vi. Continue this pattern around the entire stent. Along the curves, stay as 
close to the stent as possible when suturing through the leaflet, but do not 
pierce the stent. Keep stitches evenly spaced and approximately 
perpendicular to the curve of the stent. 
vii. Knot off using three single overhand knots at the end by using starting 
knot/suture end. 
viii. Trim the remaining suture line (both ends) to approximately 1 mm in 
length. 
d. Replace the stent/valve cylinder assembly on the Dipping/Attachment 
mandril, and use blunt tip forceps to fold the excess fabric up onto the outside 
of the assembly. Make sure to pull the material tight so that the cylinder that 
forms the leaflets covers the outside of the stent with a single layer. 
e. Trim the excess external leaflet material to approximately 1 mm above the 
height of the leaflets. Be careful not to cut the leaflets themselves. 
f. Using the 15% SIBS (8.5% styrene)/toluene solution, bond the cylinder to the 
external portion of the stent by dispensing a thin coat of the solution along the 
contact regions (i.e., where the outer fabric layer contacts the underlying stent) 
with a syringe. It may help to create a uniform coating by dispensing a small 
amount of coating then smearing it with the syringe barrel. 
g. Dry in an oven set to 80˚C for 15 min. 
h. Use scissors to cut the excess fabric so the external cover follows the contours 
of the stent. Do not damage the inner layer of fabric with the scissors tips. Be 
very careful not to cut through both layers of fabric or to cut the sutures. 
i. Add one reinforcing suture at the top of each of the stent posts to secure the 
external fabric. Suture in top hole and out the next hole down and knot off 
with a triple overhand knot on the outside of the assembly. Trim the suture 
ends to approximately 1 mm long. 
j. Forming the Leaflets 
i. Place the assembly in the leaflet forming fixture with the stent posts 
aligned with the spaces between the forming tools and the aluminum 
leaflet forming fixtures in their grooves. Confirm the valve is well seated 
in the ring. 
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ii. Mount the compression ring over the valve. Screw the ring to slip fit over 
the valve. 
iii. Place the shim stock tools between each pair of adjacent leaflets to 
prevent the adjacent leaflets from touching. 
iv. Turn the cam to its maximum compressing point to press the leaflet 
forming fixtures into the valve leaflets. The three leaflets will come 
together to form the valve shape. Confirm symmetry and proper 
alignment. 
v. Tighten the compression ring. Confirm all parts are well seated and 
aligned. 
vi. Place in the oven set to 80˚C for 1 hour to allow the leaflets to assume 
their shape. 
k. Cut to shape so that each leaflet joins in the center of the valve and creates a 
smooth contour.  
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Appendix II – Stent Drawings 
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Figure 106.  Dimensioned drawings of low profile, high profile, and medium profile stents.  
 207
Appendix III – Durability Rating 
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Table 18.  Qualitative valve failure rating 
 
Rating Surface 
Coverage 
Holes Tears Fraying Incomplete 
coaptation 
Delamination1 Excessive 
Deformation 
Other 
Mechanical 
Breakdown 
ΔP from Vivitro 
HiCycle (mmHg)
0 none none  none  none none none none none 90 +20/-0 
1 none Pin holes none Slight fraying 
of sutures and 
edges 
Minimal amount 
that doesn’t affect 
valve function 
none none  90 +20/-0 
2 Polymer surface 
cracking and 
imperfections as 
is visible under 
the microscope 
Enlargement of 
pin holes 
Small tears 
not affecting 
valve 
function 
Increase in 
edge and 
suture fraying 
not resulting 
in change in 
function 
Possible incomplete 
closure not having a 
marked impact on 
valve function 
none none none 90 +20/-0 
3 Polymer surface 
cracking and 
imperfections 
resulting in 
exposure of 
underlying 
fabric or 
tears/holes 
Pin holes 
visible with 
stroboscope 
using leaflet 
motion 
Small tears 
visible with 
stroboscope 
Increase in 
fraying 
resulting in 
minor 
delamination 
and rough 
edges 
Noticeable decrease 
in valve coaptation.  
Insufficient closure 
postulated to  result 
in increased 
regurgitation   
At tops of stent 
posts only 
Possible 
ballooning of 
leaflets at the base 
Any other factor 
contributing to 
insufficient 
opening and/or 
closing of the 
valve 
90 +20/-0 
4 Further 
breakdown 
notably 
affecting valve 
function 
Holes visible 
to the naked 
eye 
Tears visible 
to the naked 
eye 
Fraying 
resulting in 
fracture 
One or more leaflets 
motion restricted 
causing improper 
closure 
Propagation of 
delamination 
down the posts 
Of leaflets and/or 
stent 
Resulting in 
restriction in 
function 
90 +20/-0 
5 Complete 
breakdown of 
polymer coating 
Large holes 
easily visible 
during cycling 
Large tears 
and crack 
propagation 
Complete 
fracture 
Improper coaptation 
and possible 
prolapse 
Greater than 
90% 
delaminating of 
1/more leaflets 
Preventing valve 
function 
Anything 
contributing to 
complete loss of 
function 
<<90 +20/-0 
 
                                                 
1 Extent of delamination is determined by gently tugging on each leaflet with a pair of forceps, making sure not to damager the leaflet in the process 
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Appendix IV – Photogrammetry Results
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Figure 107.  Photogrammetry image pairs corresponding to Frame 1 in Figure 66. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 108.  MatLab regeneration of fiducial points from the x, y, and z coordinated generated in 
Photomodeler® from Figure 107. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 109.  Photogrammetry image pairs corresponding to Frame 2 in Figure 66. 
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Figure 110.  MatLab regeneration of fiducial points from the x, y, and z coordinated generated in 
Photomodeler® from Figure 109. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 111.  Photogrammetry image pairs corresponding to Frame 3 in Figure 66. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 112.  MatLab regeneration of fiducial points from the x, y, and z coordinated generated in 
Photomodeler® from Figure 111. 
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Figure 113.  Photogrammetry image pairs corresponding to Frame 4 in Figure 66. 
 
 
 
 
 
 
 
 
 
 
Figure 114.  MatLab regeneration of fiducial points from the x, y, and z coordinated generated in 
Photomodeler® from Figure 113. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 115.  Photogrammetry image pairs corresponding to Frame 6 in Figure 66. 
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Figure 116.  MatLab regeneration of fiducial points from the x, y, and z coordinated generated in 
Photomodeler® from Figure 115. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 117.  Photogrammetry image pairs corresponding to Frame 8 in Figure 66. 
 
 
 
 
 
 
 
 
 
Figure 118.  MatLab regeneration of fiducial points from the x, y, and z coordinated generated in 
Photomodeler® from Figure 117. 
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